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This tool kit for Integrated Vector Management (IVM) is designed to help National and Regional 
Level programme managers, to design and run large IVM programmes.  This toolkit is an extension of 
earlier guidance and teaching material provided by the World Health Organisation (WHO).  In 
particular it complements a series of WHO guidance documents published in 2012; Handbook for 
IVM, Monitoring and Evaluation Indicators for IVM, Guidance on policy-making for IVM, and Core 
structure for training curricula on IVM.   
This Toolkit is aimed at the vector control programme manager working at the National or Regional 
level.  It provides the technical detail required in order to plan, implement and monitor and 
evaluate an IVM approach to vector control.  IVM can be utilised where the aim is control or 
elimination of VBDs and can also contribute to reducing the development of insecticide resistance.  
We link to existing guidance documents where relevant, provide guidance on where VBD are 
endemic and what interventions should be implemented, give case studies on various aspects of IVM 
and highlight key points of note throughout the document.   
In terms of diseases, this toolkit focuses on malaria, lymphatic filariasis, dengue, leishmaniasis, 
onchocerciasis, human African trypanosomiasis and schistosomiasis.  To a lesser extent it also 
includes information on other viral diseases (Rift Valley fever, West Nile fever, chikungunya, 
yellow fever) and trachoma.  Other vector-borne disease may become apparent in your particular 
country or area and vector control using an IVM approach should be adopted for these diseases as 
per national priorities.  There is a strong malaria focus in this toolkit since malaria is the most 
important VBD in sub-Saharan Africa.  The majority of experience in vector control is on malaria and 
therefore there is an opportunity for other VBD programmes to learn from these examples.   
We hope that the detail provided in this Toolkit will help programme managers design and run 
effective IVM programmes. 
The main text was prepared by Prof Steve Lindsay, Miss Anne Wilson (Durham University), Dr Nick 
Golding (Oxford University), Prof. Willem Takken (Wageningen University), Dr Marlize Coleman 
(Liverpool School of Tropical Medicine) and Prof. Steve Torr (Liverpool School of Tropical 
Medicine/Warwick University).  The authors would also like to thank the following people for their 
contributions to the IVM Toolkit either during workshops in September 2013 and April 2014 or 
during the WHO Expert Review Meeting in January 2015: 
Rabindra Abeyasinghe, Regional Office for the 
Western Pacific, Philippines 
Steven Kern, Bill & Melinda Gates Foundation, 
Seattle, USA 
Chioma Amajoh, Community Vision Initiative, 
Abuja, Nigeria 
Uriel Kitron, Emory University, Atlanta, USA 
Birkinesh Ameneshewa, WHO Country Office, 
Zimbabwe 
Immo Kleinschmidt, London School of Hygiene 
and Tropical Medicine, London, UK 
Btissam Ameur, Ministry of Health, Morocco Tessa Knox, Global Malaria Programme, 
Switzerland 
Caroline Barwa, Regional Office for the 
Eastern Mediterranean, Egypt 
Jan Kolaczinski, Global Fund to Fight AIDS, 
Tuberculosis and Malaria, Switzerland 
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Hi, I am Musa! 
I am a vector control programme manager 
at the central or regional level of a country.  
I have too much to do & have few resources 
available.  Please follow my tips if you are 




Vector borne diseases (VBD) are infectious diseases transmitted by mosquitoes, ticks, flies and bugs, 
which act as vectors of the pathogens.  VBD contribute substantially to the global burden of disease 
and disproportionately affect communities living in developing countries.  There is a high burden of 
VBD in sub-Saharan Africa (SSA) and many of these diseases are present in the same geographic 
location.  In this Toolkit we focus on the key VBD affecting populations in SSA: malaria, lymphatic 
filariasis, dengue, cutaneous leishmaniasis, visceral leishmaniasis, onchocerciasis, human African 
trypanosomiasis and schistosomiasis.  To a lesser extent we include information on other viral 
diseases (Rift Valley fever, West Nile fever, chikungunya, yellow fever) and trachoma.  Other VBD 
may become apparent in your particular country or area and vector control using an IVM approach 
should be adopted for these diseases as per national priorities. 
Integrated Vector Management (IVM) is a “rational decision-making process for the optimal use of 
resources for vector control”.  The aim of the IVM approach is to contribute to achievement of the 
global targets set for VBD control – whether these targets are control or elimination.  IVM does this 
by making vector control more efficient, cost effective, ecologically sound and sustainable.  IVM is 
characterised by evidence based decision making and collaboration both within the health sector 
and between sectors.  IVM can involve multiple tools against a single VBD or single/multiple vector 
control tools used in an integrated fashion against multiple VBD.  IVM also offers a route by which 
insecticide resistance in vector populations can be managed.    
IVM requires strong political support from central government to succeed, and in particular to foster 
intra and inter-sectoral collaboration.  An IVM Steering Committee (ISC) should be set up with broad 
participation from stakeholders including government ministries, non-governmental organisations, 
industry and community organisations. The ISC has oversight for national implementation of IVM 
and this structure should be replicated at lower administrative levels where necessary.  A vector 
control needs assessment should be carried out to describe for example the policy and institutional 
framework and resources available for vector control in the country. 
IVM is a management system which is flexible and can adapt to local conditions and change.  IVM 
should follow a cyclical process with multiple rounds of situational analysis, planning, design, 
implementation and monitoring and evaluation.  A comprehensive assessment of the disease 
situation including epidemiological and vector assessment, identification of local determinants of 
disease and stratification of areas at risk is essential to tailor the IVM programme to the situational 
context.  On the basis of this assessment, knowledge of the efficacy of vector control methods and 
other considerations such as insecticide resistance and cost effectiveness, vector control 
interventions should be selected.  Needs and resources should be mapped out and implementation 
strategies planned.  Finally, the programme should be monitored and evaluated to determine the 
effect on the disease of interest and to allow feedback on programme performance to influence 
future planning and implementation.  In subsequent periods, it may be necessary to reassess the 
local disease situation. 
VBD results from the interplay between pathogen, vector, human, animal and environmental 
determinants.  In terms of pathogen-related determinants, it is important to consider which 
pathogens are responsible for disease in your area and where the diseases are endemic.  In terms of 
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the vector, it is important to determine which vectors are present, where and when they occur, their 
behavioural characteristics and susceptibility to insecticides.  Human-related determinants which 
should be investigated include; where high risk groups live, local attitudes and practices towards 
VBDs and access to diagnosis and treatment.  Animal-related determinants are those where diseases 
of humans also infect other animals, such as human African trypanosomiasis, in which case 
abundance of reservoir hosts needs to be considered.  Environmental determinants include local 
ecosystems, land use, weather patterns and vector breeding sites. It is important to consider these 
determinants and their interaction to understand why diseases occur and point to ways in which to 
control them. 
Understanding the distribution of VBD and vectors is necessary in order to plan control efforts and 
prioritise resources.  A disease assessment should be conducted in two stages – i) broad-level 
analysis and stratification (provincial level) and ii) local-level analysis (district and below).  A broad-
level analysis consists of assessing disease endemicity maps, province-level epidemiological data and 
vector distributions.  Programmes can then classify provinces according to diseases present, their 
incidence, vector species and ecology.  A local level analysis involves assessing the micro-
epidemiology of the disease including district / community level epidemiological data, as well as 
local-level environmental and human determinants.   
A wide range of vector control tools exist; which can be broadly classified into chemical-based and 
non-chemical based tools for control of either adult or immature forms of the vector.  It is important 
to choose vector control tools on the basis of their efficacy primarily against epidemiological 
parameters (prevalence or incidence of infection/disease) although evidence of efficacy against the 
vector may be useful in some circumstances.  A number of other factors should however, be taken 
into account when choosing vector control tools since some tools may not be as efficacious or 
feasible in different environments.  These other factors include: vector characteristics, resistance 
status, human and environmental safety, affordability / cost effectiveness, human resource 
requirements, community participation / intervention acceptability and product quality / 
registration. 
Resource planning is an essential step.  An inventory should be made of the resources and 
organisational structures available for vector control.  Financial, human and technical resources need 
to be estimated.  Costing should generally be conducted at national level based on a strategic plan 
with clear terms of reference.  A number of web-based tools are available for resource planning. 
With regards to implementation, there are a number of factors which need to be considered such as 
when is the best time to implement a particular intervention, areas of implementation and entities 
involved in implementation and monitoring and evaluation.  Items to consider under areas of 
implementation include populations to be targeted, geographic areas and goals of vector control 
(i.e. control or elimination).  There needs to be strong political leadership and commitment in order 
for IVM to work.  A national intersectoral steering committee should be established to oversee the 
effective coordination of IVM activities, led by a focal person who will have overall responsibility for 
the IVM programme country wide.  This needs to be accompanied by committees or task forces at 
lower administrative levels (e.g. district) who have a more hands-on role in planning and 
implementation.  Although the main responsibility for IVM falls on the health sector, it is important 
to involve different sectors, where possible, including the community.  Responsibility for monitoring 
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and evaluation can fall to external evaluators, or the programme and should be participatory where 
possible. 
In the first instance, it is recommended to introduce interventions for which there is the strongest 
evidence of efficacy, if this has not already happened.  These interventions should be aligned with 
the local entomological and socio-behavioural parameters.  Interventions for which there is more 
limited evidence should be tested in small scale pilot studies before being rolled out at scale.  At a 
minimum this should be done in two sites, one as a control site and entomological data should be 
collected both pre- and post-intervention.  For interventions which do not have a WHO 
recommendation, robust trials with epidemiological outcomes need to be performed.  These studies 
require research expertise and so should generally be carried out with the assistance of research 
institutions. 
Vector surveillance should be conducted throughout the life of the IVM programme, although 
objectives and parameters measured will change depending on the stage of the programme.  The 
most commonly measured parameter is vector density (mature or immature forms), although other 
parameters are important, particularly insecticide susceptibility.  When setting up sentinel sites 
there are a number of factors which should be considered including disease endemicity, ecological 
zones, accessibility of the site and use of insecticides in the area.  Vector surveillance can be 
conducted by vector control staff or community involvement is possible with the right training and 
support.  Data management systems need to be set up to manage and integrate the vast quantities 
of data generated on entomology, cases surveillance, surveys and intervention coverage to allow for 
effective decision making.    
Monitoring and evaluation of the IVM programme is essential to allow programme feedback, 
measure impacts and increases accountability to stakeholders and donors.  A monitoring and 
evaluation framework should be established with clear indicators by which the programme 
implementation and success is going to be tracked and measured with clear timescales and sources 
of date for each indicator.  Indicators will be intervention/disease specific, for example number of 
long-lasting insecticidal nets (LLINs) distributed or effect on disease burden and IVM programme 
specific, for example number of staff trained in IVM.  A robust data management system needs to be 






ACT artemisinin combination therapy 
APOC African Programme for Onchocerciasis Control 
Bti Bacillus thurigensis israeliensis 
CORPs community-based resource persons  
DALYs disability adjusted life years 
DDT dichlorodiphenyltrichloroethane 
DDMS disease data management system  
DEC Diethylcarbamazine citrate 
DHS demographic and health surveillance 
DHSS demographic and health surveillance sites  
ELISA enzyme-linked immunoabsorbent assay 
FFS farmer field schools 
GIS geographical information systems 
GPS global positioning system 
HAT human African trypanosomiasis 
HEW health extension workers 
HMIS health management information system 
ICER incremental cost effectiveness ratio 
IEC Information education communication 
IPM integrated pest management 
IRM insecticide resistance management  
IRS indoor residual spraying 
ISC intersectoral steering committee  
IVCC integrated vector control consortium 
IVM integrated vector management 
ITN Insecticide treated bednet  
LSTM Liverpool School of Tropical Medicine 
MDA mass drug administration 
LF lymphatic filariasis 
LLINs long-lasting insecticidal nets 
LSM larval source management 
MICS multiple indicator cluster surveys  
MIS Malaria indicator survey 
M&E monitoring and evaluation 
MFI Khartoum malaria free initiative 
MFP Malaria focal person 
MoH Ministry of Health 
NGO non-governmental organisation 
NTD neglected tropical diseases 
OCP Onchocerciasis control programme 
OPD outpatients department 
PCR polymerase chain reaction 
PDA personal digital assistant 
PMI Presidents Malaria Initiative 
PWD public works department 
RCT randomised controlled trial 
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RDT rapid diagnosis test 
REA rapid epidemiological assessment 
SIT sterile insect technique 
SMS short message service 
TCU ten cell unit 
TWG technical working group 
VBD vector borne diseases 
VCNA Vector control needs assessment 
WHO World Health Organisation 
WHOPES World Health Organisation Pesticide Evaluation Scheme 
YLD years of life lost due to disability  







advocacy Encouraging uptake of IVM 
anthropophagic Feeds predominantly on people 
anthropophilic Attracted to people 
Breteau index Number of positive containers per 100 houses inspected 
capacity building Training experts in IVM 
case surveillance Ongoing (routine) collection of data on incidence of disease cases 
container index Percentage of water-holding containers infested with larvae or pupae 
controlled before-and-
after study 
Trial with a control group in which the outcome of interest (entomological 
or disease/infection) is measured in the intervention and control arm at 
timepoint(s) before and after the intervention is implemented. 
cross resistance Whereby resistance to one insecticide confers resistance to another 
insecticide, even when the vector has not been exposed to the latter 
insecticide  
decentralisation Political reform to reduce the extent of central influence and promote 
local autonomy 
diurnal Active during the day 
exophagic Vectors that feed outdoors 
exophilic Vectors that rest outdoors 
endophagic Vectors that feed indoors 
endophilic Vectors that enter houses 
environmental 
management 
Modification and/or manipulation of environmental factors or their 
interaction with man with a view to preventing or minimising vector 
propagation and reducing man-vector-pathogen contact. It may entail one 
of two options (or both): environmental modification (permanent 
environmental changes) and environmental manipulation (recurrent 
actions aimed at achieving temporary unfavourable conditions for 
breeding  
evaluation Assessment of a programme to determine whether activities led to 
expected results in terms of outcomes and impact 
evidence-based 
decision making 
Making decisions based on evidence, not on what has traditionally been 
done 
house index Percentage of houses infested with larvae and/or pupae 
Insecticide treated net 
(ITN) 
Bednet impregnated with an insecticide, usually not a long-lasting 
formulation so requires regular re-treatment 
intrasectoral Working within a sector, such as health 
intersectoral Working with other sectors, like the department of the environment 
Long-lasting insecticidal 
net 
Bednet which has been treated with a long-lasting insecticide formulation 
that is released over an extended period of time (usually 3 years) 
Logical framework (or 
logframe) 
A tool for improving the planning, implementation, management, 
monitoring and evaluation of projects and programmes.  It is a written 
plan listing the main elements in a project and highlighting the logical 
linkages between them. 
Meta-analysis Statistical technique used to summarise the results of several studies so 
that we can obtain an average estimate of how efficacious an intervention 
is. 
monitoring Continuous tracking of programme performance against pre-determined 
objectives and targets 
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protective efficacy Percentage reduction in disease/infection among people who have 
received an intervention.  Protective efficacy is calculated as (1 – risk 
ratio) x 100.  Here, the risk ratio is the risk of disease or infection in the 
intervention group divided by the control group.  Risk ratio can be 
substituted for rate or odds ratio in this equation. 
nocturnal Active during the night 
randomised controlled 
trial (RCT) 
a trial in which individuals or areas are randomly assigned to receive 
either the intervention or control.  This is the best experimental design 
used for determining the efficacy of an intervention. 
social mobilisation Process that raises awareness and motivates people to demand change 
towards a particular goal 
stockouts Lack of medicine or other commodities in health facilities 
stratification Classification of disease endemic areas by their epidemiological and 
ecological characteristics 
subsidiarity Decisions made at the local level 
systematic review A review of literature on a particular topic that has been conducted in a 
systematic fashion so that it is more comprehensive.  Usually involves 
searching databases of publications using defined search terms to find 
studies. 
Vector surveillance Ongoing (routine) collection of entomological data 
zoophagic Feeds predominantly on animals 




 Introduction to IVM for disease control 1
1.1 Why are vector borne diseases important? 
Vector borne diseases (VBD) are infectious diseases transmitted by mosquitoes, ticks, flies and bugs, 
which act as vectors of the pathogens.  VBD, such as malaria, dengue, leishmaniasis, lymphatic 
filariasis, schistosomiasis and human African trypanosomiasis contribute significantly to the global 
burden of disease and disproportionately affect communities living in developing countries in 
tropical and sub-tropical zones.  The most important VBD is malaria; in 2013, the World Health 
Organisation (WHO) estimates that in the African region there were 165 million cases of malaria, 
which caused approximately 562,000 malaria deaths [1] (Table 1.1)1.  Other VBD such as lymphatic 
filariasis and onchocerciasis are less deadly but still result in high levels of morbidity in sub-Saharan 
Africa (SSA) [2, 3].  Dengue fever, together with associated dengue haemorrhagic fever, is the world's 
fastest growing vector borne disease and cases are becoming more widespread in SSA [4].  As well as 
their effect on public health, VBD are a major cause of poverty and underdevelopment in many 
countries [5].   
Table 1.1: Burden of vector borne diseases in sub-Saharan Africa in 2010 [6] 
Disease Deaths (thousands) and 95% 
uncertainty interval 
DALYS (thousands) and 95% 
uncertainty interval 
Malaria 1,057,078 (767,151 - 1,455,010) 76,631,962 (53,331,245 - 107,461,725) 
Lymphatic filariasis 0 987,424 (632,562 - 1,446,703) 
Dengue 1,395 (265 – 4,010) 89,099 (16,359 - 266,309) 
Leishmaniasis 10,332 (5,712 - 17,383) 733,211 (401,599 - 1,256,985) 
Onchocerciasis 0 494,038 (358,843 - 655,985) 
Human African 
trypanosomiasis 
9,111 (954 – 28,994) 560,281 (69,068 - 1,765,404) 
Schistosomiasis 62 (0 – 363) 2,799,078 (1,450,723 – 5,279,366) 
Trachoma 0 53,131 (36,966 – 73,587) 
 
VBD are widespread throughout SSA and in many cases diseases are co-endemic, i.e. co-exist in the 
same geographic area.  Figure 1.1 indicates the geographic distribution of nine major VBD 
(falciparum and vivax malaria, lymphatic filariasis, dengue, cutaneous leishmaniasis, visceral 
leishmaniasis, onchocerciasis, human African trypanosomiasis and yellow fever).  In some areas of 
SSA all eight of these VBD are co-endemic. 
 
                                                          
1
 This WHO estimate for malaria differs from that calculated by in the Global Burden of Disease project 




Figure 1.1: The global distribution of combined infection risk from nine major vector-
borne diseases (falciparum and vivax malaria, lymphatic filariasis, dengue, 
onchocerciasis, cutaneous and visceral leishmaniasis, human African trypanosomiasis 
and yellow fever).  Areas in colour are at risk from at least one disease and the number of 
diseases posing a risk is indicated by the colour scale. 
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1.2 IVM for disease control  
Integrated Vector Management (IVM) is a “rational decision-making process for the optimal use of 
resources for vector control” [7].  The aim of the IVM approach is to contribute to achievement of 
the global targets set for vector-borne disease control or elimination, by making vector control more 
efficient, cost effective, ecologically sound and sustainable.  In essence IVM is a multi-pronged 
adaptive management approach against VBDs. 
Vector control programmes currently face a number of challenges including dwindling public sector 
human and financial resources, the threat of insecticide resistant vectors, emergence of new VBD 
and pressure to lessen the environmental impact of vector control.  IVM can help address these 
challenges.   IVM can increase effectiveness of vector control by encouraging vector control 
programmes to use more local evidence to improve the choice and targeting of vector control 
approaches, to integrate interventions where appropriate and to collaborate both within the health 
sector and with other sectors.  Rather than vector control programmes with a single disease focus 
working alone, by collaborating together duplication and overlap can be reduced and costs saved by 
making better use of existing human and financial resources.  By broadening the range of tools used 
by vector control programmes, such as environmental management, encouraging use of different 
insecticide classes to attack different life stages of the vector and monitoring the effect of 
interventions on insecticide susceptibility, IVM may be able to mitigate the threat of insecticide 
resistance.  In addition, many countries are facing the emergence of new VBD and the rise of viral 
VBD such as dengue and chikungunya.  IVM can potentially help VBD control programmes to 
increase preparedness for disease introduction or re-introduction through integrated vector and 
case surveillance.  Use of non-insecticide based control measures may also help to lessen the 
environmental repercussions of chemical vector control.    
The World Health Organisation (WHO) highlighted the five major elements of an IVM strategy as i) 
an integrated approach, ii) evidence-based decision making, iii) collaboration within the health 
sector and with other sectors, iv) advocacy, social mobilisation and legislation, and v) capacity 
building [8] (summarised in Table 1.2). 
Table 1.2: Key elements of an integrated vector management (IVM) strategy (adapted from [9]) 
 Element Description 
1 Integrated approach  Addresses several diseases using vector control tools, often 
in combination and synergistically 
 Utilises chemical and non-chemical vector control methods 
 Integrates with other disease control methods, such as drugs 
and vaccines 
2 Evidence-based decision 
making 
 Strategies and interventions are adapted to local vector 
ecology and disease epidemiology and are guided by 
operational research, surveillance and monitoring and 
evaluation. 
3 Intra- and intersectoral 
collaboration 
 Collaboration within the health sector and with other sectors 
(public and private) 
 Planning and decision-making delegated to lowest possible  
level (subsidiarity) 





relevant ministries, organisations and civil society 
 Establishment / strengthening of regulatory and legislative 
controls for public health 
 Community engagement and empowerment to increase 
sustainability 
5 Capacity building  Availability of adequately trained infrastructure, financial 
and human resources at central and local level 
 Training and education in place according to IVM curricula 
 
i) Integrated approach: 
IVM involves the use of a range of proven vector control methods used either alone or in 
combination.  IVM involves use of multiple vector control methods against a single disease or a 
single method or multiple methods against multiple diseases (Figure 1.2).  Methods can be chemical 
or non-chemical.  IVM can also supplement vaccines, mass drug administration or diagnosis and 
treatment for integrated disease control.  
IVM, in certain situations, is able to address several diseases concurrently because some vectors can 
transmit several diseases (e.g. Anopheles gambiae can transmit both malaria and lymphatic filariasis, 
LF) and some interventions are effective against several vectors (e.g. Long lasting insecticidal nets 










Figure 1.2: Schematic showing use of vector control methods for IVM 
ii) Evidence-based decision making 
Selection and implementation of vector control methods should be guided based on knowledge of 
the local vector ecology and epidemiological situation.  IVM programmes should be accompanied by 
monitoring and evaluation of the effect on both the vector and disease which serve to troubleshoot 
implementation and evaluate the impact of the programme.  In addition, operational research 
priorities should also be identified and studies conducted to inform the programme.   
Method A Method B Method A 
Disease X Disease X Disease Y 
Multiple methods 
against a single disease 







iii) Collaboration within the health sector and with other sectors 
IVM should be a collaborative effort involving cooperation both within the health sectors and with 
other sectors such as government ministries (e.g. agriculture, education, housing and public works), 
local government, community groups and non-governmental organisations (NGOs) (Figure 1.3).  
Intra- and intersectoral collaboration should be coordinated by an IVM Steering Committee (ISC) 
comprising stakeholders from different ministries, local government, industry, research/academic 




















IVM can be used as a strategy for a variety of programme goals – 
whether the goal is control or elimination 
 Intra-sectoral collaboration 
(i.e., within health sector) 









































Figure 1.3: Hypothetical example of ministries/organisations involved in intra- and intersectoral 
collaboration in IVM 
iv) Advocacy, social mobilisation and legislation 
IVM needs to be communicated effectively, promoted and integrated into policies in relevant 
ministries, organisations and civil society.  Regulatory and legislative controls for public health need 
to be established or strengthened.  Involvement and engagement of communities can help to 
increase the sustainability of IVM.   Communities need to be made aware of the risks of VBD and 
take action themselves whether this is use of preventive measures or vector control in their peri-
domestic environment. 
v) Capacity building 
IVM relies on the availability of skilled personnel at national, sub-national, district and village level 
and therefore needs to be accompanied by a capacity building programme to upgrade and maintain 
the knowledge and skills of these personnel.    
1.3 IVM over time 
IVM should be seen as a dynamic, adaptive process since the relative importance of different VBDS 
will change over time as illustrated in Figure 1.4.  For example lymphatic filariasis is maintained only 
in areas of extremely high transmission.  Long-term suppression of transmission should result in the 
elimination of lymphatic filariasis well before malaria is eliminated.  As malaria declines within a 
town or city, shrinking to the edge, dengue may be identified as the preeminent VBD.  Vector control 
 Inter-sectoral collaboration 
(i.e., between health sector 
and other sectors) 
 


















programmes move from widespread control to focal control.  Eventually as development takes place 
dengue is better controlled and mosquito abatement becomes the major theme of vector control 
agencies to reduce the biting nuisance of vectors and to provide a platform against emerging VBDs.  
Such a pathway has occurred in the southern states of the United States over the last century.  It is 
important to keep pressure on using vector control in order to prevent re-introduction of disease. 




 There is a high burden of vector borne diseases in sub-Saharan Africa and many of these 
diseases are present in the same geographic location. 
 IVM is an approach that aims to make vector control more efficient, cost effective, 
ecologically sound and sustainable. 
 IVM is characterised by evidence based decision making and collaboration both within the 
health sector and between sectors. 
 IVM can be multiple tools directed against a single disease or single/multiple tools 
implemented in an integrated fashion against multiple diseases. 
 IVM is a dynamic approach which can be adapted over time to respond to changing 
vectors and diseases.  
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 Framework for planning and implementation of IVM 2
2.1 What are the steps required in order to do IVM? 
IVM should follow a cyclical process with multiple rounds of situational analysis, planning, design, 
implementation and monitoring and evaluation (Figure 2.1).  A comprehensive assessment of the 
disease situation including epidemiological and vector assessment, identification of local 
determinants of disease and stratification of areas at risk is essential to tailor the IVM programme to 
the situational context.  On the basis of this assessment, knowledge of the efficacy of vector control 
methods and other considerations such as insecticide resistance and cost effectiveness, vector 
control interventions should be selected.  Needs and resources should be mapped out and 
implementation strategies planned.  Finally, the programme should be monitored and evaluated to 
determine the effect on the disease of interest and to allow feedback on programme performance 
to influence future planning and implementation.  In subsequent periods, it may be necessary to 




Figure 2.1: Schematic indicating steps in IVM implementation and monitoring & evaluation 
feedback loop (modified from WHO 2012[10]).  
 
2. Selection of 
vector control 
methods 
3. Needs & 
resources 
4. Implementation  
5. Monitoring & 
evaluation 
 
 KEY POINT 
Figure 1.4 is the most important in the Toolkit because it shows the 
steps required to implement IVM.  Each step is explained later in the 
Toolkit 
 KEY POINT 
Figure 1.4 is the most important in the Toolkit because it shows the 
steps required to implement IVM.  Each step is explained later in the 
Toolkit 
1. Disease(s) situation 
• Epidemiological assessment 
• Vector assessment 
• Stratification 




Figure 2.1 is the most important in the Toolkit because it shows the 




2.2 Organisational structures to support IVM 
IVM will only work if there is strong political will and support at the Government level.  Political 
commitment will only be forthcoming if a strong case is made for VBD affecting economic 
development.  Therefore, a strong advocacy case needs to be built including information on the 
burden of VBD, the health, economic, social and cultural impacts of VBD (e.g. absenteeism from 
school and employment), effectiveness of IVM, benefits of inter-sectoral collaboration, cost 
effectiveness of IVM and potential cost savings.  This is a long term strategy which needs political 
commitment in order to be sustainable as IVM will evolve over time as patterns of vectors and 
disease change. 
Senior politicians must be involved to establish and sustain a programme and ensure that 
intrasectoral, and particularly intersectoral collaboration occurs.  For this reason IVM programmes 
need to be approved by the Government and run through the Department of Health in collaboration 
with other stakeholders since the main aim is to reduce morbidity and mortality of VBDs.  
 
 
A National IVM steering committee (ISC) needs to be established consisting of senior members of 
the Ministry of Health, coordinators of disease specific programmes (e.g. malaria, neglected tropical 
diseases (NTDs), Onchocerciasis Control Programme etc.,), representatives of other Government 
ministries (e.g. Ministry of Agriculture, Education, Public works etc.,), National Regulatory 
Authorities, local government, the private sector (including manufacturers, oil and mining 
companies etc.,), academic and medical research institutions and other interested parties (e.g. non-
governmental organisations (NGOs)/civil society groups) (Figure 2.2).  Note that this is not an 
exhaustive list and the representatives on the ISC will differ depending on the country context.   
Strong advocacy from the Ministry of Health is required to get the commitment of the other line 
ministries and stakeholders – focusing on increasing the awareness of their contribution and the 
responsibilities towards VBD and VBD control.  For example, the Ministry of Trade and Finance may 
have an impact on control measures for VBD through import taxes and tariffs on insecticides and 
LLINs.  Research institutions can assist in the evaluation of vector control interventions.  
Representation from the regions on the national ISC is important to increase knowledge sharing 
between the regions and national level and gain buy-in to activities.  The ISC should be chaired by 
the Minister of Health and should meet on a regular basis.  The ISC should have defined terms of 
reference (ToR) which outline the roles and responsibilities of the members.  It is a good idea to set 
minimum terms for participation in the ISC and meetings to ensure that there are few changes in 
membership of the ISC and more continuity.  Under the ISC, technical working groups with specific 
IVM will only work if there is strong political 
commitment from the outset.  Strong messages 
advocating for integrated VBD control need to be 
relayed to the government and other 
stakeholders.   
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expertise could be set up with specific terms of reference, for example to discuss capacity-building 
or monitoring and evaluation. 
 
The work of the ISC should be guided by a high level IVM strategic plan.  The first version of the IVM 
strategic plan should be prepared by the Ministry of Health and this can then be evaluated and 
reviewed by the other stakeholders.  In this plan the following should be outlined; the roles and 
responsibilities of relevant stakeholders, situation analysis and implementation strategy, cost 
implications, sources of funding and funding structure, summary of monitoring and evaluation 
(M&E) plan and how to ensure sustainability. 
The representatives of each of the ministries/organisations sitting on the ISC are then responsible 
for taking this high level IVM strategic plan and advocating for IVM and ensuring that IVM is placed 
in the strategic plans for their own ministries/organisations.  This will help the stakeholder to 
advocate for funding and allocation of other resources (e.g. human resources or materials) to IVM.  
It may therefore be helpful to make sure the first IVM strategic plan is in place 6 months to 1 year 
before the strategic plan revision cycles of the individual ministries (usually every 5 years).  Based on 
the individual strategic plans for the ministries/organisations, each line ministry (and other 
stakeholders) should allocate monies for IVM activities.    
In small countries such as The Gambia, the ISC could be backed up by IVM Focal Persons in each 
region.  However, in large countries such as Nigeria with decentralised government then the ISC 
shown in Figure 2.2 should be replicated at regional level – with representation from line ministries 
and other organisations working at regional level.  At the regional level, the ISC should therefore also 
be comprised of representatives of the regional ministries and organisations and led by a Focal 
Person.  At district level in large countries, an IVM Focal Person should be assigned.  The IVM Focal 
Persons at regional or district level are responsible for coordination and for driving the IVM 
programme forward in their region or district.  They should work closely with the VBD control 
programmes in their area and so have a strong awareness of vector control needs.  The IVM Focal 
Persons are also responsible for identifying opportunities for inter-sectoral collaboration, bringing 
VBD control programmes together and increasing community awareness and participation in vector 
control.  At all levels but particularly at the level of the IVM Focal Person in the regions or district it is 
important to identify stakeholder in the project.   A simple stakeholder analysis tool which could be 
used by programmes to identify stakeholders as well as their interests, power and influence, 
allowing formulation of a stakeholder participation strategy can be found in Appendix 1. 
Box 2.1 outlines some key tips on governance and planning to support the IVM programme in 
Morocco. 
KEY POINT 
It is essential that a steering committee is set up to oversee the 
IVM programme. The committee should comprise members of 
the different disease control programmes, as well as 
representatives of other sectors. 
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to get IVM into strategic plan (and 
budget) of their ministry / 
organisation 
High level support 
















Box 2.1: Structures and planning for IVM – the Moroccan experience and lessons learnt
 
1. It is essential to establish a National IVM Steering Committee.  
With the support of WHO, the Ministry of Health, Morocco adopted the IVM approach in 2005, with the 
establishment of a National IVM steering committee to strengthen collaboration among relevant ministries 
and coordination between the organizational structures within the Ministry of Health. The committee is 
composed of representatives from key line ministries such as agriculture, environment, interior and health 
and an academic institution. 
2. The National IVM Steering Committee should have defined terms of reference. 
The National IVM Committee has clearly defined terms of reference which cover the study of all aspects of 
vector control; standardization of control methods; coordination of the actions of the various departments 
with the management at the national level and oversight of projects to promote the implementation of IVM. 
3. The National IVM Steering Committee needs strong leadership with expertise in and ability to advocate 
for VBD. 
The Head of Department of Vector Control, acts as the national focal point of IVM and is under the authority 
of the Chief of the Division of Environmental Health, the Presidency and the secretariat of the committee. 
4. The IVM Committee should undertake a vector control needs assessment prior to preparing an IVM 
strategic plan 
The IVM committee has conducted a situation analysis and identification of needs in 2007 and consequently 
prepared a national plan of action of IVM for the period 2008-2012.  The IVM strategy has gradually been 
implemented in several provinces, through awareness of the authorities and local authorities, decentralized 
services of the ministries concerned, local associations and the local committees of the IVM.   
5. It is beneficial to replicate the IVM Steering Committee at lower levels incorporating locally active 
stakeholders such as civil society and local government. 
IVM Steering Committees are also replicated at Regional and Provincial levels.  The functions of Provincial 
and local IVM committees are as follows: advocacy and awareness of IVM; situation analysis and needs 
assessment; planning and implementation of interventions; the appropriate selection of control methods;  
resource mobilization; monitoring and evaluation of the impact of IVM;  capacity building (training, studies, 
etc.,).  The decentralized services of the Ministries of Agriculture, Interior, Environment, Education and 
Health and the civil society are represented in these committees.  An IVM manual was developed in 2012 
and distributed to all regions and provinces to give guidance on the process to adopt IVM at the 
decentralised level.   
6. Take advantage of opportunities for advocacy in support of IVM 
The opportunity of the celebration of World Health Day 2014 themed around VBDs was taken to 
institutionalise the national, regional and provincial committees by a decision signed by several key 




2.3 Vector Control Needs Assessment (VCNA) and other needs 
assessments 
The vector control needs assessment (VCNA) process is established in many countries in sub-Saharan 
Africa (SSA) [11, 12] and there may be other needs assessments which have been carried out for 
specific diseases such as those conducted under the auspices of Roll Back Malaria.  The VCNA is 
useful in helping countries to describe the policy and institutional framework within which vector 
control decision making takes place, the institutional arrangements that support the vector control 
programme, the management procedures leading to vector control operations and the resource 
base which supports these operations.  We therefore recommend that countries undertake the 
VCNA situation analysis or revisit this process if it was conducted some time ago. 
The VCNA involves conducting a situation analysis, an assessment of bottlenecks that constrain 
implementation of vector control and a needs assessment.  The process and items which should be 
considered in a VCNA are shown in Table 2.1. 
Table 2.1: Vector control needs assessment – situation analysis and needs assessment – what 
should be considered? [11, 12] 
Situation analysis 





 General health sector policies 
Policies by VBD control programmes 







Place and structure of vector control 
Inter/intra-sectoral collaboration and coordination 
Communication and information flow 
Human resources 
Financial resources 






 VBD burden distribution and vectors 
Tools, methods, strategies and coverage 







Opportunities for Strengthening Policy for IVM  
Opportunities for strengthening institutional frameworks for IVM  
Strengthening human resources and systems for vector control  
Leadership and Governance  
Sustainable Financing for IVM  
Strengthening Information Systems for IVM  
Enhancing Implementation: Tools, technologies and logistics  
Opportunities for community mobilization  
28 
 
The situation analysis describes the policy framework, management procedures, institutional 
arrangements structures, resources and functions supporting vector control activities.  These items 
should be assessed at national, regional and district level.  The situation analysis also includes a brief 
assessment of VBD burden, distribution and vectors.  It is important to note however, that the 
sections in this toolkit on evaluating the current epidemiological situation and vector bionomics (e.g. 
ecology, insecticide resistance) go into much more detail than the VCNA and so should be referred 
to fully given the importance of this aspect for evidence-based vector control.   
Based on information collected in situation analysis, bottlenecks that constrain implementation of 
vector control and specific needs can be identified.  The needs assessment covers for example policy 
needs (to generate an enabling environment for vector control), institution building needs 
(strengthen structures for effective delivery of interventions), managerial needs (decision making 






 IVM should follow a cyclical process with multiple rounds of situational analysis, planning, 
design, implementation and monitoring and evaluation. 
 Advocacy is needed to gain strong political commitment and support for VBD control and 
IVM. 
 A National IVM Steering Committee (ISC) should be set up with oversight for national 
implementation of IVM; this structure should be replicated at lower administrative levels 
where necessary. 
 The national ISC should develop a high level strategic plan and stakeholders sitting on the 
ISC should take responsibility for getting specific activities on his plan into their own 
strategic plans and budgets. 
 The ISC should identify opportunities for inter-sectoral action in planning and 
implementation of IVM. 
 A vector control needs assessment should be carried out to describe for example the policy 
and institutional framework and resources available for vector control in the country.  
 Disease situation analysis 3
3.1 Introduction 
It is important to understand the distribution of vector borne diseases (VBDs) and vectors in order to 
plan control efforts and prioritise resources.  An epidemiological assessment requires data primarily 
showing where the VBDs are endemic.  Disease endemicity is determined by four or five factors; the 
pathogen, vector, human, environmental and in some case animal determinants, which all need to 
be considered by programme managers.  You can find more information on these determinants in 
Appendix 2.   
A flowchart which walks through the steps on how this information should be gathered and 
integrated is shown in Figure 3.1.  This flowchart splits activities into those which should be 
conducted at broad level (national and first administrative level - region) and local level (district and 
below).  A broad-level analysis is needed to stratify areas of the country according to diseases 
present and disease incidence, or risk of infection even if cases have not been reported from the 
area, vector species and ecology.  At a more local level, the micro-epidemiology of the disease, 








































































Where are vector borne 
diseases endemic or where is 
there a risk of infection? 
Investigate epidemiological data at national  
and first administrative level 
Which vectors are responsible 
for disease transmission and 
what is their ecology? 
Are there hotspots of disease 
transmission? 
 
Are there other environmental 
and human factors which 
should be considered? 
 
Develop and assess maps indicating where 
diseases are endemic or where there is a risk 
of infection 
Are there differences in disease 
incidence by geographic area? 
Assess vector distribution maps, vector 
surveillance data and ecosystems present 
Investigate epidemiological data (lower 
administrative levels – district and below) 
Community consultation to identify disease 
determinants 
Stratification – classify areas according to diseases present and their current incidence 
Assess natural features of the environment 
and land use. 
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3.2 Broad-level analysis 
 
 Step 1: Examine disease endemicity maps  3.2.1
Maps have been produced which indicate the likely geographic distribution of risk of infection with 
nine major vector borne pathogens; falciparum and vivax malaria, lymphatic filariasis (LF), cutaneous 
leishmaniasis, visceral leishmaniasis, dengue, human African trypanosomiasis (HAT), onchocerciasis 
and yellow fever  (Figure 3.2, 3.3, 3.6- 3.12).  For Plasmodium falciparum and P. vivax, malaria maps 
are available which represent more epidemiologically relevant quantities, such as the parasite rate 
or case incidence rate [13].   
For some of these diseases (falciparum and vivax malaria, LF and onchocerciasis) the maps are likely 
to be reliable since a large amount of information on sub-national disease endemicity was used to 
generate them.  For dengue and leishmaniasis the predicted extents of the maps are less certain.  
For yellow fever very little information was available and this map should therefore be considered 
only a very rough estimate of the extents of infection risk (the map is likely to overestimate the area 
at risk of infection). 
While the maps show the distribution of infection risk for each disease, it is important to note that 
diseases/infections may also be co-endemic i.e. more than one disease/infection is present in a 
particular geographic area.  Therefore, you may need to look at the maps side by side to work out 
whether populations in areas of your country are at risk of more than one infection.   
Maps of other VBDs are available.  Schistosomiasis infections cannot be accurately predicted on a 
broad scale. This is because infections are highly focal as transmission requires contamination of 
freshwater bodies by infected people urinating in water bodies or defaecating in the open, specific 
freshwater snails as intermediate hosts, and human water contact.  Maps indicating where 
schistosomiasis surveys have been done and the information on parasitological prevalence 
(presence of schistosome eggs in urine or stool samples) or blood in the urine are available for 
individual countries at http://www.thiswormyworld.org [14].  Maps illustrating the distribution of 
trachoma (active trachoma in children aged 1-9 years and trichiasis in adults) can be found at 
http://www.trachomaatlas.org [15].   
CONSIDER: 1.  Which vector borne diseases are endemic and where are cases 
occurring?  Or where is there a risk of infection?   
2.  Are some diseases or infections co-endemic, and if so, where are they 
found? 
   3.  Are there differences in disease risk by geographic area? 






Unfortunately, there is limited information on the distribution of other mosquito borne viral 
diseases such as chikungunya, Rift Valley fever, West Nile virus and O’nyong-nyong in sub-Saharan 
Africa and so we are not currently aware of any maps illustrating infection risk for these diseases.  
 
Figure 3.2: Distribution of Plasmodium falciparum malaria infection risk in Africa.  
Areas at risk (coloured green) are those predicted in 2010 to have had an annual parasite incidence 




Figure 3.3: Distribution of Plasmodium vivax malaria infection risk in Africa.  
Areas at risk (coloured green) are those predicted in 2010 to have had an annual parasite incidence 






Figure 3.4: The distribution of dominant Anopheles vectors of malaria in Africa.   
The coloured regions indicated which species are considered the most important for malaria 
transmission in that area. The distribution of these species was estimated using mosquito 
occurrence data collected between 1985 and 2009. Available at: http://www.map.ox.ac.uk/browse-








Figure 3.5: The distribution of secondary Anopheles vectors of malaria in Africa.  
The coloured regions indicated which species are considered to play a less important role in malaria 
transmission in that area. The distribution of these species was estimated using mosquito 
occurrence data collected between 1985 and 2009. Available at: http://www.map.ox.ac.uk/browse-










Figure 3.6: Distribution of lymphatic filariasis infection risk in Africa.    
Areas at risk (coloured green) are those predicted to be environmentally suitable for the disease by 
[18].  Areas in light green are predicted to be suitable, but lie in countries which are not considered 






Figure 3.7: Distribution of onchocerciasis infection risk in Africa.    
Areas at risk (coloured green) are those where control is deemed by the African Programme for 
Onchocerciasis Control (APOC) carried out between 2006 and 2013, or (in West Africa) regions of 






Figure 3.8: Distribution of dengue infection risk in Africa.  
Areas at risk (coloured green) are those predicted to be environmentally suitable for the disease by 
[22].  Areas in light green are predicted to be suitable, but lie in countries which are not considered 






Figure 3.9:   Distribution of cutaneous leishmaniasis infection risk in Africa.  Areas at risk (coloured 
green) are those predicted to be environmentally suitable for the disease by [24]. Areas in light 
green are predicted to be suitable, but lie in countries which are not considered endemic for the 




Figure 3.10: Distribution of visceral leishmaniasis infection risk in Africa.   
Areas at risk (coloured green) are those predicted to be environmentally suitable for the disease by 
[24].  Areas in light green are predicted to be suitable, but lie in countries which are not considered 






Figure 3.11: Distribution of human African trypanosomiasis infection risk in Africa.    







Figure 3.12: Distribution of yellow fever infection risk in Africa.  






 Step 2: Investigate epidemiological data (first administrative level) 3.2.2
Our maps provide a rough guide to where populations are at risk from infection with vector-borne 
pathogens at national and first administrative level.  These maps are a guide only and have several 
limitations.  Firstly, these maps show areas where populations are at risk from infection, rather than 
giving an indication of how high the incidence or prevalence of disease/infection is which is a more 
epidemiologically relevant parameter (although these maps are available for malaria [13]).  
Secondly, infection risk is not static over time and may vary over the year and between years.  
Thirdly, infection risk will vary between populations within geographic areas.  It is important for 
programme managers to consider whether the distribution of risk shown in the maps seems a 
realistic representation of their local situation.  Do the maps highlight gaps in your understanding of 
disease distributions?  Gaps in your understanding of risk should be investigated further using 
surveys or data collection.  In the absence of local data, we suggest that these maps be used to 
identify at first administrative level (regional level), diseases which could be targeted by integrated 
vector management (IVM).  However, additional epidemiological data are likely to be available in-
country and should be consulted where possible. 
Epidemiological data can come from public or private health facilities via in-country health 
management information systems, community surveys or external sources (Table 3.1).  These data, 
where available, could be used instead of or in tandem with the disease distribution maps included 
in this Toolkit.  Knowledge of the prevalence or incidence of an infection or disease will allow 
resources to be targeted efficiently to most at risk populations. 
Table 3.1: Sources of epidemiological data on VBD 
Source Disease(s) covered Resource 
Health management 
information system 
All endemic diseases 
Country / programme data Community surveys  Differs 
Rapid epidemiological 
assessment / mapping  
Onchocerciasis  




Demographic and health 
surveys (DHS) 
Malaria http://www.dhsprogram.com/ 
Malaria indicator survey (MIS) Malaria http://www.dhsprogram.com/ 
www.malariasurveys.org 
Malaria Atlas Project  Malaria http://www.map.ox.ac.uk/ 
KEY POINT 
While maps can be a good guide to infection/disease risk, they are 
not foolproof!  Always check country epidemiological data.  If the 
maps identify gaps or highlight the potential for pathogen 
transmission in areas where you have not looked previously, then 
this might suggest the need for local surveys and data collection. 
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Global Atlas of Helminth 
Infections  
Lymphatic filariasis and 
schistosomiasis 
http://www.thiswormyworld.org/ 
Global Neglected Tropical 
Diseases Database 





Sightsavers, Helen Keller 
International and Carter 
Center (trachoma and 
onchocerciasis), 









 Step 3: Assess vector distribution and ecology 3.2.3
As well as knowing where there is a risk of infection with a particular vector-borne pathogen, 
assessment of vector distributions is essential for IVM.  This is so that we can tailor the control 
programme to the individual vectors, which have different biology, ecology and behaviour and so 
may require the use of different vector control methods.         
Whilst our maps of disease risk show areas where suitable vector species are present for each 
disease, they do not identify which vector species are most important in each area.  There are 
excellent published data on geographic distributions of dominant Anopheles vectors of malaria 
(Figure 3.4 and 3.5) but less information is available for other disease vectors.  Sources of more 
information are outlined in Table 3.2.  There is currently, little information on the geographic 
distribution of snails as intermediate hosts of schistosomiasis or flies as vectors of Chlamydia 
trachomatis given their ubiquity. 
Table 3.2:  Sources of information on geographic distributions of disease vectors     
Disease Source of information on vector distribution 
Malaria and 
O’nyong-nyong virus 
Figure 3.4 and 3.5 
More detailed information on the ecology and bionomics (e.g. larval site 
characteristics, adult feeding and resting) of these species can be found in 
the paper:  Sinka et al (2010) The dominant Anopheles vectors of human 
malaria in Africa, Europe and the Middle East: occurrence data, distribution 




See Figure 3.4 and 4.5 for Anopheles vectors shared with malaria. 
Annex 1 lists primary and secondary vectors by large geographic region: in 
WHO (2013). Lymphatic filariasis: a handbook of practical entomology for 
national lymphatic filariasis elimination programmes.  [27] 
Dengue, yellow 
fever, Rift Valley 
fever and 
chikungunya 
Maps of the global distributions of the dengue vector mosquitoes Aedes 
aegypti (which also transmits yellow fever and chikungunya) and Ae. 
albopictus are given in [28], although these national level maps provide little 
spatial precision.  
Leishmaniasis A list of the dominant sandfly vectors of leishmaniasis in each endemic 
country can be found in [29]. Information on the main transmission cycles of 
the leishmaniases, the regions in which they occur and the vector species 
responsible is given in [30]. 
Human African 
trypanosomiasis 




Onchocerciasis Very little information is available on the dominant blackfly vectors 
 
In addition to published maps, programmes may have their own data on vectors collected through 
existing surveillance schemes.  Therefore, it is a good idea to check VBD control programme reports, 
as well as information collected by other entities such as veterinary services, ministry of agriculture, 
and non-governmental organisations (NGOs).     
If information on vector distributions is patchy, it may be beneficial to identify which ecosystems are 
present in your country, since this can give an indication of which vectors and diseases can be 
expected.  There are six main ecosystems (village, urban, riceland, river and estuary ecosystems, 
small-scale farming systems and plantations) which are outlined in Box 3.1 [32].  In most instances, a 
combination of ecosystems will be found, for example, in villages near rural settings, or where 
riverine systems adjoin small-scale farming.  Determining the ecosystem type in an area is not a 
shortcut to determining control interventions but can be a useful process to think through the 
disease risks and opportunities for control [33]. 
Vector distributions and ecosystems also give an indication of which types of VBD may emerge over 
time in your setting or have the potential for re-introduction if they have been eliminated.  Maps 
provided in this Toolkit which predict risk using environmental suitability (leishmaniasis, dengue and 






















Village ecosystems (Major: malaria, lymphatic filariasis, Minor: leishmaniasis, human African 
trypanosomiasis): 
Village agro-ecosystems are defined as human 
settlements comprising of 10 or more                                                                      
households that form an agriculture-based 
economic and social entity which provides 
certain facilities (e.g. school, health centre, 
farming co-operative) that benefit the 
community.  In this environment human 
settlement for the production of food creates 
numerous opportunities for disease vectors to 
thrive – primarily Anopheles spp. (malaria and 
lymphatic filariasis vectors).   
Climatic conditions in sub-Saharan Africa (SSA) are suitable for vectors at nearly all times of the 
year, although temperature in highland areas and rain may be limiting factors. 
Urban ecosystems (Major: malaria, lymphatic filariasis, dengue, chikungunya): 
SSA is experiencing rapid urbanisation.  Rapid urban growth is often accompanied by poor housing, 
overcrowding, pollution, no waste collection, lack of hygiene and sanitation, difficult access to 
water, unprotected water reservoirs, weak services, low productivity, and widespread economic 
disparity.  Urbanisation leads to changes in vector ecology and can present new risks for VBD.  For 
example, inappropriately designed latrines and open drains provide breeding sites for Culex 
quinquefasciatus, the lymphatic filariasis vector.  Market gardens for growing fruits and vegetables 
and shallow drains provide breeding sites for malaria vectors of the Anopheles spp.  Water storage 
tanks and other containers provide breeding habitats for the dengue vector Aedes aegypti.     
Riceland ecosystems (Major: malaria, Minor: lymphatic filariasis, dengue): 
Rice growing areas are found in the 
floodplains of seasonal rivers, natural 
wetland areas and man-made irrigation 
systems (e.g. Office du Niger, Mali; Vallée du 
Kou, Burkina Faso, Benue river system, 
Cameroon and Mwea irrigation system, 
Kenya).  The expansion of rice growing into 
these areas had created breeding habitats for 
malaria vectors (Anopheles gambiae s.l., An. 
funestus and An. arabiensis). 
 
 
Rice plants being removed for transplanting in fields 
near Tananarive, Madagascar (UN Photo)  
 
Corn crop, Ghana (UN Photo) 
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  River and estuary ecosystems (Major: malaria, onchocerciasis, African trypanosomiasis, Minor: 
leishmaniasis, west Nile virus, Rift Valley fever, lymphatic filariasis): 
Small, fast flowing streams are breeding 
sites for blackflies (Simulium spp.) that lay 
their eggs on plants hanging or growing in 
running water.   
Several species of riverine tsetse flies are 
strongly associated with riverine and 
lacustrine (lake) systems which provide the 
relatively high humidity required by adults 
and pupae.  Adult flies find blood meals on 
animals and humans living in or entering 
the riverine or lacustrine habitats. 
Where rivers flow into the sea, mangrove forests provide shelter and breeding sites for vectors 
adapted to brackish water conditions.  For example, the saltwater mosquitoes Anopheles melas 
(West Africa) and An. merus (East Africa) can be locally important malaria vectors.  The flood 
plains of large river such as the River Nile, Zambezi River, Congo River and Niger River) are used 
for cultivation of crops including rice, resulting in proliferation of malaria vectors.   
Small-scale farming systems (Major: malaria, lymphatic filariasis, Minor: human African 
trypanosomiasis): 
Small-scale farming systems are defined as less than 10 households that engage in farming 
activities, chiefly subsistence farming, as the chief economic activity and that do not provide 
communal services.  Poor education and lack of income prevent the improvement of living 
conditions (such as a better constructed house or installation of a water tap) and preventive 
measures are not used.  Communities are often remote and have difficult access to health 
facilities.  Subsistence farming is strongly associated with poverty and VBD, particularly malaria 
and lymphatic filariasis.  Pastoral and village cattle may be reservoirs of African trypanosomiasis, 
particularly in East Africa.   
Plantations (Major: human African trypanosomiasis, malaria): 
Commercial (plantation) agriculture often 
causes dramatic shifts in the environment, 
often replacing tropical rainforest with tea, 
coffee, oil palm, sisal, cocoa or cotton.  Many 
vectors have been able to adjust and adapt 
to these man-made environments, including 
the malaria vector Anopheles spp. that breed 
in drainage channels, pools and puddles and 
tsetse flies (Glossina spp.) which find 
sufficient shade and blood meals from 
mammals within the plantations for survival 
and efficient transmission of the  disease.  
 
Crops growing on flood plain of River Niger, Bamako, 
Mali (A. Wilson) 





 Step 4: Stratify areas according to diseases present and their current 3.2.4
incidence 
Once you have assessed the disease situation in steps 1-3, programme managers should be in a 
position to stratify (classify) disease endemic areas according to their epidemiological and ecological 
characteristics.  Hence, stratification is used to identify areas in which different approaches to 
disease control are indicated.  When a country is co-endemic for multiple VBDs, stratification 
becomes more complicated.   
This is usually done at first administrative level (region), since this is the level at which VBD 
programmes are usually organised.  Stratification of areas should be a collaborative process 
involving programme staff from the regions and other stakeholders, such as NGOs.  It is important to 
use the most current data available on disease incidence and the vector.  Stratification should be 
revisited regularly to take into account changing disease and vector patterns.   














Urban ecosystems can present new habitats for vectors and drive 
VBD.  Therefore, it is a good idea to assess population density in your 
country and identify rural and urban areas.  If you do not have this 
information to hand you can access population maps from websites 















The steps required in stratification are outlined below: 
Step 1: Assess maps and list diseases present by first administrative level (region).   
Maps indicating risk of infection or disease endemicity risk maps for Tanzania are shown.  Dengue fever, human 
African trypanosomiasis, P. falciparum malaria, onchocerciasis, lymphatic filariasis, schistosomiasis and 
trachoma (www.trachomaatlas.org) were found to be endemic.  There are areas of Tanzania that are predicted 
to be suitable for transmission of leishmaniasis, but no occurrence records were found and Tanzania is not 
considered endemic for this disease.   Maps do not indicate that yellow fever or P. vivax malaria is endemic in 
Tanzania.  
Region Disease 





Tabora x x x x x   
Rukwa x x - x x   
Morogoro x - x x x   
Lindi x - - x x   
Ruvuma x - x x x   
Mbeya x - x x x   
Make sure you use only up-to-date data on diseases present or infection risk since the disease situation is likely 
to change over time and new VBD may appear.   
Step 2: Investigate epidemiological data at first administrative level  
Possible sources of epidemiological data include country data as well as external sources such as the Malaria 
Atlas Project maps for malaria.  The disease with the highest burden should guide the IVM programme at 
the first administrative level.  Of all the VBD present in Tanzania, malaria has the highest burden.  Determine 
which areas have the highest incidence / prevalence of malaria and categorise them from highest to lowest 
for prioritisation of intervention.  The figure shows malaria prevalence in under 5s in Tanzania from the 
HMIS survey (2011-12).   
                                                                                                                                                                                                           
The same process of identifying high and low prevalence areas for prioritising intervention should be used 




    
Dengue fever     Human African trypanosomiasis 
   
P. falciparum malaria         Onchocerciasis 
   
































































Step 3: Think about what determines disease ecology 
Think about where diseases are and how this relates to factors such as population density, 
socioeconomic conditions and the environment (e.g. elevation, land use, water bodies, potential 
animal reservoirs of infection).  Many countries will already have thought about this to some 
extent, particularly with respect to eco-epidemiological types e.g. tropical Africa savannah, forest 
and forest fringes, highland and desert fringes (See Box 4.1).  
In Tanzania dengue risk is clustered in more highly populated regions, while onchocerciasis occurs 
in mountainous regions near Iringa.  Human African trypanosomiasis is correlated to some extent 
with large game parks and reserves. 
Step 4: Assess vector distribution  
Using published information or in-country data, identify which are the main disease vectors 
present. 
Step 5: Identify potential animal reservoirs 
Identify where large concentrations of cattle or wildlife are found. 
Step 6: Where evidence on disease endemicity is weak or patchy, additional surveys are 
recommended. 
For example, maps indicate the areas of Tanzania are environmentally suitable for leishmaniasis, 
although cases have not been reported from Tanzania.  It may be that leishmaniasis is actually 
present in this area and therefore it would be advisable to conduct population based surveys to 









While stratification at a regional level is useful in decision making and prioritising resources at a 
coarse scale, in many cases the main determinants of VBDs show heterogeneity at a much finer 
scale.  For example, determinants may include concentrations of human habitation, at-risk groups 
such as hunters who are active throughout the night or a major vector breeding habitat such as an 
area of irrigated rice production.  Determinants of disease therefore need to be identified and 
mapped at lower levels of administration (district and below).  You can find more information on 
these determinants in Appendix 2. 
A local-level analysis consists of two steps.  Firstly, local-level epidemiological data should be 
assessed, for example district level incidence figures from health facilities.  This can help to locate 
‘hotspots’ of disease transmission and give some clues as to risk factors for VBDs.  There is more 
information on how to identify ‘hotspots’ of transmission in order to target IVM interventions in 5.1.  
Secondly, environmental and human factors which may be influencing disease on smaller scale 
should be identified. 
 Step 1: Investigate epidemiological data (lower administrative level) 3.3.1
Regional vector control programmes should be familiar with the incidence / prevalence of disease 
within their region.  Sources of data include health management information system (HMIS) data, 
health centre records, out-patient or in-patient records from health facilities or community surveys 
(for diseases such as human African trypanosomiasis or onchocerciasis where patients often do not 
present at health facilities).  Are there differences in disease incidence / prevalence by geographic 
area or over time?  Also it is helpful to consider whether there are differences in disease incidence / 
prevalence by for example age, sex, ethnic group, occupation, community or according to whether 
people use preventive measures.  This can help identify human risk factors for disease transmission.  
If these data are not collected routinely, these types of questions could be added to hospital logs or 
survey forms.  Sudden changes in epidemiological data may be a result of changes in diagnostic 
practice or reporting and so it is important to rule this out before taking any action. 
Surveillance should be strengthened to capture data on emerging or re-introduced infections or 
diseases. 
 Step 2: Consider other environmental factors, alternate hosts and human 3.3.2
factors which may be influencing disease 
A number of environmental and human determinants can influence VBD (outlined in Appendix 2).  
Vector control programmes at provincial level should have an indication of what natural features 
there are (e.g. rivers, lakes, forests, wetlands), land use (e.g. plantations, rice or cotton agriculture) 
CONSIDER: Are there differences in disease incidence within regions?   
Are there other environmental and human factors which should be 




and the presence and distribution of alternate hosts (e.g. livestock, wild animals).  It may be helpful 
to think in terms of ecosystems present since this will give an indication of the likely disease-vector 
complexes, although within a province there may be several ecosystems.  More information on 
common ecosystems is given in Box 3.1.  Areas of economic or socio-political instability, such as 
camps for displaced people should also be a priority for VBD assessment and intervention. 
Identifying human determinants of VBD such as socio-economic conditions, population movement, 
practices and attitudes towards VBD and access to diagnosis and treatment is important.  Provincial 
level VBD control programmes should largely be aware of these determinants.  However, from time 
to time it may be useful to hold a meeting with community stakeholders such as village chiefs, 
religious leaders and community groups, particularly if there are changes in epidemiological 
parameters.   
 
 
Figure 3.13: Participatory research – generating a seasonal 
calendar (photo courtesy of S. Lindsay) 
An extension of a simple 
consultation meeting would be to 
use participatory mapping 
whereby stakeholders such as 
village chiefs, religious leaders 
and community groups help to 
map variables such as where 
people live, the patterns of their 
movements, infrastructure (e.g. 
roads, locations of markets and 
schools), vector breeding sites, 
locations of health services, land 
use, vegetation and water bodies.  
Similarly, stakeholders can help to 
generate a seasonal calendar 
including information on the 
timing of peaks of disease 
incidence, when people move 
(e.g. religious festivals) and timing 
of the main agricultural activities 
(e.g. planting, harvesting, or 
movements of livestock) (Figure 
3.13).  Participatory and temporal 
mapping can help to identify VBD 
risks and periods of increased risk 
and improve targeting of control. 
 
An added advantage of these participatory processes is that they can lead to community 
empowerment, increased understanding of disease risks and compliance with control measures.  
More examples, of community participation and its value in IVM are given in Chapter 5, including for 
example involvement of school children in malaria control in Khartoum, Sudan and Chapter 8, 








If there appears to be a ‘hotspot’ of disease, consider that this may 
be caused by failings in the current disease control system before 
considering additional methods.  For example, health centres may be 
prescribing ineffective drugs, or there may be low coverage or non-
compliance with preventive measures.    
 
CHAPTER SUMMARY 
 Understanding the distribution of diseases and vectors is necessary in order to plan control 
efforts and prioritise resources.   
 A disease assessment should be conducted in two stages – i) broad-level analysis and 
stratification (provincial level) and ii) local-level analysis (district and below). 
 A broad-level analysis consists of assessing disease endemicity maps, province-level 
epidemiological data and vector distributions.  Programmes can then classify provinces 
according to diseases present, their incidence, vector species and ecology.   
 A local level analysis involves assessing the micro-epidemiology of the disease including 
district / community level epidemiological data, as well as local-level environmental and 
human determinants.   
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 Selection of vector control methods  4
 
 
4.1 What factors need to be considered when selecting vector control 
tools? 
The main factor when deciding on vector control tools is the effectiveness of the tool in reducing 
disease or infection.  However, other factors which need to be considered include vector 
characteristics (including insecticide resistance), human and environmental safety, affordability/cost 
effectiveness, acceptability and community participation and logistics/policy support for the 












3. Selection of 
vector control 
methods 
4. Needs & 
resources 
5. Implementation  
6. Monitoring & 
evaluation 
1. Disease situation 
• Epidemiological assessment 
• Vector assessment 
• Stratification 




   Efficacy or effectiveness  
   Vector characteristics including insecticide resistance  
   Human and environmental safety  
   Affordability / cost effectiveness 
   Acceptability and community participation 
   Implementation / delivery of the intervention 
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 Efficacy of vector control tools against VBD 4.1.1
A wide range of vector control tools exist; which can be broadly classified into chemical-based and 
non-chemical based tools for control of either adult or immature forms of the vector.  This chapter 
provides guidance on what vector control interventions should be implemented.  Previous guidance 
on vector control has not included detail on tool efficacy and assumes that all tools are equally 
effective, which is not the case.  In many situations we lack the evidence that some vector control 
tools in common use today are actually effective.  In this Toolkit we only recommend vector control 
tools that have been shown to be effective because one of the central tenets of IVM is to make 
evidence-based decisions.  In assessing the efficacy of vector control tools for each disease we draw 
on evidence from systematic reviews and meta-analyses, as well as individual studies such as 
randomised controlled trials (RCTs) and programme data.   It is realised that there are some 
interesting developments on novel vector control tools but these are still experimental and 
therefore are not included in this Toolkit.   
It is important to choose vector control tools on the basis of their efficacy against epidemiological 
parameters (prevalence or incidence of infection/disease), where possible.  Evidence of efficacy 
against the vector may be useful in some circumstances but this does not always correlate with 
impact on disease and so should be viewed more cautiously.   
In the following sections we have separated vector control tools into three levels: 
1) Tools with a WHO recommendation for which there is strong evidence of their efficacy. 
2) Tools with some evidence to recommend their use or evidence to recommend their use in certain 
settings or populations. 
3) Tools for which there is currently insufficient evidence to recommend their use. 
 Efficacy of vector control tools against malaria 4.1.2
Tools with a WHO 
recommendation 
Tools with some evidence / or 
evidence to recommend their 
use in certain settings or 
populations 
Tools for which there is 
currently insufficient evidence 
to recommend their use 
Long-lasting insecticidal nets 
(LLINs) [34, 35] 
House improvement / 
screening 
Larvivorous fish 
Indoor residual spraying (IRS) 
[36] 
Insecticide-treated sheeting / 
tents / wall linings 
Spatial repellents 
Larval source management 
(LSM) (supplementary tool) [37] 




4.1.2.1 WHO recommended vector control tools against malaria 
The main vector control tools effective against malaria and recommended by the WHO are long-
lasting insecticidal nets (LLINs) [34, 35] and indoor residual spraying (IRS) [36], which are similarly 
effective.  Larval source management (LSM) (Box 4.1) is recommended by the WHO as a 
supplementary malaria vector control methods in some specific locations where breeding sites are 
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‘few, fixed and findable’ [37].  LLINs and IRS are effective against indoor biting and resting Anopheles 
mosquitoes.  LSM will serve to reduce densities of mosquitoes indoors and outdoors.  There are no 
other recommended interventions for outdoor biting mosquitoes, except for LSM – this is an active 
area of research.   
Box 4.1: What is larval source management (LSM)? (Adapted from [38]) 
 
 
Figure 4.1: Larviciding of Anopheles breeding sites in The Gambia (photo courtesy of S. Lindsay) 
Larval source management encompasses any of the below interventions: 
 Habitat modification - a permanent change of land and water. It includes landscaping; 
drainage of surface water; land reclamation and filling; coverage of large water storage 
containers (for example, wells) with mosquito-proof lids and permanent slabs, building 
covered areas for potential breeding sites (for example, shelters for tyres) or complete 
coverage of water surfaces with a material that is impenetrable to mosquitoes (for 
example, expanded polystyrene beads. 
 Habitat manipulation - a recurrent activity and includes water-level manipulation, flushing 
of streams, drain clearance, shading, proper disposal of garbage, regular emptying and 
cleaning of domestic containers (e.g. flower pots, animal drinking water troughs), or 
exposing habitats to the sun depending on the ecology of the vector.  
 Larviciding - regular application of microbial or chemical insecticides to larval habitats to 
control mosquitoes (Figure 4.1). 
 Biological control - introduction of natural enemies of mosquitoes into aquatic habitats 
e.g. predatory fish or invertebrates, parasites, or other disease-causing organisms. 




4.1.2.2 Recommendation on combined use of LLINs and IRS for malaria control 
The WHO recently released a position statement on combined use of LLINs and IRS [39].  Several 
studies have been conducted looking at whether IRS confers an additional benefit on top of LLINs.  A 
cluster-randomised trial in The Gambia reported no significant benefit of LLINs and IRS in 
comparison to LLINs alone [40].  However, a study in Tanzania did show additional benefit of LLINs 
and IRS although the LLIN usage in this study was much lower (between 36% and 53%) [41].  The 
overall conclusion is that in areas with high LLIN coverage and where LLINs remain effective, IRS may 
have limited utility in reducing malaria morbidity and mortality [39].  However, as part of a 
resistance management strategy there may be benefit in implementing both interventions together, 
but only if a different (i.e. non-pyrethroid) insecticide is used for IRS [39, 42].  Programmes should 
prioritize delivering either LLINs or IRS at high coverage and to a high standard rather than 
introducing the second intervention as a means of compensating for deficiencies in the 
implementation of the first [39]. 
4.1.2.3 Vector control tools with some evidence to recommend their use for malaria / or 
in specific settings/populations 
A large number of studies have shown that improved housing such as closing eaves, ceilings and 
installing screening on doors and windows can reduce mosquito numbers in the home and malaria 
[43].  A RCT in The Gambia found lower mosquito densities and lower prevalence of anaemia among 
inhabitants of screened homes compared to control homes; with fully screened homes (screened 
windows and doors and closed eaves) performing better than partially screened homes (installation 
of screened ceilings only) [44].   
Insecticide-treated plastic sheeting may have benefit in temporary settlements such as refugee 
camps.  A RCT conducted in refugee camps in Sierra Leone found a 61% protective efficacy against 
malaria of deltamethrin-treated plastic sheeting attached to the walls and ceilings of temporary 
shelters compared to untreated sheeting [45].  A controlled before-and-after study which compared 
insecticide-treated plastic sheeting versus untreated plastic sheeting for construction of temporary 
labour camps in India showed a 96% (95% CI: 70% - 99%) reduction in malaria incidence [46].  
Insecticide-treated plastic sheeting should be applied to both walls and ceilings of these shelters for 
maximum effect.  Insecticide-treated plastic sheeting has also shown some benefit when used as 
wall linings in houses.  An RCT in India reported a 71% (95% CI: 47% - 84%) reduction in malaria 
incidence in a village in which deltamethrin-treated plastic wall and ceiling linings were installed 
compared to a village not using these plastic linings [47].   
Studies of insecticide-treated clothing, shawls and bedsheets have also shown promise in preventing 
malaria.  A study in Kenya reported a 81% reduction in malaria cases in the group using permethrin-
impregnated shawls (shukas) compared to the control group [48].  An RCT assessing the use of 
permethrin-treated clothing and bedding among refugees in Kenya found a 69% reduction in clinical 
malaria [49].  Insecticide treated clothing or sheets are advantageous over topical repellents in that 
their use may be more consistent although re-treatment with insecticides will be required at regular 
intervals. 
4.1.2.4 Vector control tools with currently insufficient evidence to recommend their use 
for malaria  
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Fish are able to reduce mosquito larval densities in breeding sites [50].  However, a systematic 
review of larvivorous fish as an intervention against malaria found no convincing evidence that fish 
suppress larval populations to an extent whereby they reduce malaria in the local human population 
[51].   
Spatial repellents such as mosquito coils are commonly purchased by households to reduce 
mosquito nuisance.  Although many studies have shown beneficial effects of mosquito coils on 
mortality, deterrence, repellency and feeding inhibition in both laboratory and semi-field 
environments, evidence against clinical outcomes is weak.  Further research on new forms of spatial 
repellents, such as passive emanators is being conducted. 
A meta-analysis of the efficacy of personal repellents against malaria did not show any effect against 
either Plasmodium falciparum malaria (PE 18%, between -8% and 38%) or P. vivax malaria (PE 20%, 
between     -37% and 53%) [52].  Given the limited evidence we do not recommend the routine use 
of personal repellents against malaria in endemic populations, although they can help reduce biting 







 Efficacy of vector control tools against lymphatic filariasis 4.1.3
Tools with a WHO 
recommendation 
Tools with some evidence / or 
evidence to recommend their 
use in certain settings or 
populations 
Tools for which there is 
currently insufficient evidence 
to recommend their use 
(Preventive chemotherapy* 
[53]) 
LLINs (anophelines) LLINs (culicines) 
 IRS (anophelines) IRS (culicines) 
 House improvement / 
screening (anophelines) 
 
 LSM (culicines)  
*except where Loa Loa is co-endemic 
 
KEY POINT 
The key vector control interventions we recommend for control of 
malaria are LLINs and/or IRS.  The selection of these should be based 
on local epidemiology and the insecticide resistance profile.  LSM can 
be a useful supplement to core interventions but its use is only 
recommended in some specific locations where breeding sites are 
‘few, fixed and findable’. 
Other interventions to consider as part of an integrated strategy or in 
specific settings/populations are housing improvements such as 
screening, insecticide-treated walling lining and plastic sheeting for 




4.1.3.1 Vector control tools with some evidence to recommend their use for lymphatic 
filariasis / or in specific settings/populations 
The primary intervention against lymphatic filariasis (LF) is preventive chemotherapy (Mass drug 
administration, MDA) with either ivermectin or diethylcarbamazine citrate (DEC) in combination 
with albendazole [53].  However, the role of vector control is increasingly recognised as part of an 
integrated strategy and is the only method possible in areas where Loa Loa is endemic [54, 55].  
Combining MDA and vector control has several advantages including supressing transmission 
without the need to identify all foci of infection and minimising the risk of re-establishment of 
transmission from positive individuals [55].      
Since malaria and LF share the same Anopheles vector in rural areas, we would expect LLINs to be 
effective against both diseases.  To our knowledge, no RCTs have addressed this question.  However, 
observational studies in Papua New Guinea and Nigeria have shown a beneficial effect of insecticide-
treated nets (ITNs) on LF transmission where the disease is transmitted by Anopheles mosquitoes 
[56-59] and LLINs may be particularly useful in areas co-endemic for LF and Loa Loa where MDA with 
ivermectin is contraindicated due to serious adverse events [60].   
House spraying with residual DDT alone led to interruption of transmission of LF by Anopheles 
mosquitoes in the Solomon Islands [61] and Indonesia [62].  In both of these cases, use of DDT IRS 
and elimination of LF was a by-product of the malaria control programme.  Although this evidence is 
convincing, few other studies have been conducted and the efficacy of other residual insecticides 
has not been rigorously tested.  In addition, given the long lifespan of the adult filarial worms 
(estimated to be between 4 and 10 years), IRS would need to be implemented consistently for an 
extended period (as in the study in the Solomon Islands) which may not be feasible in some settings.     
LSM, whether this is microbial larvicide, environmental management or polystyrene beads has also 
been shown to be effective against culicine vectors of LF.  These interventions are well adapted to 
target the breeding sites of Culex vectors which predominate in urban and semi-urban 
environments.  Treatment of enclosed water bodies such as latrines with a floating layer of 
expanded polystyrene beads can prevent mosquito breeding for extended periods [63-65] (Figure 
4.2).   
Treatment of open breeding sites (e.g. drains) with insecticides such microbial larvicides (e.g. Bacillus 
thuringiensis israelensis (Bti) and Bacillus sphaericus) [66-70] or insect growth regulators (e.g. 
pyriproxyfen) [71] has also been shown to reduce mosquito breeding.  Importantly, several studies 
have shown the additional benefits of LSM in addition to MDA on microfilarial infections.  In 
Makunduchi, a town in Zanzibar, Tanzania a single MDA with DEC combined with treatment of pit 
latrines with polystyrene beads was followed by a progressive decline in the microfilarial rate from 
49% to 3% [72].  The added contribution of vector control to this decline in microfilarial rate was 
shown by comparison with another town where only MDA was implemented and where infection 
resurged 3-6 years after the MDA campaign.  In this campaign, biting nuisance was also reduced 
which greatly increased public appreciation of the programme [73].  Several studies from India have 
also shown beneficial effects of multiple LSM strategies (e.g. larviciding, polystyrene beads and fish) 





Figure 4.2: Treatment of latrines with expanded polystyrene beads (courtesy of J. Ensink) 
Given that house improvement such as closing the eaves and installing screening is able to reduce 
house entry of Anopheles mosquitoes [43], we would also expect this intervention to be effective 
against LF in rural areas. 
4.1.3.2 Vector control tools with currently insufficient evidence to recommend their use 
for lymphatic filariasis  
LLINs and IRS are less effective against culicine vectors of LF because Culex mosquitoes are more 
robust vectors that are less susceptible to insecticides than Anopheles [77-79].  For example, a study 
by Bøgh et al. reported that ITNs reduced indoor resting density of Cx. quinquefasciatus by 16% 
compared to a 98% reduction in Anopheles species [80].  A study in India did not show any effect of 
bendiocarb IRS on the density of Cx. quinquefasciatus [81].  To the best of our knowledge, no studies 
have assessed the efficacy of LLINs or IRS against clinical parameters of LF transmitted by culicines 
and therefore there is insufficient evidence to recommend these interventions.  Insecticide 
resistance in culicine mosquitoes has also been reported in some countries such as Zanzibar which 
may limit the utility of LLINs and IRS should vector control be implemented as part of an elimination 





In combination with MDA, we recommend the following vector 
control interventions for lymphatic filariasis: 
- LLINs (and possibly also IRS where there is a commitment to 
implement repeatedly for an extended time period) where 
anophelines are responsible for transmission 
- LSM where culicines are responsible for transmission. 
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 Efficacy of vector control tools against dengue  4.1.4
Tools with a WHO recommendation Tools with some 
evidence / or evidence 
to recommend their use  
Tools for which there is 
currently insufficient evidence 
to recommend their use 
SUSTAINED MANAGEMENT 
Indoor spraying (preferably with 
residual insecticides) 
 Aerial and truck mounted ULV 
space spraying 
Perifocal spraying e.g. tyres with 
residual insecticides 
  
Container removal    
Water container covers   
Container larviciding (insecticides or 
biologicals) 
  
Social mobilisation campaigns 
(education / public relations) 
  
Legislation (enforcement and 
incentives) 
  
Environmental management    




Indoor ULV space spraying  Aerial and truck mounted ULV 
space spraying 
IRS  Topical repellents 
LLINs, insecticide treated 
curtains/screening 
  
Legislation (e.g. granting immediate 
access to premises) 
  
 
Vector control tools for dengue can be split into those used for sustained management of vectors 
and those used for epidemic mitigation, when an outbreak has occurred and the aim is to prevent 
more dengue cases [83].  Unfortunately, the evidence base on vector control is hampered by a lack 
of methodologically strong studies able to attribute declines in cases/vector populations to vector 
control interventions used and studies with entomological endpoints (especially those that do not 
correlate well with adult density), rather than epidemiological endpoints.  Vector control tools for 
dengue recommended in this section are based on a critical assessment carried out by dengue 
experts as part of the Partnership for Dengue Control Initiative [83] (www.controldengue.org/) 
based on WHO –recommended tools [84].  The critical assessment concluded that the experts were 
not able to recommend a specific intervention because of the limitations of the data, in particular 
the absence of data showing a clear positive health impact.  It should also be noted that there is no 
or little evidence available on dengue interventions which have been tested in Africa and therefore it 
is important to learn lessons from other countries and continents where there is a large amount of 
experience on dengue control. 
4.1.4.1 WHO recommended vector control tools against dengue  
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4.1.4.1.1 Sustained management 
IRS for sustained management of dengue vectors has only been conducted on a few occasions.  
However, studies in Cairns in Australia show that IRS is able to reduce adult female density [85] and 
can reduce dengue virus (DENV) transmission risk when used appropriately [86].   
Perifocal spraying of containers using residual insecticides for control of larvae and adult resting 
mosquitoes has been shown to be successful in two Aedes aegypti eradication programmes from the 
Australian Northern Territories in the 2000’s [87]. 
Environmental management methods such as container removal or washing, bleaching containers, 
or covering containers with lids, usually done in combination and with community mobilisation and 
participation for increased sustainability have been shown to reduce entomological parameters in 
the large number of studies  [88-93].  More recently, studies in Latin America have shown beneficial 
effects of insecticide-treated net covers for containers (in combination with insecticide-treated 
curtains) on larval and pupal demographic indices [94, 95].   
 
Treatment of containers using chemical (e.g. temephos) or microbial (e.g. Bti) larvicides has been 
shown to reduce entomological parameters in a number of studies [96-98].  A systematic review [99] 
identified one study in Cambodia which reported a 53% protective efficacy (95% CI: 50-55%) of 
water treatment with temephos against dengue incidence [100].  A systematic review of the 
effectiveness of Bti when used as a single agent for the control of dengue vectors [101] identified 
fourteen studies, of which twelve reported reductions in entomological indices with an average 
duration of control of 2-4 weeks.  The review identified one study which looked at dengue incidence 
which reported a single dengue case in the Bti area compared to 15 cases in the untreated area 
when an outbreak occurred [102].  More recently, a study of targeted treatment of productive 
breeding sites with spinosad and long-lasting insecticidal net screens showed lower adult and pupal-
based vector indices compared to control (no intervention) [103]. 
Studies show that larval predators e.g. lavivorous fish, copepods, insects are able to reduce Ae. 
aegypti larval indices, although whether this translates into an effect on adults or dengue incidence 
is unclear.  A meta-analysis of nine biological control studies resulted in an average reduction in 
container index of 82% (95% CI: 56 – 93%) [99].   
As mentioned, community mobilisation and participation in dengue control is crucial given that 
many of the breeding sites are local to households and tied in with daily activities and that 
sustainability of efforts is key to long term Ae. aegypti vector management strategies.  A number of 
studies have shown beneficial effects of community-based dengue control e.g. education campaigns, 
social mobilisation [90, 104-106]. 
Use of legislation as a component of sustained mitigation programmes was considered to be 
effective by the expert panel [83].  Legislation for dengue control can include holding citizens and 
local government directly responsible for failing to deal with breeding sites around the home or 
making local authorities responsible for maintaining drains, water courses or swamps and canals 
within their administrative limits, and in particular imposing penalties if they don’t comply.  
Legislation has been used to good effect for dengue control in Singapore [107] and similar legislation 
has been promulgated in other areas, including for example Sindh Province, Pakistan and Sri Lanka.   
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A systematic review suggests that LLINs, insecticide-treated curtains and screening may be effective 
against dengue [108] with several studies reporting reductions in entomological parameters[94, 109-
111] and one study reporting a high protective efficacy of  insecticide-treated screening against IgM 
seropositivity [112, 113].  These interventions are most likely to be in place for sustained 
management but could also be rolled out for epidemic control.  Studies suggest that high coverage 
of insecticide-treated interventions in the home (~70%) are required to generate a community-level 
effect against dengue vectors [111].   
A review looking at the efficacy of biological methods, chemical methods, environmental 
management or a combination of these methods found that combinations are most effective [99].  
In conclusion, a package of vector control interventions against dengue is advised, ideally combining 
chemical and environmental methods or biological and environmental methods.  In addition, 
methods should ideally target both the immature and adult stages of the vector.   
4.1.4.1.2 Epidemic control 
Indoor ultra-low volume (ULV) insecticide application usually administered using portable handheld 
or backpack sprayers has been shown to reduce the number of dengue cases in Iquitos, Peru if 
applied early in the epidemic transmission season [114].  IRS has also been used successfully for 
epidemic control in Brazil and Hawaii [86, 115].  Implementing interventions in the household can be 
operationally difficult during outbreaks, particularly in large settlements, where it may be difficult to 
gain access to sufficient houses to achieve high intervention coverage in a short period of time [83].  
4.1.4.2 Vector control tools with currently insufficient evidence to recommend their use 
for dengue  
The expert group recommends the use of topical repellents, alongside IRS for epidemic control [83].  
However, to the best of our knowledge there are no studies of topical repellent for dengue control 
with epidemiological outcomes and evidence from a systematic review on malaria suggests that 
topical repellents will not be effective against disease outcomes [52].   
The expert review does not recommend the use of aerial or truck mounted ULV since this has no 
sustained impact on mosquito populations and is not cost effective for routine delivery during 
outbreaks [83, 116, 117].  Use of aerial or truck mounted ULV is often politically motivated as they 
are highly visible interventions.  However, the killing effect is transient and mosquito populations 
can recover rapidly and efficacy is variable because droplets may not penetrate inside houses to 
where Ae. aegypti are resting [118, 119], especially if householders don’t comply with requests to 




For dengue vector control we recommend using a combination of 
vector control methods.   
Ideally these methods should span 2 or more categories (chemical, 
biological or environmental) and should target both immature and 
adult vectors.     
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 Efficacy of vector control tools against cutaneous and visceral 4.1.5
leishmaniasis 
Tools with a WHO 
recommendation 
Tools with some evidence to 
recommend their use  
Tools for which there is 
currently insufficient evidence 
to recommend their use 
IRS (where vectors bite or rest 
indoors) 
Environmental modification  
LLINs / insecticide-treated 
curtains or screening (where 
vectors bite or rest indoors) 
  
Reservoir management 
(zoonotic and sylvatic cycles) 
  
 
4.1.5.1 WHO recommended vector control tools against cutaneous and visceral 
leishmaniasis 
The efficacy of vector control tools against leishmaniasis depends on the parasite, vector and 
transmission cycle.  However, in general we can say that if the sandfly vector is biting or resting 
indoors, then LLINs or IRS will be effective interventions against cutaneous or visceral leishmaniasis.  
For example, even vectors with a sylvatic cycle, may be feeding or resting indoors, especially if 
habitat change or increased human activity or urbanisation in sylvatic fringe areas has encouraged 
domestication of vectors.  If feeding or resting is occurring away from the home then other 
strategies need to be considered.  It is therefore hugely important to have a sound grasp of sandfly 
biology and human behaviour in a particular setting before planning specific intervention strategies.    
 
A systematic review [108] identified three studies assessing the efficacy of LLINs or ITNs against 
cutaneous leishmaniasis transmitted by Phlebotomus papatasi or P. sergenti which reported high 
protective efficacies against cutaneous leishmaniasis ranging from 50% to 98% [121-123].  A study of 
LLINs against visceral leishmaniasis did not show a significant effect on incident Leishmania donovani 
infections or incident cases of visceral leishmaniasis in India and Nepal [124].  However, transmission 
was likely occurring outside the home where LLINs would not be able to prevent sandfly-human 
contact.  Insecticide treatment of nets provides better protection than untreated nets [125], 
although the mesh size of nets should be considered since nets designed to be cooler which have 
large holes are more likely to let sandflies though, even if they are insecticide treated [126, 127].  
Other insecticide-treated materials such as insecticide-treated curtains or screening have also been 
shown to reduce vector density within the home [128-130], although evidence of their efficacy 
against clinical disease is less strong than for LLINs [129, 131].   
KEY POINT 
It is important to have a sound grasp of sandfly biology and human 
behaviour in a particular setting in order to understand where 
transmission is occurring or where vectors rest before planning 
specific intervention strategies.    
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IRS is also highly effective against cutaneous and visceral leishmaniasis where vectors come indoors.  
For example, RCTs reported protective efficacies of 54% (95% CI: 3-78%) in Peru [132] and 47% (95% 
CI: 32-59%) in Afghanistan against cutaneous leishmaniasis [123].  A number of other studies and 
programmatic evidence from a DDT IRS anti-malaria campaign in Peru which reported drastic 
reductions in transmission of cutaneous leishmaniasis also supports these findings [133-135].  
Similarly, there is good programmatic evidence from India to suggest that IRS is effective against 
visceral leishmaniasis with reductions in visceral leishmaniasis cases during DDT campaigns 
introduced for malaria control [136-138].  For peridomestic species, outer walls and animal 
accommodations should also be sprayed with IRS, as well as inside houses. 
Leishmaniasis transmission can also be zoonotic, with wild animals (sylvatic zoonosis) or domestic 
animals (domestic zoonosis) acting as reservoir hosts.  In some cases, reservoir control is 
recommended, alongside or to replace vector control measures.  Table 4.1 outlines some of the 
major parasite transmission systems operating in SSA and provides guidance on potential reservoir 
and vector control methods (more detail in [29]).  Where studies have been identified on these 
reservoir and vector control measures, these are cited in the table.  Some of the WHO 
recommended methods have little or no evidence to support their use, although small-scale studies 
could be conducted to verify their efficacy in your setting. 
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Table 4.1: Zoonotic and sylvatic transmission cycles operating in SSA and guidance on potential reservoir and vector control methods [29]   





donovani and L. 
infantum 
Eritrea, Ethiopia (Metema-Humera in the 
northwestern lowlands; Libo Kemkem and 
Fogera districts in Amhara regional State and 
north of Lake Turkana; in the south, the Segen 
and Woito valleys, the Genale and Gelana 
river basins and west Moyale at the border 
with Kenya), Djibouti, Kenya (Machacos, Kitui, 
West Pokot, Masinga, Meru, Baringo, 
Turkana), Somalia, the Sudan (North: Gadaref, 
Blue Nile, White Nile, Sinnar, South Kordofan 
and West Darfur states; South: Upper Nile, 
Jonglei, Unity States, Eastern Equatoria) and 
Uganda (northeastern focus: Pokot 
Department)  
L. donovani mainly 
anthroponotic. 
 
Foci of zoonotic 
transmission related to L. 
infantum with domestic 

















L. infantum Algeria, Chad, Central African Republic, Egypt, 
Gambia, Libyan Arab Jamahiriya, 
Mauritania, Morocco, Senegal and Tunisia  
Domestic dogs and wild 
canines (foxes, jackals, 
wolves). 
Management of 
domestic and feral 
dog populations 
through treatment 






may have some 
benefit [141]. 
 






L. tropica Algeria, Egypt, Ethiopia, Israel, Jordan, Kenya, 
Libyan Arab Jamahiriya, Morocco, Namibia, 
and Tunisia  
Suspected to be zoonotic. 
Hyraxes are among 







L. major Algeria, Burkina Faso, Cameroon, Chad, Egypt, 
Ethiopia, Gambia, Ghana, Guinea, Guinea 
Four main transmission 
systems: R. opimus (great 
Studies of poisoned 









Bissau, Kenya, Kuwait, the Libyan Arab 
Jamahiriya, Mali, Mauritania, Morocco, Niger, 
Nigeria, Senegal, the Sudan and Tunisia 
gerbil) and P. papatasi; 
Psammomys spp. (fat 
sand rats) and P. 
papatasi; Meriones spp. 
(jirds) and P. papatasi or 
P. salehi; and Arvicanthis, 
Tatera or Mastomys spp. 
and P. duboscqi or P. 
papatasi. 
rodent have been 
shown in a number 
of studies to reduce 
cases of zoonotic CL 
[142-144].  Deep 
ploughing or other 
mechanical 
destruction of 
rodent habitats has 
been tested in a 
number of countries 
(e.g. [145]) but is 






L. aethiopica East Africa Highlands: Ethiopia, Kenya, 
Uganda 
Stable foci of low 
endemicity are 
maintained by hyraxes 
(Procavia, Heterohyrax 
and Dendrohyrax spp.), 
and the parasite (L. 
aethiopica) is transmitted 




hyraxes close to 
settlements  




4.1.5.2 Tools with some evidence to recommend their use against cutaneous and 
visceral leishmaniasis  
Environmental modification through cleaning and clearing of rubbish from around houses, streets 
and vacant land, covering cracks and crevices in walls of buildings with plaster, asphalting streets 
and covering courtyards with bricks, cement or other materials may be effective to prevent sandfly 
breeding.  Studies have shown that plastering of walls and cracks with lime or mud is able to reduce 
the density of visceral leishmaniasis vectors in the home but epidemiological data was not collected 
[146, 147].  Environmental modification may not be effective as a standalone intervention but 
should be considered as part of a long term strategy if sustainability can be achieved. 
 
 
 Efficacy of vector control tools against human African trypanosomiasis 4.1.6
Tools with a WHO 
recommendation 
Tools with some evidence / or 
evidence to recommend their 
use in certain settings or 
populations 
Tools for which there is 
currently insufficient evidence 
to recommend their use 
Traps and targets (insecticide-
treated) 
Insecticide-treated cattle   
 Aerial spraying  
 Sterile insect technique  
 
Control of human African trypanosomiasis (HAT) relies on reduction of the parasite reservoir (human 
and/or animal) and/or vector control.   Case detection and treatment has played a major role in 
efforts against Gambian HAT [148].  Vector control can contribute towards control of Gambian HAT 
and can play an especially important role against Rhodesian HAT which is a zoonosis.  Various tools 
are available, including traps and targets that attract host-seeking tsetse flies, insecticide-treated 
cattle, aerial spraying of tsetse habitat and the sterile insect technique (SIT).  
4.1.6.1 WHO recommended vector control tools against human African trypanosomiasis 
Traps and targets (insecticide-impregnated screens) are highly effective against tsetse flies [149].  
They function by simulating hosts and attract tsetse flies to the device with odorant cues and/or 
visual cues such as size, shape and colour.  While traps can be used for surveillance and control, 
targets are used only for control.  Impregnation of the targets or traps with an insecticide makes 
them highly effective killing devices upon fly impact.  Various designs of trap and target have been 
developed for use against particular target species in particular environments (more detail in: [148].  
KEY POINT 
If sandfly vectors bite or rest indoors, then LLINs and IRS should be 
effective interventions against cutaneous or visceral leishmaniasis.  
Reservoir control methods should be considered if the parasite is 
maintained in domestic or wild hosts.     
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For example, the use of biconical tsetse traps was highly effective in Uganda [150].  Traps are highly 
effective but they are more expensive and difficult to construct and use, and they are more fragile 
than targets [148] and require more regular maintenance. 
Sufficient traps need to be put in place per unit area in order to successfully reduce tsetse density.  
For savannah tsetse species, traps placed at a density of 4 baits (traps or targets) per sq. km. have 
been shown to reduce trypanosomiasis effectively [151].   For riverine species of tsetse found in 
Central and West Africa, traps or targets can be placed linearly at a distance of 1 trap/target per 50m 
[152].  Here, flies are attracted mostly to the colour of the trap/target and use of odourants is less 
effective [153, 154].   
Recently, smaller insecticide-treated targets of 50 X 25 cm2 have been found to be highly attractive 
to riverine species of tsetse e.g. Glossina fuscipes fuscipes [155, 156], in contrast to savannah flies, 
where reducing the target size drastically reduced the number of tsetse caught [157].  These tiny 
targets consist of a square of phthalogen blue polyester cloth (25x25cm) attached to fine black 
polyethylene mosquito netting (25x25cm) impregnated with insecticide (Figure 4.3).  A study in 
northern Uganda found that tiny targets reduced G. fuscipes populations by more than 90% in 12 
months [158].  A study of screening and treatment with or without vector control using tiny targets 
in Guinea found a lower incidence of HAT in the arm including vector control compared to screening 
and treatment alone [159].  Tiny targets are easy to deploy due to their small size, cheap to 
manufacture and probably require less maintenance than traps or larger screens.  Smaller screens 
with netting were estimated to improve cost effectiveness by sixfold compared to standard 1m x 1m 
targets for control of G. p. gambiensis and G. tachinoides [155].  Studies show the insecticide on the 
netting is effective for up to 8 months but starts to fall after 5 months [158]. 
 
Figure 4.3: Tiny targets for tsetse control (photo courtesy of S. Torr) 
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4.1.6.2 Vector control tools with some evidence to recommend their use against human 
African trypanosomiasis 
Use of insecticide-treated cattle to control tsetse has shown mixed success [160], with some 
successful examples [161, 162] and others which were not successful [163, 164].  This is probably 
because of differences in the numbers and distribution of treated cattle, area covered by the treated 
animals and by rapid loss of the effective insecticidal dose on the animal.  Also when alternative 
hosts such as wildlife are abundant, the flies can feed successfully on these hosts reducing the 
effectiveness of the treated cattle [165].  Insecticide-treated cattle are not used widely because 
there are few cattle in many foci of Gambian HAT in Central and West Africa.  The intervention 
requires continued support from farmers and sustainability may be increased if implemented in 
areas where tsetse also transmit livestock trypanosomes that cause nagana, for example in Uganda 
where Rhodesian sleeping sickness is prevalent [166].  Since tsetse preferentially land on the legs 
and belly of cattle (75-95% of tsetse), restricting the insecticide application to only the legs and belly 
of older cattle can be more cost effective [167, 168] and reduces risks to non-target organisms [169].   
In areas where tsetse flies are widespread, large scale aerial spraying of insecticides has been 
conducted.  Aerial spraying of insecticide has been tried for both Gambian and Rhodesian tsetse but 
performs better for Rhodesian sleeping sickness where woodland surrounding tsetse habitats is less 
dense.  Suitable concentrations of endosulfan or deltamethrin were sprayed using sequential ULV 
aerial spraying (sequential aerosol technique or SAT) techniques over forested habitats where the 
flies were killed upon impact with micro-droplets of insecticide [170, 171].  Aerial spraying can be 
highly effective, but is costly compared to the traps and target technology and there are concerns 
about the environmental impact of widespread application of insecticides.  
Focal and ground spraying of insecticide targeting resting sites e.g. lower branches and tree trunks 
and pupal development sites e.g. ant-bear holes, springhare and hyena dens has been used 
successfully in a number of locations including Zimbabwe and Botswana [172, 173].  In the past DDT 
was used but this is no longer possible due to environmental concerns.  More recently, pyrethroids 
have been tested for bush spraying  and shown to reduce tsetse catches and HAT cases [174].  Focal 
and ground spraying is not widely used nowadays, as implementation over large areas on a regular 
basis is difficult. 
Once tsetse populations have been reduced to low levels, sterile insect release (SIT) can be used to 
eliminate the last remaining flies.  SIT has been used to successfully eliminate tsetse (Glossina 
austeni) from Unguja Island, Zanzibar from 1994-97 [175].  However, this technique may not be 
suitable everywhere due to its high cost, logistical difficulty, the potential for reinvasion outside of 
island populations and doubtful feasibility in areas with multiple species.  Releasing sterile males 
may actually increase the amount of transmission because males are vectors of human African 
trypanosomiasis too. 
 Efficacy of vector control tools against schistosomiasis 4.1.7
Tools with a WHO 
recommendation 
Tools with some evidence / or 
evidence to recommend their 
use in certain settings or 
populations 
Tools for which there is 
currently insufficient evidence 





 Biological control using fish 
Provision of potable water and 
sanitation (WASH) 
 Molluscicidal plants 
Health education   
Molluscicides   
Environmental management   
 
The mainstay of control for schistosomiasis is regular preventive chemotherapy with praziquantel 
[53].  Other interventions which may be of importance in the control and elimination of 
schistosomiasis include provision of potable water and sanitation (WASH), snail control using 
molluscicides, environmental management or biological methods and health education to change 
water use habits, reduce open defecation and urination and encourage attendance for diseases 
screening. 
4.1.7.1 WHO recommended vector control tools against schistosomiasis 
Given that schistosomiasis results from the unsanitary disposal of human waste and absence of safe 
sources of water, it is not surprising that provision of safe water and sanitation is associated with a 
reduction in schistosomiasis [176, 177].   
A number of effective tools are available for snail control including molluscicides and environmental 
management [178].  Molluscicides such as niclosamide ethanolamine salt have been used 
successfully for snail control in schistosomiasis control programmes in Morocco, Egypt and the 
People’s Republic of China [179-182] and niclosamide is recommended by the WHO for snail control 
[183].  Molluscicides are expensive when used on a large scale, requires skilled personnel, logistics 
and equipment [184].  Focal mollusciciding where molluscicides are targeted to transmission sites 
with high prevalence can be used in smaller circumscribed transmission sites.  Rapid reinvasion can 
occur so regular treatment is necessary and it can be difficult to know where and when to treat 
particularly where contact with contaminated water occurs over a large area [184]. 
Environmental management for schistosomiasis includes alteration of the flow rate of the water 
(river flushing e.g., [185]), removal of vegetation or drainage at specific times of the year.  
Environmental management may have some disadvantages.  For example, removal of vegetation 
may affect fish stocks and increasing the flow rate of rivers to wash away snails may perversely 
create breeding habitats for Simulium (black fly) vectors of onchocerciasis, which prefer fast flowing 
water.  Environmental management also plays a role where man-made habitats are being created 
for example, through dams, man-made lakes, irrigation schemes, aquaculture etc.   Where irrigation 
schemes are being introduced, overhead or drip irrigation may reduce the risk of increased 
schistosomiasis transmission associated with traditional surface irrigation [184].  In irrigated rice 
growing areas, multiple cropping or alternate cropping systems can be used to reduce snail habitats 
[184] 
4.1.7.2 Vector control tools with currently insufficient evidence to recommend their use 
for schistosomiasis control 
 73 
 
A number of methods of biological control have been attempted.  Biological control of Biomphalaria 
glabrata by competitor snails of the Ampullariidae (Pomacea glauca, Marisa cornuarietis) and 
Thiaridae (Tarebia granifera, Melanoides tuberculata) families has shown some success in the 
Caribbean [186-189].  However, there is a risk that the new colonising snails can become susceptible 
to the local schistosome, as occurred in Brazil [190, 191].  Snail control using fish has been tested in a 
number of locations including Lake Malawi and Lake Victoria but has largely been unsuccessful [192].   
Several plants contain natural molluscicides (e.g. saponins from Phytolacca dodecandra [193, 194] 
and isoflavonoids from Millettia thonningii).  However, experimental studies have not led to 
recommendations on these interventions due to for example toxicity or problems with large scale 
production [178].   
 Efficacy of vector control tools against trachoma 4.1.8
The strategy for control of trachoma consists of surgery, antibiotics for treatment, facial cleanliness 
and environmental change (SAFE).  
Tools with a WHO 
recommendation 
Tools with some evidence / or 
evidence to recommend their 
use in certain settings or 
populations 
Tools for which there is 
currently insufficient evidence 
to recommend their use 
Surgery   
Antibiotics   
Facial cleanliness   
Environmental change 
(environmental sanitation, 
physical or chemical methods) 
  
 
4.1.8.1 WHO recommended vector control tools for trachoma 
The flies that transmit trachoma can be controlled by environmental sanitation or using physical or 
chemical methods [195].  Environmental sanitation includes provision of water and sanitation 
facilities and hygiene promotion (e.g. discouraging open defecation, promoting proper disposal of 
household waste) and has knock on benefits on a host of other diseases including childhood 
diarrhoea.  Therefore, these interventions should be considered as a priority.  Provision of latrines 
has been shown in a cluster randomised controlled trial to reduce trachoma prevalence by 30% in 
The Gambia [196].  Space spraying, spraying of residual insecticide on outside of houses where flies 
rest or use of fly traps can also be useful but are not considered as long term strategies.  
Deltamethrin spraying has been shown to reduce trachoma prevalence by over 80% in a cluster-RCT 
in The Gambia [196] but continuous repeat spraying will generate resistance in the flies and this is 
usually only considered in areas where there is an unusual and temporary increase in transmission 
risk [195]. 
 Efficacy of vector control tools against onchocerciasis 4.1.9
Onchocerciasis can be controlled by targeting the parasite using ivermectin chemotherapy [53] and 
the vector using vector control measures, in particular larviciding of breeding grounds using 
chemical or microbial larvicides (Figure 4.4).  Although the current strategy for onchocerciasis 
 74 
 
control relies mostly on drugs it is important to note that the major reductions were brought about 
by a combination of drug treatment and vector control.  Vector control has also re-emerged as an 
important strategy now that onchocerciasis is targeted for elimination.   
 
Figure 4.4: Larviciding for onchocerciasis control, Sanaga River, Cameroon (photo courtesy of Didier 
Baleguel) 
Aerial larviciding was responsible for the near-elimination of river blindness from much of West 
Africa (Benin, Burkina Faso, Côte d'Ivoire, Ghana, Guinea Bissau, Guinea, Mali, Niger, Senegal, Sierra 
Leone and Togo) as part of the Onchocerciasis Control Programme (OCP) from 1974 to 2002 [197].  A 
number of insecticides were used in rotation (chemical and microbial) to prevent development of 
resistance, following early development of resistance of Simulium damnosum to temephos and 
phoxim.  Despite the success of the OCP there has however been resurgence in blackflies in some of 
the former OCP countries indicating the need for continued vector surveillance. 
In 1995, the African Programme for Onchocerciasis Control (APOC) was launched in 19 African 
countries not covered by the OCP [198, 199].  APOC relies heavily on MDA using ivermectin, 
although activities are also done to eliminate the blackfly vector in Uganda, Tanzania and Equatorial 
Guinea, where vector control is feasible and cost-effective.  Ground larviciding with environmentally 
safe insecticides continued for two to three years, concluding in 2005.  APOC is monitoring the areas’ 
blackfly population to confirm vector elimination. 
 Efficacy of vector control tools against other viral infections excluding 4.1.10
dengue 
Vector control programmes need to remain vigilant for epidemics of arboviruses that can emerge 
quickly infecting large numbers of people.  Importantly, in the future new human pathogens may 
emerge transmitted by vectors [200, 201].  Since these diseases are epidemic in nature there have 
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been few studies which have assessed whether particular interventions are effective at controlling 
outbreaks.  There is a little evidence on effective tools against these viral infections although some 
guidance based on expert opinion is given in Box 4.2.  
Box 4.2: Vector control tools for use against viral infections excluding dengue  
Rift Valley fever: 
Many species of mosquito are able to act as vectors for transmission of the Rift Valley fever (RVF) 
virus and these vary between different regions [202-205].  Among animals, the RVF virus is spread 
primarily by Aedes species, which can acquire the virus from feeding on infected animals. During 
periods of heavy rainfall, larval habitats frequently become flooded enabling the eggs to hatch and 
the mosquito population to increase rapidly, spreading the virus to the animals on which they feed. 
LSM is the most effective form of vector control if breeding sites can be clearly identified and are 
limited in size and extent.  During periods of flooding, however, the number and extent of breeding 
sites is usually too high for larviciding measures to be feasible.  
West Nile virus: 
West Nile virus (WNV) is found in Africa and maintained in nature in a cycle involving transmission 
between birds and mosquitoes [206, 207].  Humans, horses and other mammals can be also 
infected.  Mosquitoes of the genus Culex are generally considered the principal vectors of WNV, in 
particular Cx. pipiens.  WNV is maintained in mosquito populations through vertical transmission 
(adults to eggs).  Prevention of human WNV infections depends on the development of an effective 
IVM programme where the virus occurs.  Studies should identify local mosquito species that play a 
role in WNV transmission, including those that might serve as a “bridge” from birds to human 
beings.  Emphasis should be on LSM including source reduction, water management, and larviciding. 
Yellow fever: 
Several different species of Aedes mosquitoes transmit the yellow fever virus [208-210].  Mosquitoes 
carry the virus from one host to another, primarily between monkeys, from monkeys to humans, 
and from person to person.  The mosquitoes either breed around houses (domestic), in the forest 
(wild) or in both habitats (semi-domestic).  There are three types of transmission cycles. 
 Sylvatic (or forest) yellow fever: In tropical rainforests, yellow fever occurs in monkeys that 
are infected by wild mosquitoes. The infected monkeys then pass the virus to other 
mosquitoes that feed on them. The infected mosquitoes bite humans entering the forest, 
resulting in occasional cases of yellow fever. Most infections occur in young men working in 
the forest (e.g. for logging).  
 Intermediate yellow fever: In humid or semi-humid parts of Africa, small-scale epidemics 
occur.  Semi-domestic mosquitoes (that breed in the wild and around households) infect 
both monkeys and humans. Increased contact between people and infected mosquitoes 
leads to transmission.  Many separate villages in an area can suffer cases simultaneously. 
This is the most common type of outbreak in Africa.  An outbreak can become a more severe 
epidemic if the infection is carried into an area populated with both domestic mosquitoes 
and un-vaccinated people.  
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 Urban yellow fever: Large epidemics occur when infected people introduce the virus into 
densely populated areas with a high number of non-immune people and Aedes mosquitoes. 
Infected mosquitoes transmit the virus from person to person. 
 
The risk of yellow fever transmission in urban areas can be reduced by eliminating potential 
mosquito breeding sites and larviciding.  Application of spray insecticides to kill adult mosquitoes 
during urban epidemics, combined with emergency vaccination campaigns, can reduce or halt yellow 
fever transmission, "buying time" for vaccinated populations to build immunity.   
Mosquito control programmes targeting wild mosquitoes in forested areas are not practical for 
preventing forest (or sylvatic) yellow fever transmission.  
Chikungunya: 
Chikungunya virus (CHIKV) is transmitted from human to human by the bites of infected female 
mosquitoes and occurs in a number of locations including sub-Saharan Africa (SSA) [211-214].  Most 
commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus [215], 2 species which 
can also transmit other mosquito-borne viruses, including dengue.  Both Ae. aegypti and Ae. 
albopictus have been implicated in large outbreaks of chikungunya.  In recent decades, Ae. 
albopictus has spread from Asia to become established in areas of Africa.  Ae. albopictus thrives in a 
wider range of water-filled breeding sites than Ae. aegypti, including coconut husks, cocoa pods, 
bamboo stumps, tree holes and rock pools, in addition to artificial containers such as vehicle tyres 
and saucers beneath plant pots.  This diversity of habitats explains the abundance of Ae. albopictus 
in rural as well as peri-urban areas and shady city parks. Ae. aegypti is more closely associated with 
human habitation and uses indoor breeding sites, including flower vases, water storage vessels and 
concrete water tanks in bathrooms, as well as the same artificial outdoor habitats as Ae. albopictus.  
In Africa several other mosquito vectors have also been implicated in disease transmission, including 
species of the A. furcifer-taylori group and A. luteocephalus.  There is evidence that some animals, 
including non-primates, rodents, birds and small mammals may act as reservoirs. 
The proximity of mosquito vector breeding sites to human habitation is a significant risk factor for 
chikungunya as well as for other diseases that these species transmit. Prevention and control relies 
heavily on reducing or treating natural and artificial water-filled container habitats that support 
breeding of the mosquitoes. This requires mobilization of affected communities. During outbreaks, 
insecticides may be sprayed to kill flying mosquitoes, applied to surfaces in and around containers 
where the mosquitoes land, and used to treat water in containers to kill the immature larvae. 
For protection during outbreaks of chikungunya, clothing which minimizes skin exposure to the day-
biting vectors is advised.  Repellents can be also be used and people should sleep under mosquito 
nets at night.  Basic precautions should be taken by people traveling to risk areas and these include 
use of repellents, wearing long sleeves and pants and ensuring rooms are fitted with screens to 
prevent mosquitoes from entering. 
O’nyong-nyong: 
O’nyong-nyong (ONNV) is an alphavirus which is closely related to CHIK virus but is transmitted by 
anopheline mosquitoes (An. funestus and An. gambiae).  It has a similar clinical picture to CHIKV  
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(self-limiting febrile illness characterised by headache, rash, joint pain).  Secondary hosts have not 
been formally identified although antibodies against ONNV have been found in game animals in SSA 
[216].  There have been sporadic outbreaks in west and East Africa, and a recent study in coastal 
Kenya found seropositivity rates of 56% [217].  Since the vector is shared with malaria, standard 
control measures such as LLINs, IRS and LSM are likely to be effective against ONNV. 
 
 Multiple diseases and multiple interventions 4.1.11
In areas where diseases are co-endemic, it is recommended to roll out vector control interventions 
that are active against both or multiple diseases.  In this way, there are likely to be cost savings and 
greater efficiencies.  Table 4.2 summarises in a matrix form recommended vector control 
interventions to use when diseases are co-endemic.  For example, the control of Anopheles should 
lead to a reduction in malaria, LF, rift valley fever, west nile virus and o’nyong-nyong [218-221].  
WHO-recommended primary vector control tools are shown in green, and supplementary methods 
in orange.   
Combinations of interventions are likely to be more effective against a disease than a single 
intervention.  For example, combinations of interventions with different modes of action (chemical, 
biological, environmental) targeting immature and adult mosquitoes are recommended for dengue 
control.  Studies of LLINs and IRS for malaria were discussed in 4.1.2.2. For other diseases, there are 
fewer studies of combinations of interventions.  
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Table 4.2: Matrix showing WHO-recommended vector control tools by disease  (WHO-recommended primary tools indicated in green and supplementary 



















































































































































































































































































                  
Dengue                   
Leishmaniasis * * *                
Human African 
trypanosomiasis 
                  
Schistosomiasis                   
Trachoma                   
Onchocerciasis                   
Yellow  fever                   
West Nile virus                   
Rift Valley fever                   
Chikungunya                   
O’nyong-nyong                   
*where sandfly vectors bite or rest indoors 
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 Vector characteristics, vector resistance status and risk for development of 4.1.12
resistance 
Information from the initial vector assessment on ecology and behaviour of the target species 
should feed into the decision on choice of vector control tools.  Vector control tools may show 
differing efficacy against different vector species according to their biology, ecology and behaviour.  
For example LLINs are more effective at controlling anopheline mosquitoes than culicines and those 
vector species that are more endophilic than exophilic. 
It is also important to consider the vector resistance status and risk for development of resistance 
when using insecticide-based vector control tools.  Development of insecticide resistance, 
particularly in malaria vectors is on the increase and may eventually threaten the effectiveness of 
vector control [222].  At present there are few, if any, places in sub-Saharan Africa where there is no 
resistance to pyrethroid insecticides, the only class of insecticide currently used for impregnating 
bed nets.  More information on types and mechanisms of insecticide resistance, the distribution of 
insecticide resistance in sub-Saharan Africa across vector species and how to test for insecticide 
resistance is given in Chapter 9. 
4.1.12.1 Insecticide resistance management considerations when selecting interventions 
What interventions should be implemented to mitigate insecticide resistance or maintain 
effectiveness if insecticide resistance is already present?  Insecticide resistance management (IRM) 
strategies are available and technical guidance has been elaborated for malaria (where the threat is 
greatest) in the Global Plan for Insecticide Resistance Management (GPIRM) in malaria vectors 
document [42].  Additional guidance including decision trees to support decision making on 
intervention choice will soon be available in a WHO Framework document which assists countries in 
developing IRM plans.  The WHO website should also be consulted since this is a fast moving area.  
In general, IRM strategies incorporate diversifying the range of interventions used and reducing 
reliance on insecticides.  It might be useful to learn from experiences in agricultural pest 
management in this regard [223]. 
In summary IRM options include: rotation of different classes of insecticide and using combinations 
of interventions.  When rotating insecticides, 2, or preferably more, insecticides with different 
modes of action are rotated from one spray round to the next.  Combinations of interventions are 
particularly useful in preventing selection for resistance because when 2 or more insecticide-based 
vector control interventions are used in a house (e.g. pyrethroids on nets and an insecticide of a 
different class on the walls), the same insect is likely, but not guaranteed, to come into contact with 
the second insecticide if it survives exposure to the first.  Using a combination of DDT IRS and LLINs, 
that are currently treated with pyrethroids, is likely to lead to cross resistance between DDT and 
pyrethroids as they have the same mode of action.  If LLINs and IRS are combined it is essential to 
use LLINs with IRS using a carbamate or organophosphate insecticide. If one suspects pyrethroid 
resistance, the WHO recommends using IRS with an organophosphate or carbamate insecticide, 
provided there is no cross resistance to these classes of insecticide [42].  If there is strong evidence 
of resistance against all classes of insecticide compromising malaria control then the focus should be 




Experimental options for IRM both of which pertain to IRS and are yet to be fully tested are i) mosaic 
spraying (insecticides of different classes are used in neighbouring geographic areas) and ii) use of 
mixtures (insecticides of different classes are mixed to make a single formulation so that the 
mosquito is guaranteed to come into contact with the two classes at the same time).   
The GPIRM does not elaborate on the potential for non-insecticide-based vector control 
interventions to reduce vector density and pathogen transmission.  However, by expanding the 
variety of interventions available for vector control including non-insecticide based vector control, 
IVM can make a real contribution to IRM and can help to prevent insecticide resistance occurring.  
For example, strategies such as LSM or environmental management can be used in some settings to 
reduce mosquito numbers without the need for insecticides and so reduce selection pressure on 
insecticides. For example, the risk of vectors developing resistance to Bacillus thuringiensis 
israeliensis which contains four toxic proteins is considered minimal [224]. 
The risk of development of resistance will be affected by the volumes of insecticides used, frequency 
of application and other factors.  Insecticide use in other programmes and sectors may be 
contributing to selection pressure for insecticide resistance.  Communication between VBD control 
programmes and between the health sector and other sectors e.g. cotton and rice growers should 
therefore be encouraged to determine what insecticides and in what volumes are being used where.  
Insecticide use in one VBD control programme may be having inadvertent effects on other vectors 




 Human and environmental safety 4.1.13
Another consideration when deciding on vector control methods is the risk of the intervention to 
human and environmental health.  Some known side effects of vector control methods are outlined 
in Table 4.3.  
KEY POINT 
It is important to remember that strategies such as LSM or 
environmental management can be used in some settings to reduce 
mosquito numbers without the need for insecticides and so reduce 
selection pressure on insecticides. 
 
KEY POINT 
Using a combination of DDT indoor residual spraying (IRS) and long-
lasting insecticidal nets (LLINs), that are currently treated with 
pyrethroids, is likely to lead to cross resistance between DDT and 
pyrethroids.  If LLINs and IRS are combined it is essential to use LLINs 
with IRS using a carbamate or organophosphate insecticide. 
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Table 4.3: Side effects of vector control methods (adapted from [32]) 
Method Side effects Importance 
Chemical methods: 
Long lasting insecticidal nets / 
insecticide-treated curtains 
Risk of resistance + 
Human toxicity  - 
Ventilation + 
Indoor residual spraying 
Risk of resistance + 
Human toxicity +- 
Smell + 
Residue on walls +- 
Effect on ecosystems - 
Indoor ULV space spraying 
Risk of resistance +- 
Human toxicity +- 
Effect on ecosystems - 
Insecticide-treated sheeting / tents / 
wall linings 
Risk of resistance + 
Human toxicity - 
Insecticide treated clothing or 
bedsheets 
Risk of resistance +- 
Human toxicity +- 
Insecticidal treatment of habitat e.g., 
focal, perifocal, ground or aerial 
spraying 
Effect on ecosystems ++ 
Risk of resistance + 
Insecticide-treated cattle 
Human toxicity (food chain) +- 
Effect on ecosystems +- 
Sterile insect technique for HAT Effect on ecosystems + 
Insecticide-treated traps and targets 
Animal/human toxicity +- 
Effect on ecosystems +- 
Pit latrine treatment Effect on ground water +- 
 Environmental pollution 
(polystyrene beads) 
+/- 
Non chemical methods: 
Source reduction Effect on ecosystems  - 
Habitat manipulation Effect on ecosystems - 
Irrigation management Effect on ecosystems - 
Design of irrigation structures None  
House improvement / screening Reduced ventilation +- 
Pit latrine adaptation None  
Waste water management None  
Solid waste management None  
Predation None, if indigenous species used  
Biological larvicides Risk of resistance - 
Repellent plants Human toxicity - 
Removal trapping None  
Zooprophylaxis None  
Polystyrene beads Pollution - 
-, not important; ±, somewhat important; +, important; ++, very important 
 
The judicious use of pesticides is essential given the development of insecticide resistance, scarcity 
of new compounds under development, high costs of many insecticides and possible adverse effects 
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on human health (through acute or chronic exposure) and the environment (e.g. other arthropods, 
fish).  Guidance on decision making for the judicious use of insecticides is provided by WHOPES 
[225].  Guidelines on distribution and use of pesticides should be followed in order to minimise 
potential health and environmental risks [226].  Countries should aim to reduce and eventually 
phase out use of persistent organic pollutants (POPs) including DDT according to the aims of the 
Stockholm Convention on POPs (http://chm.pops.int/Home/tabid/2121/Default.aspx).  IVM offers 
an opportunity to reduce use of DDT by utilising alternative insecticides for chemical-based control 
and diversifying the interventions available for vector control. 
Non-chemical methods have limited side effects, with the possible exception of certain structural 
adaptations that introduce changes in human work load or that affect the ventilation in houses.   
4.1.13.1 Affordability and cost effectiveness 
Affordability is another consideration in selecting vector control methods.  Affordability refers not 
only to national or decentralized budgets allocated to health, but also to the contributions of other 
sectors and the willingness of communities to invest time and resources.   
Cost effectiveness is a form of economic analysis (Box 4.3).  There are limited data on cost 
effectiveness for interventions other than LLINs, IRS and LSM for malaria control [227].   
Box 4.3:  What is cost effectiveness? 
 
A review has shown that from a provider perspective, the median incremental cost effectiveness 
ratio (ICER) per disability adjusted life year (DALY) averted was $27 (range $8.15-$110) for ITNs and 
$143 (range $135-$150) for IRS.  Despite variations in delivery costs between studies and settings, 
these interventions were consistently cost-effective against a threshold of $150 per DALY averted.  
This review was not able to conclude whether ITNs were more cost effective than IRS.  However, 
three studies comparing ITNs and IRS head-to-head showed that ITNs are more cost effective than 
IRS[228-230], and one study found that IRS was more cost-effective than ITNs where malaria was 
epidemic [231].  It should be recognised that cost effectiveness of IRS is heavily dependent on the 
cost of insecticides, with some insecticides being considerably more expensive than others – i.e., 
carbamates and organophosphates are substantially more expensive than pyrethroids.   
Behaviour change campaigns and other activities need to be taken into account when calculating 
cost effectiveness.  Often these campaigns increase use and coverage to the extent that even with 
Cost effectiveness is a form of economic analysis.  It compares the relative costs and effects of 
two different courses of action.  The incremental cost effectiveness ratio or ICER is the ratio of the 
change in costs to incremental benefits of an intervention.   
The equation is:  ICER = (C1 – C2) / (E1 – E2) 
where C1 and E1 are the cost and effect in the intervention group and where C2 and E2 are the 
cost and effect in the control group.   
Costs are usually described in monetary units while the effect is measured in terms of lives, cases 






the increased cost of additional activities, cost effectiveness is higher.  Box 4.4 provides an example 
of cost effectiveness of LLIN distribution and hang-up campaigns in Ghana.  
Box 4.4: Cost effectiveness of distribution and hang-up activities - evaluation of a universal LLIN 
distribution campaign in Ghana (adapted from [232]) 
 
Cost effectiveness during routine vector control may be different from cost effectiveness during 
elimination campaigns or epidemics.  For example during intense epidemics, IRS carried out by 
experienced sprayers is probably the most rapid tool to contain transmission and is likely to be more 
cost effective than LLINs. 
An economic evaluation was carried out of environmental management against malaria (clearing 
vegetation, modifying river boundaries and draining swamps) in copper mining communities in 
Zambia [227, 233].  The cost per DALY averted was 762$, with declining costs (32 - 133$) after the 5 
year start-up period.  In the long run, this intervention is likely to be cost effective, despite high 
start-up costs.    
Ghana launched a national universal mass distribution of LLINs between May 2010 and October 
2012 and distributed 12.5 million LLINs.  The campaign involved a number of activities including 
pre-registration of persons and sleeping spaces, distribution of LLINs door to door with ‘hang up’ 
campaigns by volunteers and ‘keep up’ behaviour change communication activities to achieve 
high and sustained use of the LLINs.   
A study assessed the cost and cost-effectiveness of the LLIN campaign in three regions of Ghana 
(Brong Ahafo, Central and Western).  The evaluation used a before-and-after design.  The 
incremental cost-effectiveness of the ‘hang-up’ component could be assessed using data on 
variation in the extent to which the ‘hang-up’ campaign was implemented and LLIN use.  
Economic costs were estimated from a societal perspective assuming LLINs would be replaced 
after 3 years, and included the time of unpaid volunteers and household contributions given to 
volunteers. 
In total 3.6 million campaign LLINs were distributed and 46% of households reported that that 
LLINs received were hung-up by a volunteer.  The financial cost of the campaign was 6.51 US$ 
per LLIN delivered and the average annual economic cost was 2.90 US$ per LLIN delivered.  It 
cost 6,619 US$ per additional child death averted by the campaign.  Hang-up activities 
constituted 7% of the annual economic cost, though the additional financial cost was modest 
given the use of volunteers.   
Importantly, it was shown that LLIN use was greater in households in which one or more 
campaign LLINs were hung by a volunteer – with more than 1.5 times the odds of the LLIN being 
used.  The additional economic cost of the hang-up activities was USD 0.23 per LLIN delivered, 
and achieved a net saving per LLIN used and per death averted. 
In this campaign, hang-up activities were estimated to be cost saving if hang-up increased LLIN 




No studies have assessed the cost effectiveness of LSM.  One study has however estimated the 
economic and financial costs per person protected per year for large-scale LSM using microbial 
larvicides in three ecologically diverse settings [234].  The cost per person protected by larval control 
in this analysis ranged from US$0.79 to US$2.50, which is comparable with other malaria 
interventions.  For example, the cost of IRS ranges from US$0.88-4.94 per person protected (2000 
US$), the cost per treated net year for conventional ITNs was found to range from US$1.21-6.05 and 
for LLINs US$1.38-1.90 (2005 US$) [235, 236]. 
4.1.13.2 Acceptability and community participation  
It is important to consider the cultural and social context in which vector control interventions are to 
be implemented.  Acceptability of vector control interventions by communities is key to correct use 
of personal protective measures and sustained interest and participation in vector control and 
therefore intervention effectiveness.  When introducing interventions into your setting, it is a good 
idea to assess their acceptability to communities.  This can be done using social research methods 
such as holding a community forum meeting or a focus group (see Box 9.5).  Three examples of 
studies which used social research methods to determine community acceptability are provided: 
house screening for mosquito control in The Gambia (Box 4.5), tsetse control baits in Uganda (Box 
4.6) and larviciding for malaria control in Tanzania (Box 4.7). 
Community participation is a key aspect of the effectiveness of most, if not all, vector control 
methods.  Participation ranges from adherence to interventions, such as IRS, to active involvement 
in environmental management.  Public health education is needed before programmes start to make 
sure everyone understands what is being done and why.  Who you engage with and how you do it 
depends on your local circumstances. However, in rural Africa this is typically done by consulting 
with and involvement of village leaders, and sometimes religious leaders, from the outset before 
having community meetings in the villages.  Community participation is often critical for achieving 
coverage and for the sustainability of control activities but does require investment in 


















An acceptability study was conducted alongside a randomised controlled trial of house screening 
(either complete (doors and windows screened and eaves closed) or ceilings screened only) versus 
control in the North Bank Division, The Gambia.   Screening reduced entry of An. gambiae at night 
with a 59% reduction in fully screened houses and 47% reduction in screened ceiling houses versus 
control houses.  Also a reduction in anaemia prevalence among children of about a half in 
screened houses and screened ceiling houses versus control houses was observed.  
Qualitative and quantitative methods were used in the acceptability study.  Firstly, focus group 
discussions were held with a selection of householders in each trial arm to gather information on 
general perceptions of the types of screening and to identify the key concerns and benefits of the 
screening as perceived by those taking part in the trial.  The results of the FGD were then used to 
design a questionnaire survey which was taken by a wider selection of study participants.  In the 
questionnaire the participants were asked to choose whether to keep the screening they had been 
allocated, have it removed or have the other type of screening.  Data collection also included 
durability surveys at 6 and 12 months after the screening was installed and assessment of the 
indoor climatic conditions. 
Most of the participants recognized that screening stopped mosquitoes and other insects from 
entering their houses.  A reduction in other animals such as bats and geckos was also noted and 
some participants reported sleeping more soundly as they felt more secure and screening 
prevented dust and dirt falling on them while they slept in times of high wind or rain.  Key 
problems identified were difficulty in cleaning the white ceiling netting in the screened ceiling 
group and damage to the screened doors by children and domestic animals in the fully screened 
group.  9% of those with fully screened houses and 17% of those with screened ceilings said they 
made the house hotter.  The screened houses were indeed hotter but only by half a degree Celsius 
hotter than control houses on average.  When offered a choice of screening, most participants 
chose full screening regardless of whether they initially received screened ceilings, full screening, 
or no screening. 
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Box 4.6: Community acceptance of tsetse control baits in Arua District, North West Uganda [238] 
 
 
Tsetse baits (traps or targets) are a type of control method for human African trypanosomiasis 
(HAT).  Effectiveness of traps and targets will depend to some extent on their acceptance by 
community. Previously it has been shown that negative associations of communities towards traps 
led to damage or theft of traps, and ultimately the failure of control programmes.   
A qualitative study was conducted to explore knowledge, perceptions and acceptance of tsetse 
baits (traps / targets) in villages where they had or had not been used previously in Arua District, 
North West Uganda, an area endemic for Gambian HAT.  Focus group discussions were held with 
groups of men and women from villages that had been exposed previously to tsetse traps as part 
of a control programme or had not been exposed previously.   
The villages which were new to traps perceived the traps negatively, associating them with 
witchcraft and ghosts.  This was largely due to the position of traps next to the river (described as 
being home to ghosts) and unease about who had positioned the traps and for what purpose.  
Villagers that had been previously exposed to traps said they initially felt similarly anxious when 
first exposed to the traps but now perceived them positively and beneficial, showing that negative 
perceptions are prone to change over time.  Most participants were aware of the purpose of the 
traps and being able to see insects trapped seemed to reinforce positive attitudes, particularly 
among women.  Villagers that had been explained the purpose of the trap (either by the person 
setting up the trap or another community member) said this information helped them to put aside 
associations with supernatural powers.  Participants expressed a willingness and motivation to be 
involved in tsetse control and villagers in the group previously exposed to traps reported 
contributing to tsetse control, for example by maintaining traps and cutting back vegetation 
around rivers). 
This study reinforces the need to understand community perceptions of new interventions.  Tsetse 
control programmes should plan and budget for community involvement at all stages e.g. 
sensitisation, deployment and maintenance to ensure that programmes are effective and 





Box 4.7: Community awareness and acceptability of microbial larvicides for malaria control in a 
rural district of East-Central Tanzania [239] 
 
 Intervention delivery / implementation 4.1.14
The choice of vector control tool should also take into account the feasibility and logistics of 
delivering or implementing the particular intervention.  Interventions can be implemented by vector 
control services, other sectors or the community with VBD control programme oversight.  Also for 
some interventions, for example LLINs, a number of different delivery mechanisms exist including 
mass campaigns and continuous distribution through various channels.  Delivery or implementation 
mechanisms may differ for routine and epidemic control.  More information on this topic is given in 
Chapter 5. 
4.1.14.1 Assessment of product quality, efficacy and safety  
The WHO Pesticide Evaluation Scheme (WHOPES) is responsible for promoting and coordinating the 
testing and evaluation of pesticides for public health.  In its present form, WHOPES comprises a four-
phase evaluation and testing programme, studying the safety, efficacy and operational acceptability 
of public health pesticides and developing specifications for quality control and international trade.  
Its recommendations facilitate the registration of pesticides by Member States.  Currently, WHOPES 
This study assessed the community acceptability of larviciding in Mvomero District in east-central 
Tanzania as part of a large cluster-randomised community-supported larviciding trial. 
Data was collected using household surveys, focus group discussions (FGD) and in-depth 
interviews (IDI).  The study was unusual in that data were collected during the baseline year of the 
trial meaning that participants had not yet been exposed to the larviciding intervention or 
observed its benefits. 
Study participants were generally aware the mosquitoes transmit malaria and about two-thirds of 
IDI participants understood that larvae were breeding in water bodies.  Participants were unaware 
of larviciding as a potential intervention but were generally receptive to its use after hearing a 
brief description of the method which was read to them by the investigator.  Some respondents 
were worried about larvicide being applied to water bodies which are used as sources of drinking 
water and for other domestic purposes and some expressed concern about larvicide being washed 
away during the rains.  Despite a generally positive reaction to larviciding, participants expressed 
the need for community sensitisation before implementation which would enable community 
members to understand its benefits and safety to humans, animals, and plants. 
Respondents were asked about their willingness to contribute financially to sustain a larviciding 
programme.  88% of participants in the FGDs were willing to contribute a small amount of money 
to the program at regular intervals, e.g., 3 or 6 months with a minimum contribution of 1,000 
Tanzanian Shillings (TShs.) (TShs. 1,000 is approximately US$ 0.60).  However, some respondents 
had concerns about proper use of financial contributions from the community after some bad 
experiences with community-supported programmes in the past where money was not used for 
its intended purpose.  Others said that once benefits of larviciding were observed, community 




releases lists of recommended insecticides for IRS, ITNs and space spraying and long lasting 
insecticidal nets (LLINs) and larvicides which are available on the WHOPES website 
(http://www.who.int/whopes/en/).  Countries should use only those products recommended by 
WHOPES and meeting the quality control specifications.  Lists of approved products (LLINs, 
insecticides for IRS and larvicides) are available on the WHOPES website.  Based on WHOPES 
recommendations, countries can register the product with their National Regulatory Authority. 
 
Although products may have met WHOPES standards, it is the responsibility of National Regulatory 
Authorities or procurement agencies (e.g. Presidents Malaria Initiative or Global Fund) to ensure the 
quality of the products by conducting batch testing of products pre-shipment.  Batch testing should 
be done in a Good Laboratory Practice (GLP) certified laboratory to check whether the products 
meet WHO or country specifications.  This process is outlined in WHO or other (e.g. Global Fund) 
procurement guidelines [240].  The time required for batch testing needs to be figured into leads 
times to ensure there is no delay in release of products for use in the field. 
 
It is important to ensure that products delivered to the field are of good quality.  Guidelines for 
appropriate storage and shelf lives should be adhered to.  However, products that have passed their 
shelf life can still be used for up to 6 months as long as batch testing shows they still meet 
specifications.  Quality assurance procedures should be put in place to ensure delivery of high 
quality interventions in the field – for example, checking the level of insecticide on a random sample 
of sprayed surfaces for IRS.  An insecticide quantification kit will soon be available which can assess 
the level of insecticide on sprayed surfaces.  Quality assurance indicators should be added to 










When selecting the most appropriate vector control method or 
combination of methods it is important to consider their effectiveness, 
the local ecology and behaviour of the target species, resources available 
for implementation (human, financial and material), the cultural context 
in which control interventions are carried out, the feasibility of applying 
them in a timely manner, and the adequacy of coverage.  Countries 
should use only those products recommended by WHOPES and meeting 






 A wide range of vector control tools exist; which can be broadly classified into chemical-
based and non-chemical based tools for control of either adult or immature forms of the 
vector.   
 It is important to choose vector control tools on the basis of their efficacy primarily against 
epidemiological parameters (prevalence or incidence of infection/disease) although 
evidence of efficacy against the vector may be useful in some circumstances.  
 Vector control tools may be effective against multiple diseases, for example IRS against 
malaria, lymphatic filariasis, dengue and leishmaniasis.  
 A number of other factors should however, be taken into account when choosing vector 
control tools including vector characteristics such as insecticide resistance, human and 
environmental safety, affordability/cost effectiveness, acceptability and community 
participation and intervention implementation/delivery.   
 Only WHOPES approved products should be used and pre-shipment batch testing should 





 Implementation strategy 5
 
 
In terms of implementation of IVM, you should consider: 
1. What interventions you are going to deliver (Chapter 4) 
2. Where these interventions are going to be implemented 
3. When the interventions are going to be implemented  
4. by whom are the interventions going to be delivered and how? 
We attempt to cover these last four considerations in this Chapter.  
5.1 Spatio-temporal targeting of IVM 
 Spatial targeting of IVM 5.1.1
IVM is about doing vector control is a smarter manner – making use of information on where vector 
borne pathogens and diseases are present in order to make better use of limited resources and 
target interventions to populations at highest risk.  Therefore, it is very likely that specific IVM 
interventions will be targeted to specific geographic locations or on a finer scale, hotspots of disease.  
Since malaria is still the greatest killer in sub-Saharan Africa it is areas or populations with the 
highest burden of malaria morbidity or mortality that should be targeted first.  However, against a 
backdrop of high LLIN coverage, IRS and LSM may for example be used in a more targeted manner 
for malaria and lymphatic filariasis control in rural areas.  As well as more strategic use of resources, 
targeted IVM can be utilised for a number of other goals, including for outbreak response, 
elimination or tackling foci of high insecticide resistance.   
5.1.1.1 Targeting hotspots of disease either routinely or for elimination 
Hotspots of disease may exist ordinarily as areas of higher transmission than surrounding areas or 
can appear when transmission has been reduced substantially so that only some patchy foci of 
3. Selection of 
vector control 
methods 
4. Needs & 
resources 
5. Implementation  
6. Monitoring & 
evaluation 
1. Disease situation 
• Epidemiological assessment 
• Vector assessment 
• Stratification 





transmission remain.  For example, although the main intervention for lymphatic filariasis is 
preventive chemotherapy, there may be some areas where repeated rounds of chemotherapy have 
failed to reduce transmission substantially and here it may be appropriate to implement vector 
control measures in addition to standard practice.   
A targeted (proactive) IVM approach can be used to direct VBD control activities to small 
geographical areas where high transmission is expected based on historical data.  See 3.2.2 and 9.5.1 
for sources of information on disease incidence/prevalence in your country.  This technique should 
be validated over time in your setting since it relies on hotspots of transmission being relatively 
constant over time.  Although this method does not require timely and well-functioning case 
notification, it does require case locations to be geo-located and requires some expertise in 
identifying the ‘most at risk populations’ or hotspots.  In a resource poor environment, geographic 
locations of cases can simply be plotted on a map to allow programme staff to visualise risk by 
geographic area.  Community participation can be sought to identify breeding sites and other 
features such as health centres can be mapped.  Programmes with greater expertise or links with 
research institutions can use more complex tools to identify clusters of cases in time and space using 
historic data.  For example, the open-source software SaTScan (www.satscan.org) was used by the 
Malaria Control Programme in Mpumalanga Province to detect local malaria clusters [241] .  This 
software scans the data with a series of circles looking for clusters of cases. Observed cases in a 
cluster are compared to the distribution of expected cases if spatial and temporal locations of all 
cases were independent. Identification of clusters assisted with the timely planning of public health 
activities and facilitated implementation of measures over and above standard practice in the 
identified hotspots.  These included active case detection, early diagnosis and treatment of positive 
cases in the areas of the clusters, additional IRS, focal larviciding where breeding sites are few, fixed 
and findable and health promotion activities. 
5.1.1.2 Targeting outbreaks to prevent epidemics 
Targeted IVM can be used where transmission is unstable with the potential for outbreaks or for 
epidemic response.  This can be for example where transmission is spikey in space and time e.g. 
dengue or unstable malaria or where population movement brings non-immunes in contact with 
vector-borne pathogens e.g. refugee camps.    
This approach requires a well-functioning surveillance and health information system with capacity 
for prompt recognition and reporting of an increase in cases and adequate resources allowing for an 
integrated response in a timely manner.  Cases are reported at health facility level and this 
information is relayed back to the vector control programme (Figure 5.1).  Often outreach teams go 
to the household of the case and conduct active case detection in the neighbourhood.  Pre-
determined thresholds specific to each health facility and/or village/area are used to determine 
when intervention is necessary.  An example of the use of thresholds for outbreak detection in an 
unstable malaria transmission setting in South Africa is given in Box 5.1. 
In areas at risk of unstable or epidemic malaria, we would recommend the use of IRS as an epidemic 
response tool as it has a rapid and reliable short term impact.  In addition, detection and treatment 
of cases should be strengthened and LSM could be considered.  LLINs are not recommended as an 




Figure 5.1: Schematic illustrating use of IVM to target outbreaks
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Box 5.1: Use of case thresholds to identify outbreaks and direct use of targeted IVM
 
A relatively simple malaria outbreak identification system was evaluated in the epidemic prone 
rural area of Mpumalanga Province, South Africa, for timely identification of malaria outbreaks 
and guiding focal malaria control.  The study used a threshold system of cases to trigger malaria 
control responses.  A 3 tier system was used with thresholds at facility level, town/village level 
and Provincial Malaria Information System.  Using 5 years of historical notification data, binomial 
thresholds were determined for each primary health care facility in the highest malaria risk area 
of Mpumalanga province.  Wall charts were developed which showed outbreak thresholds (level 
1 and level 2 outbreak) and allowed daily tallies of confirmed cases to be cumulatively charted 
against the weekly threshold.   
If thresholds were exceeded at facility level (tier 1), then the staff notified the malaria control 
programme (MCP) who ensured that stocks of rapid diagnostic tests (RDTs) and treatments were 
sufficient to manage additional cases.  The cases were followed up at household level to verify 
the likely source of infection.  If thresholds were exceeded at town/village level (tier 2), then 
environmental assessment was conducted to identify breeding sites and larviciding was 
performed using an organophosphate.  IRS coverage was also confirmed and if the number of 
cases was sufficiently high at town/village level for more than one successive week, additional 
IRS was considered.   
In addition, an automated electronic outbreak identification system at town/village level (tier 2) 
was integrated into the Provincial Malaria Information System (tier 3) to ensure that unexpected 
increases in case notification were not missed.  Automatic email alerts meant that managers at 
the MCP were able to conduct performance monitoring of tier 2 responses. 
 
The threshold system was positively viewed by staff. 84% of health facilities reported outbreaks 
within 24 hours (n=95), 92% within 48 hours (n=104) and 100% within 72 hours (n=113). 
Appropriate response to all outbreaks was achieved within 24 hours (tier 1 n=113, tier 2 n=46).  
The binomial outbreak thresholds method performed well compared to other currently 
recommended outbreak thresholds such as those recommended by WHO (mean + 2 standard 




This approach may not work for all diseases and settings.  For example, countries prone to dengue 
epidemics often implement dengue control measures after the onset of an epidemic which is in 
most cases too late to have any impact. 
5.1.1.3 Targeting foci of insecticide resistance 
Lastly, targeted IVM may be of use for management of foci of insecticide resistance.  For example, 
reducing the source of mosquitoes by tackling breeding sites using LSM with environmental 
management of chemicals/biologicals to which there is no resistance in the vector population, 
introduction of LLINs with 2 active ingredients or rotation with expensive insecticides for IRS should 
be targeted to sites of high insecticide resistance if a blanket approach is not operationally or 
financially feasible.   
 Temporal targeting of IVM 5.1.2
Certain vectors can be responsible for transmitting more than one disease – for example Anopheles 
gambiae transmits both malaria and lymphatic filariasis and Aedes albopictus transmits both dengue 
and chikungunya.  Also vectors of a number of VBDs increase during the rainy season.  This offers 
opportunities for combining operations, thus increasing efficiency, especially where vectors can be 
controlled by the same or similar interventions.   In general, vector populations should be targeted 
when they are at their lowest point and before they begin to rise. 
5.1.2.1 Malaria vector control 
Malaria vector control should be continuous in order to supress transmission.  In areas of moderate 
or intense seasonal malaria transmission LLINs or IRS need to be distributed before or at the start of 
the rainy season.  LLINs are likely to remain effective for about 3 years but IRS will provide 
protection for around 6 months at most.  This means that where transmission is perennial 2 rounds 
of spraying are needed each year.  Again, if possible these spray operations should take place early 
on in the transmission season to provide maximum protection.  If breeding sites can be located 
readily during the dry season these should be larvicided or the breeding sites removed by 
environmental management.  Communities and the Ministry of Public works should also be engaged 
to remove waste and clear drains or build drains before the start of the rainy season.  It does not 
make sense to larvicide during periods of exceptionally heavy rainfall since many larvae will be 
washed away and the larvicide diluted.  Housing improvement should be done on a continuous basis 
and be seen as a long term investment for when control with LLINs and IRS stops.   
5.1.2.2 Lymphatic filariasis vector control 
Where lymphatic filariasis is transmitted by An. gambiae then the same timings of interventions as 
for malaria control should be implemented – distribution of LLINs or IRS before the rainy season and 
targeting of breeding sites with LSM during the dry season to hit residual breeding sites or at the 
beginning of the rainy season.  Polystyrene beads to target culicines in closed habitats should be put 
in place at any time except during heavy rains or flooding when balls can be washed away. 
5.1.2.3 Cutaneous and visceral leishmaniasis vector control 
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Interventions against sandflies with seasonal changes in abundance should be targeted at the time 
of year before adult vectors begin to rise [242].  Visceral leishmaniasis has a long incubation period 
and so interventions should be put in place where it has been ascertained that transmission is 
ongoing. 
5.1.2.4 Onchocerciasis vector control 
Larvicides should be applied when the flow rate of rivers is lowest.  At this time the vector 
population will be concentrated in specific areas and the cost of larviciding will be reduced.   
5.1.2.5 Dengue vector control 
Peak transmission of dengue virus is often, but not always, associated with periods of high rainfall 
and high temperatures.  Rainfall increases the number of breeding sites available for vectors and 
high temperatures increase the frequency with which vectors take blood meals and reduce the 
extrinsic incubation time. 
With regards to dengue, some interventions should be in place continually in at risk areas as a 
preventive measure, for example LSM (e.g. container surveillance for Ae. aegypti and treatment or 
elimination of positive sites) and insecticide-treated materials.  Other interventions should be 
reserved for epidemic control, for example adulticide spraying conducted in addition to the routine 
interventions.   
5.1.2.6 Human African trypanosomiasis vector control 
Vector control interventions should be targeted when tsetse populations are at their lowest.  In 
particular, during the dry season riverine tsetse will have retracted into dense forest where they are 
most easily attacked [243].  Often target deployments take place at the start of season in which the 
risk of floods and the degree of vegetation growth are minimal. 
5.2 Delivery and implementation of IVM 
Once a decision has been made on the types of vector control tools to roll-out, it is also important to 
consider how the intervention is going to be delivered or implemented and by who.  Interventions 
can be implemented by vector control programmes, other sectors or community members.  By 
whom and how the interventions are implemented may differ depending on the setting, resources 
available, groups or areas targeted by the intervention and aims of the programme (e.g. routine 
control, outbreak or epidemic control, elimination, mosquito abatement etc).  As well as considering 
how the intervention will be implemented, control programmes should also consider supporting 
interventions to increase uptake and correct use of interventions and sustainability. 
High coverage of vector control interventions is necessary in order to be effective against vector 
populations and pathogen transmission.  This applies whether the aim is universal coverage of LLINs 
or targeted LSM for malaria control in a village where a substantial proportion of breeding sites will 
still need to be covered.  A number of coverage targets have been set and internationally agreed 
(Table 5.1).  Of particular importance is WHO guidance on achieving universal coverage of LLINs for 
populations at risk of malaria, which recommends using a combination of delivery methods - mass 
free distributions and continuous distributions through multiple channels, in particular antenatal and 
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immunisation services [35].  Programmes should try to achieve these where possible and this should 
be tracked and documented as an indicator in your monitoring and evaluation plan. 

































      
Dengue  >70% 
[111] 
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Universal coverage is defined as one LLIN per two persons, *most likely to be effective at lower coverage [245], 
Tbg = Trypanosoma brucei gambiense, Tbr = Trypanosoma brucei rhodesiense 
 
 Implementation by vector control programmes 5.2.1
Interventions that require strong logistical or technical knowledge such as aerial spraying for tsetse 
control or indoor ULV in a dengue epidemic situation will need to be delivered by vector control 
programmes.  VBD control programmes may be able to share costs and resources in the delivery of 
interventions.  For example, the malaria control programme should work in tandem with the 
lymphatic filariasis control programme to deliver LLINs to areas where both diseases are endemic.    
 97 
 
Cost savings and other benefits are also achievable when interventions are delivered in tandem, for 
example the same vector control team performing LSM and IRS, or co-delivery of mass drug 
administration and LLINs.  An example of co-delivery of interventions is integration of LLIN 
distribution with mass drug administration (MDA) for lymphatic filariasis and onchocerciasis in 
central Nigeria  is given in Box 5.2.  Although the number of LLINs distributed in this example is 
relatively low (38,600) it does show the feasibility of this approach.  Integration of activities not only 
saves resources but can have synergistic effects on pathogen transmission.  For example, integration 
of active screening for human African trypanosomiasis and vector control in the form of tiny targets 
had a greater impact on disease prevelance than active screening alone [159].    
Box 5.2: Successful integration of LLIN distribution with MDA for lymphatic filariasis and 
onchocerciasis in central Nigeria (adapted from [246]) 
 
In Africa anopheline mosquitoes transmit malaria and lymphatic filariasis (LF) and long-lasting 
insecticidal nets (LLINs) are likely to reduce transmission of both diseases.   Provision of LLINs, in 
particular to target groups such as children aged under 5 years old and pregnant women is a 
major goal but use of LLINs remains relatively low due to a number of factors.  This study 
attempted to deliver LLINs alongside mass drug administration (MDA) for LF and onchocerciasis.  
LLIN distribution was integrated with the 2004 LF/onchocerciasis MDA programme in central 
Nigeria.  Community volunteers distributed 38,600 LLINs, while simultaneously treating 150,800 
persons with ivermectin/albendazole (compared with 135,600 in 2003).  Changes in LLIN 
coverage and use were assessed with a 30-cluster survey.  Among surveyed households 
containing children aged under 5 years/pregnant women, 80% (95% CI, 72-87%) owned > or = 1 
insecticide-treated bed net, a 9-fold increase from 2003.  
Graph shows percentage LLIN ownership and use by households with vulnerable sleeping spaces 
prior to the MDA (2003) and after MDA (2004). 
 
Linkage of LLIN distribution with MDA resulted in substantial improvement in LLIN ownership and 
usage, without adversely affecting MDA coverage. Such integration allowed 2 programs to share 
resources while realizing mutual benefit, and is one model for rapidly improving insecticide-






























5.3 Involving the non-health sector in IVM 
The health sector has conventionally been responsible for vector control, and interventions that 
require strong logistic support, such as IRS, usually require the specialist skills and capacity of the 
health sector.  However, implementation and maintenance of each type of intervention need not 
necessarily be carried out by the Government’s health sector.  Government offices other than health 
and other organisations can and should, however, share the responsibility for certain vector control 
methods or certain areas.  Other partners, such as non-governmental organisations (NGOs), 
communities, schools, the private sector and public sectors such as agriculture, construction and 
local government also have important roles in planning and implementing vector control and 
personal protection.  Strong policy support and advocacy from the IVM Steering Committee (ISC) is 
required for intersectoral collaboration.  As well as reducing VBDs, interventions in other sectors can 
also help to improve wellbeing.  For example, drainage of wetland areas can reduce biting mosquito 
nuisance and installation of piped water for dengue control rather than storing water in the home is 
beneficial for women and children.  The ISC should build an awareness of the important contribution 
of the non-health sector to VBD and VBD control – for example, by highlighting the role of dam 
construction and agricultural irrigation schemes in creating suitable vector habitats.   
Examples of interventions against 
VBD that can be initiated outside the 
health sector are outlined in Table 
5.2.  For example LLINs can be 
distributed by NGOs.  Drainage 
schemes to reduce mosquito 
breeding may be done outside the 
health sector, for example, by the 
Ministry of Public Works.  Wetlands 
can be dried by planting eucalyptus 
trees, an activity that would fall 
under the Department of Forestry, or 
made unfavourable for the aquatic 
forms of An. gambiae by 
regenerating papyrus swamps which 
would provide shaded areas 
unsuitable for this mosquito. 
Environmental management in 
agricultural areas, irrigation systems, 
construction sites, waterways and 
peri-urban areas could be 
administered by the agriculture, 
irrigation and environment sectors 
and local government (Figure 5.2).   
 
Figure 5.2: Environmental management through drain 
clearing to reduce breeding sites (photo courtesy of S. 
Lindsay) 
Schools and work places may be particularly important for daytime biting vectors (e.g. dengue) and 
so should be involved in vector control activities.  Box 5.3 gives a practical example of the 
involvement of the Ministry of Education in health promotion to primary school children regarding 
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dengue.  Malaria control in Khartoum through the Khartoum Malaria Free Initiative (MFI) provides a 
good example of the involvement of a number of sectors and community participation in vector 
control (Box 5.4).  Strong political will and effective intersectoral collaboration has been integral to 
the success and sustainability of the MFI.  While interventions can be initiated and implemented 
outside the health sectors, these activities should be overseen and coordinated by the IVM Focal 
Person at regional or district level.   
Table 5.2: Interventions against VBD that could be initiated outside the health sector 
Interventions Ministries/organisations involved in 
implementation 
Health education & promotion Schools, Ministry of Education, work places, the 
media (TV, radio, internet), drama groups, NGOs, 
religious and community groups 
LLINs / IRS / insecticide treated sheeting or 
tents 
NGOs, UN, VBD control programmes, private sector, 
ministry of tourism, womens groups,  
House improvements and screening Ministry of Housing, NGOs, community members 
Drainage Department of Public Works, local government 
Drain clearance Youth groups who collect rubbish to sell, 
community members (Figure 5.3) 
Drying out of breeding sites Department of Forestry, local government, 
community groups 
Swampland restoration Department of the Environment 
Removal of obsolete concrete water storage 
containers (used for building) 
Department of Public Works, contractor, local 
government 
Filling & levelling  Department of Public Works, local government 
Maintenance of irrigation channels or 
flushing 
Farmers, Ministry of Agriculture, irrigation authority 
Removal of vegetation from edges of water 
bodies 
Farmers, community members 
Intermittent irrigation Farmers, Ministry of Agriculture, irrigation authority 
Improved housing NGOs, microfinance initiatives, Department of 
Housing 
Larval or snail surveys / application of 
larvicides or molluscicides 
Schools, community groups, municipal 
corporations, public health staff, farmers 
Improvement of environmental sanitation NGOs, Department of Public Works, local 
government 
Water supply and sanitation Ministry of water resources, Ministry of 
environment and sanitation, NGOs 
Social and environmental responsibility e.g., 
tyre disposal 
Private companies 
Solid waste and container disposal Garbage collectors, local government, youth 
groups, industry 
Insecticide-treated cattle Farmers, ranch owners, veterinary services 
Topical insecticide on dogs or insecticide 
treated collars 
Dog owners, veterinary services, local municipalities 
Culling of reservoir animals Community members, veterinary services, local 
municipalities 
Destruction of habitats of rodent reservoirs 
of leishmaniasis  




Figure 5.3: Drains are excellent breeding sites for culicines and should be cleaned , treated or 
made inaccessible to vectors (photo courtesy of S. Lindsay) 
Box 5.3: Primary school education as a strategy for dengue control [247] 
 
  
A study was carried out in the city of Botucatu, São Paulo (Brazil) to see whether education of 
primary school children could be used as a strategy for dengue control, with the aim of 
empowering these children to be ‘agents of change’ in their community.  An educational 
intervention was put in place consisting of an explanation of the biology and development of the 
mosquito, information on the disease, virus, transmission and prevention.  In addition, a video on 
dengue was shown, debates were held, children observed the life cycle of the mosquito under a 
microscope, and children completed exercises in an exercise book.   
The effect of the teaching intervention was measured by giving the children quizzes before and 
after the 2 week programme of lessons.  Children who had participated in the lessons scored better 
on the quiz post-intervention, with a better knowledge of the life cycle, transmission of dengue by 
adult mosquitoes, breeding sites (including identifying breeding sites in their homes), control 
measures and disease symptoms. 
While the study is not able to show whether the educational intervention had an impact on action 
being taken against the vector, some studies have shown that such interventions can favour a 
change in the behaviour of the population resulting in a decline in breeding sites. 
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Box 5.4: Malaria control in Khartoum [248-250] 
 
The Khartoum Malaria Free Initiative (MFI) was launched in 2002 by the State and Federal Ministry 
of Health.  This was in response to a high malaria burden – in the 1980s and 1990s malaria was the 
major cause of outpatient attendances, admissions and deaths in Khartoum.  Since the MFI was 
launched total malaria deaths have declined by almost 75% from 1,070 in 1999 to 274 in 2004 and 
parasite prevalence has declined from 0∙78% to 0∙04% (1995-2008). 
The MFI comprises three components (diagnosis and treatment, prevention and epidemic 
surveillance).  The mainstay of prevention is control of the primary malaria vector Anopheles 
arabiensis, which breeds largely in irrigation canals, pools created from broken water pipes, water 
basins and storage tanks.  New agricultural schemes and new construction sites continually create 
more breeding sites.  A number of vector control methods have been put in place: 
 Larviciding and environmental management is undertaken by the MFI which employs 14 
trained medical entomologists, 60 public health officers, 180 sanitary overseers, 360 
assistant sanitary overseers and 1170 spraying men.  
 Removal of water basins and storage tanks is enforceable by law. 
 Regular drying of irrigated fields is compulsory in Government and private irrigation 
schemes and is supported by the Farmers Union and the Ministry of Agriculture.  In 2011, 
98% of irrigation schemes were dried for at least 24 hours. 
 In conjunction with the Ministries of Irrigation and Agriculture, any leakages from 
irrigation canals are repaired and vegetation around canals is cleared. 
 The Ministry of Health collaborates with the Public Works Department (PWD) to repair or 
replace broken water pipes.  The MFI is responsible for surveillance, reporting and 
transportation while the PWD provides engineers and equipment.  By 2004, just under 
4km of water pipes had been replaced and over 6km repaired. 
 The MFI has strong community support which is generated through the distribution of 
information leaflets, regular radio broadcasts and television coverage, health education in 
schools in collaboration with the Ministry of Education, the organisation of an annual 
‘Khartoum State Malaria Day’, public meetings and the establishment of malaria control 
committees and societies. 
 405 schools and 287,000 pupils are involved in mosquito larval control activities.   
 IRS and LLIN distributions are not carried out in Khartoum but LLINs are exempt from 
import tax to encourage sales in the private sector. 
 Malaria case management is strengthened through training on malaria diagnosis and case 
management and provision of antimalarial drugs through the ‘revolving drugs fund’. 
The MFI has strong political support at both State and Federal Level and there is close 
collaboration between the State and Federal Ministry of Health and other Ministries including 
Ministries of Health, Education, Public Works & Agriculture.  Involvement of other sectors has also 
helped to keep costs low – the total annual cost of the programme (which targets a total 
population of 2 million in urban areas, 3 million in peri-urban areas and 0.6 million in rural areas) is 
US$600,000 or around US$0∙10 per person protected per year.  
  
 Community participation in IVM 5.3.1
All vector control activities need community support and participation so considerable effort must 
go into engaging with local communities.  Communities can be actively involved in some vector 
control activities, in particular environmental management.  For example, community participation 
can be crucial for source reduction.  We also provide examples of community participation for 
dengue control in South America (Box 5.5) and community-based environmental management for 
urban malaria control in Uganda (Box 5.6).  Dengue in Africa is an emerging problem and so it is 
useful to learn from established programmes in South America that incorporate strong elements of 
community empowerment and intersectoral collaboration.  We also present the example of Farmer 
Field Schools whereby standard curricula aimed at improving crop yields and reducing pests are 
tailored to include malaria control and farmers are empowered to design and evaluate their own 
control experiments (Box 5.7).  Box 5.8 gives an example of community-based trapping for tsetse 
control in South Sudan which showed benefits against disease but also community empowerment.  
An excellent example of capacity building of community-based Health Extension Workers (HEW) to 
implement IRS in Ethiopia is given in Box 7.3. 
Box 5.5: Community involvement in dengue control [251, 252] 
  
 
Community-based strategies for dengue control incorporating intersectoral collaboration, health 
education, environmental management and community participation have been tested in a 
number of settings in South America.   
‘Clean Backyard’ strategy - Mexico 
In Mexico, the Patio Limpio or ‘clean backyard’ strategy has been implemented.  The idea of this 
strategy is to train community members to identify and eliminate breeding sites, emphasising the 
importance of each household in contributing to fight against dengue and the common aim of 
dengue free community.  During the implementation phase a local assembly is held with 
community members where the concept is explained.  Community leaders known as ‘block 
activators’ are identified from each block and receive training.  The ‘block activators’ then train 
the community members from their block on how to identify and eliminate breeding sites and to 
help them understand the benefits of keeping the household clean.  The ‘block activators’ 
perform a monthly assessment of area the under their control and attend community 
assemblies.  The results of surveillance activities are fed back to the ‘block activators’ and 
recommendations made when expected outcomes are not met.  The effect of the ‘clean 
backyard’ strategy on mosquito breeding sites in Guerrero, a state in south Mexico was assessed 
over one year (2007).  As well as training of the ‘block activators’ and community mobilisation, 
the communication strategy included displaying 18 signboards and 130 posters, three daily 
loudspeaker transmissions in areas such as shopping centres and markets throughout the 
community, and distributing pamphlets to every household visited by block activators.  More 
than 1000 block activators were identified and trained, with an average of approximately 15 
households managed by each activator.  From a sample of 5477 backyards, approximately 54% 
(2918) were designated as ‘clean’ and free of breeding sites.  Further analysis revealed that 
households not visited and assessed by a block activator, had a 2.4-times higher risk of 
developing dengue, compared to those who had been trained and supervised by an activator. In 
addition, 80% of trained households were able to identify a breeding site and mosquito larvae at 
the 3-month follow-up visit.  Sustaining the behaviour change was however, identified as a 
problem with the following up survey at the one year timepoint indicating that only 30% of 
trained households had a clean backyard and were aware of the risks associated with breeding 






Action research to stimulate community participation – Santiago de Cuba, Cuba 
A quasi-experimental study was conducted in Santiago de Cuba, Cuba to assess the effect of an 
intervention to increase stimulate community participation in dengue control on entomological 
parameters.  The intervention aimed to mobilise the community for all stages of A. aegypti 
control, from problem identification, planning, implementation and evaluation.  The intervention 
was implemented according to the following steps: 
1. Formative research using social research methods (e.g. KAP surveys, focus group 
discussions, behavioural observations) to inform the design of the intervention. 
2. Community Working Groups (CWG) were implemented comprising 10-20 members 
including formal and informal leaders, public health workers from the governmental 
vector control programme and the doctors and nurses of the neighbourhoods’ family 
medicine practices.  CWG became responsible for co-ordination of intersectoral action at 
the local level and were asked to rethink ways of involving the community. 
3. CWGs held meetings with the community to identify local needs and priorities for 
dengue control.   
4. Action plans were developed and implemented based on the priorities of the vector 
control teams and community members. 
A social communication strategy using interpersonal communication in face-to-face encounters 
and community meetings, as well as local mass media was used to mobilise the community and 
promote behaviour change.  Behaviour change was promoted with respect to LSM and 
environmental management – for example covering water storage containers, removing 
containers that may fill with water and not removing temephos from water storage containers.  
The CWG secured provision of materials for repair of water containers and construction of covers 
free of charge from the local government.  The CWG also worked with government intersectoral 
committees to negotiate action on larger projects including repairing broken water pipes and 
sealing the foundations of some buildings that served as breeding sites.   For the repair of water 
storage containers and the construction of covers, they secured cement, wood and nylon, which 
was provided free of charge to the community by the local government.  Additionally, risk 
surveillance was set up and consequently conducted by the community through the introduction 
of tools for mapping intradomiciliary and extradomiciliary environmental risks. 
After implementation of the intervention, household risk behaviour was reduced - uncovered 
water storage containers decreased from 49% to 3% and removing larvicide from water 
containers dropped from 46% to 1% between 2000 and 2002.  There was also a reduction in 
entomological parameters with a reduction in the absolute number of positive container by 75% 
and a significant reduction from 1.23% to 0.35% in the house index.   
In conclusion, local CWG were able to engage community members and local government to 




Box 5.6: Community-based environmental management for urban malaria control in Uganda 




Environmental management for vector control involves either habitat modification or 
manipulation with a view to preventing or minimising vector propagation.  A study was conducted 
to assess the strengths and weaknesses of a community-based environmental management for 
malaria control in 2 Ugandan cities: Kampala and Jinja.  Both cities provide ample breeding sites 
for malaria vectors.  In Kampala, high rainfall results in rapid run off of large volumes of water that 
collects in valley bottoms throughout the city and Jinja, being located next to Lake Victoria has 
large areas of swamp. 
Initially, entomological and clinical surveys were conducted to determine the level of transmission 
and intensity of infection in different areas of the city.  Four sites were chosen – in Kampala 
sampling was done in small valleys where flooded brick pits (where clay is collected for brick 
making) and in Jinja sampling sites were close to farmland or swamps. 
In partnership with the local health authorities, community mobilisation by way of house visits 
and meetings was used to inform and engage communities (e.g. youth and womens groups, 
brickmakers).  Based on the survey findings, control options were identified and a participatory 
approach was used to develop community action plans specific to the vector ecology and setting 
in each site.  Communities selected packages of interventions they felt were appropriate to their 
setting.  For example, in Kampala communities decided to fill in puddles, drain the brick pits and 
introduce larvivorous fish into larger water bodies.  In the second year of the study, the 
communities implemented their action plans with support from local health authorities, the study 
team and engineers.   
  










Agricultural environments can provide excellent breeding sites for malaria vectors with clear, 
temporary water bodies coinciding with the time of crop cultivation and a ready supply of human 
and animal hosts for feeding in close proximity.  Widespread use of insecticides for agriculture is 
likely contributing to resistance to public health insecticides such as those used for malaria 
control. 
Malaria control has been integrated into a complementary intervention in rural development 
known as Farmer Field School (FFS) on Integrated Pest Management (IPM).  The FFS is a form of 
education that uses the concept of ‘learning based on experience’ to build farmers expertise.  
During the crop cycle, a group of 15-30 neighbouring farmers meet weekly to make field 
observations and discuss together regarding crop pests, beneficial organisms, plants, soil and 
environmental conditions. The farmers are encouraged to brainstorm and design experiments 
(e.g. "what if, instead of spraying, we drain the water to control planthoppers in rice"), which are 
then evaluated the following week.  These weekly completed learning cycles result in 
strengthened skills and increased confidence of farmers and group dynamics and communication 
exercises are conducted to strengthen group cohesion, maintain motivation and help participants 
to develop organizational skills.  A review of FFS experiences indicated positive outcomes 
including drastic reductions in agro-pesticide use, economic benefits and empowerment effects. 
In malarious areas the IPM curriculum is amended to include the ecology and control of malaria, 
and to involve farmers and others in the control of malaria in their environment.  This combined 
strategy has been labelled Integrated Pest and Vector Management (IPVM).  The best 
documented pilot of this approach is from Sri Lanka where the IPVM curriculum has recently been 
developed for the wetland rice ecosystem.  Learning activities include encouraging farmers to 
identify malaria breeding habitats by sampling using dippers, study the mosquito lifecycle by 
rearing young larvae in water jars covered with mesh and sample and identify adults of the 3 main 
mosquito genera at different times and habitats to gain an understanding of disease vector 
activity.  Farmers also assess the effects of agricultural methods to suppress mosquito breeding 
(e.g. alternate wet-dry irrigation of study field plots, land levelling at planting) and draw maps of 
the village environment with water bodies, crops, houses, etc. to facilitate planning for 




There are 4 different mechanisms by which IPVM FFS can impact on malaria disease i) reduced 
pesticide use reduces selection pressure on malaria mosquitoes, ii) increased awareness and 
understanding about malaria on personal protection measures and treatment-seeking behaviour, 
iii) effect of increased profits from agriculture on housing, nutrition, treatment access etc and iv) 
the effect of environmental management on vector breeding and thus on the transmission of 
disease. 
 
Although this example is from Sri Lanka, the FFS concept is established in sub-Saharan Africa (SSA) 
for increasing agricultural productivity and so the curricula could be adapted to different 
ecosystems where malaria and other VBD are present.  
 
























Box 5.8: Community-based tsetse trapping in South Sudan [255] 
 
 Involving the private sector in IVM 5.3.2
In some areas it may also be beneficial to involve the private sector in IVM, whether this is the 
tourism sector, employer-based VBD control programmes or social responsibility projects.  The 
tourism sector in particular should be encouraged to invest in VBD control since a reduction in VBD 
in an area will have a positive impact on visitor numbers.  For example, hotels may have a role in 
introduction of new dengue virus strains and so should be encouraged to practice source reduction 
around the premises and provide bednets to prevent the establishment of new strains in the 
community.  Businesses such as mines or plantations may provide employer-based VBD control 
programmes run in collaboration with local partners or as a complement to national scale-up 
activities, such as the example of Anglo Gold Ashanti (Box 5.9).  Ranches in human African 
trypanosomiasis endemic areas could be encouraged to implement control measures such as 
insecticide-treated cattle [160].  There are economic and social benefits of businesses investing in 
VBD control and several examples exist showing the cost effectiveness of employer-based malaria 
control programme [256].  Companies can be encouraged to implement social responsibility projects 
in communities, such as the work of Marathon Oil supporting the National Malaria Control 
Programme (NMCP) in Bioko Island, Equatorial Guinea which has helped to reduce the malaria 
burden [257].  Alternatively, vector control programmes can exploit the leveraging effect of private 
companies, for example to secure funding from external donors, jump start intervention scale-up or 
build on existing NMCP operations by providing financial or human resources, expertise and 
South Sudan experienced a resurgence of human African trypanosomiasis in the 1990’s.  
Seroprevalence surveys organised by Cooperative for Assistance and Relief Everywhere (CARE), the 
International Medical Corps, and the US Centers for Disease Control and Prevention (CDC) 
identified foci of high transmission.  In one of these foci (Tambura County) a community-based 
tsetse trapping project was introduced alongside mass screening and treatment.  Villages 
participated in making, setting and maintaining more than 3000 pyramidal traps which were 
placed near places of increased human-vector contact including near village farm plots, water 
sources, and areas in which people gathered firewood. 
A train-the-trainer approach was used.  National health officials were trained on tsetse fly biology 
and control methods.  Community mobilisation was carried out before community selection of 350 
volunteers.  Volunteers were mainly traditional birth attendants.  County health officials worked 
with volunteers to prepare village maps marked with key sites for trap placement.  Volunteers 
were trained to collect flies from the traps and received bicycles to enable them to collect and 
submit caught flies to county health officials.  County officials, in collaboration with CARE 
monitored fly density over time.   
Fly densities caught in traps dropped from 25 per trap per week at the beginning of the project to 
fewer than 3 flies per trap per week.  Importantly, seroprevalence fell from 9% to 2% between 
1997 and 1999. Another benefit of the intervention being community-based was that the 
community members learnt about the causes and prevention of sleeping sickness and were more 
willing to participate in screening and seek treatment.    
  
advocacy.   A management guide to help any company or organization operating in malaria-endemic 





Box 5.9: Business investment in malaria control – Anglo Gold Ashanti in Ghana (adapted from 
[256]) 
 
5.3.2.1 Supporting interventions 
Once vector control tools have been selected, it is important to consider which supporting 
interventions need to be rolled out.  Communities need to be informed about diseases, their 
transmission and control methods.  Supporting interventions can play a major role in encouraging 
correct use and care of interventions such as LLINs and IRS.  For example, LLIN distribution 
campaigns may be accompanied by distribution of Behaviour Change Communication (BCC) 
messages using radio spots, posters and leaflets, or may be followed up by hang-up campaigns 
where community volunteers visit households to hang up nets and distribute messages about 
The gold mining company Anglo Gold Ashanti are based in Obuasi, Ghana, a malaria endemic area.  
In 2004, malaria accounted for 22% of all deaths in the community and the local hospital and 
clinics saw as many as 12 000 confirmed and unconfirmed cases of malaria per month.  The cost to 
the company in providing malaria care to workers and their dependants was also massive, with 
approximately US$ 55 000 spent each month on treatment alone. 
To address this problem, in 2005 the company decided to implement an integrated malaria 
control programme focusing on mineworker housing and infrastructure, as well as surrounding 
villages.  Importantly, the programme was developed and conducted in partnership with the 
Ghana Health Service, Ghana National Malaria Control Programme and the Obuasi Municipal 
Assembly. It also had to be aligned closely to Ghana’s National Malaria Plan.  The programme 
consisted of vector control (LLINs, IRS and larviciding) and diagnosis and treatment of confirmed 
cases with artemisinin-combination therapies (ACTs), alongside information, education and 
communication campaigns. 
After implementation of the programme there was a drop in the number of malaria cases 
reported at the mine hospital from 6600 cases per month in 2005 to 1150 cases per month in 
2009.  Absenteeism due to malaria was also reduced – average monthly lost days of work due to 
malaria fell from 6983 in 2005 to 282 in 2009.  There was also a reduction in average monthly 
medication costs to the company from US$ 55,000 in 2005 to US$ 9,800 in 2009.   
KEY POINT 
Vector control programmes should consider involving the 
private sector in VBD control activities.  There are economic 
(reduced direct and indirect costs of VBD) and social (build 
reputation of company for social responsibility and good 
corporate citizenship) benefits of businesses investing in VBD 
control.   
  
benefits and use of LLINs.  The use of theatre, songs and dance to inform communities about 
diseases and control methods and encourage behaviour change is described in two examples in Box 
5.10.  Text-messaging could also be used to distribute messages and encourage behaviour change 
[259].  For example, text message reminders of intermittent preventive treatment of malaria in 
pregnancy (IPTp) visits could be combined with messages on LLIN use for pregnant women [260].   
Box 5.10: The use of folk theatre to encourage behaviour change for malaria control [261, 262] 
 
Kalajatha is a popular, traditional art form of folk theatre in India.  It is an effective medium of 
mass communication in the Indian sub-continent, especially in rural areas where due to the low 
literacy rate many conventional methods such as posters, pamphlets, hoardings and electronic 
media have limited effects.  
In 2001 Kalajatha was used disseminate health education messages for bio-environmental control 
of malaria in Tumkur District, Karnataka State, south India.  The National Institute of Malaria 
Research (NIMR) and Community Health Cell (CHC), Bangalore jointly initiated the programme and 
an inter-sectoral co-ordination committee was formed for coordination purposes.  Support of local 
government was obtained.  The district health committee headed by the District Commissioner 
approved the proposal of the Kalajatha programme.  NIMR and CHC, the Departments of Health, 
Education, Child and Women's Welfare, Rural Development and Panchayat Raj, Tumkur Science 
Forum, local political and religious leaders actively participated in this programme. 
Thirty local artists were selected and scriptwriter wrote songs, drama s and musical dramas.  
Topics covered by the theatre included signs and symptoms of sickness, treatment, health 
facilities, transmission, role of anopheles mosquitoes and breeding sites of mosquito vectors.  The 
theatre pieces also covered malaria control strategies focusing especially on larvivorous fish 
(Poecilia reticulata and Gambusia affinis) and environmental management.  Events were publicised 
widely and community consent was given for the events to take place by community leaders.  
Local media covered the events also and helped in spreading the key messages. 
The impact of the folk theatre events was assessed after 2 months by comparing the knowledge of 
Kalajatha attendees versus those that were not exposed using semi-structured questionnaires.  
Kalajatha attendees had a significant increase in knowledge about malaria, its symptoms, 
transmission and control methods.  They could easily associate clean water with anopheline 
breeding and the role of larvivorous fish in malaria control.  The year after the Kalajatha events 






 Cross-border initiatives for vector control 5.3.3
In some situations it may be worth considering cross-border initiatives for VBD control.  There are 
several examples of this including the Trans-Kunene Malaria Initiative (TKMI) in the Trans-Kunene 
region comprised of Cunene and Namibe provinces in Angola and Kunene, Ohangwena, Omusati 
regions in Namibia.  A good example for malaria control is provided by the Lubombo Spatial 
An example of the use of folk theatre for behaviour change communication in sub-Saharan Africa 
is that of Netos de Bandim.  This is a youth dance group based in Guinea-Bissau which designs 
community education campaigns using dance, theatre, music, poetry and community dialogues to 
convey public education messages.  They have conducted campaigns focusing on HIV/AIDS, 
cholera and malaria. 
In 2011 Netos de Bandim worked with UNICEF to educate over 2000 families in 10 Bissau 
neighbourhoods about malaria prevention and protection.  The leaders of Netos de Bandim learn 
about the issues they will be working on and teach the youth members of the dance group about 
it.  The youth then work in groups or individually to come up with role-plays, songs and poetry to 
help convey the message.  The dance group deliver these behaviour change messages by 
organising large block parties in Bissau neighbourhoods which drew large crowds due to the big 
reputation and following of Netos de Bandim.  Once the young people of the community see the 
plays they mimic them and reproduce them daily in their communities as a game.  This helps to 
reinforce the messages expressed. 
 
The project enabled over 100 young people of the dance group to learn about malaria and to 
exercise leadership through teaching their community about malaria prevention.  The approach 
also preserves and encourages appreciation for various cultural dance forms and other cultural 
traditions, which helps to promote ethnic tolerance and social cohesion. 
  
Development Initiative (LSDI) cross-border collaboration for malaria control between Swaziland, 
Mozambique and South Africa is outlined in Box 5.11.  In the past, cross-border initiatives have also 
been implemented for control of human African trypanosomiasis.  For example, the Regional Tsetse 
and Trypanosomiasis Control Programme (RTTCP) between Zimbabwe, Mozambique, Malawi and 
Zambia in the 1980’s [263]and Farming in Tsetse Controlled Areas (FITCA) between Uganda, 
Ethiopia, Kenya and Tanzania in the late-1990’s to early 2000’s [264].  Where areas of tsetse 
infestation cross country boundaries, coordinated effort is required to control tsetse successfully 
and prevent re-invasion. 
Box 5.11: Lubombo Spatial Development Initiative (LSDI) for malaria control [265, 266] 
 
The Lubombo Spatial Development Initiative (LSDI) is a tri-lateral development programme 
between the governments of Mozambique, Swaziland and South Africa which includes malaria 
control as a key component.  The Lubombo region comprises of eastern Swaziland, southern 
Mozambique (Maputo province), and northeastern KwaZulu-Natal.  The LDSI was established in 
1999 with the signing of a protocol of understanding by the heads of state of the 3 countries who 
set up a tri-national malaria control programme (MCP) coordinated by the Malaria Research Unit 
(MRU) of the South African Medical Research Council (MRC).  The tri-national MCP met quarterly 
to address any issues.  Comparatively strong control programmes in Swaziland and South Africa 
meant that the programme focused on extending effective control into southern Mozambique 
which was an important reservoir of transmission and point source for imported cases given the 
substantial levels of population movement across the region.  The programme is 2-pronged: 
prompt diagnosis and treatment of malaria cases and vector control, mainly using IRS.  Vector 
control using IRS was rolled out into southern Mozambique in a staged fashion from between 
2000 and 2004.  Impact was monitored using annual cross-sectional surveys to assess prevalence 
of P. falciparum infection, entomological monitoring and malaria case notification in neighbouring 
Swaziland and South Africa.  Significant reductions in Plasmodium falciparum prevalence were 
reported in southern Mozambique, along with reductions in notified cases in Swaziland and South 
Africa over the same time period.  The project was so successful that it was expanded in Gaza 
Province in Mozambique which borders on Mpumalanga and Limpopo provinces in South Africa. 
This brought the contiguous area under malaria control by the LSDI malaria control programme to 
more than 200,000 km2. 
Capacity and infrastructure development played a large role in the programme.  For example, the 
LSDI malaria control offices set up in close collaboration with provincial health departments in 
Mozambique.  Local staff were trained in order to be able to coordinate and manage the 
programmes with skills transfer and supervision from experts in Swaziland and South Africa. 
Annual training camps for IRS operators were held before the onset of each spraying round to 
ensure sprayers were competent and maintain consistency across areas.  Healthcare providers 
were trained in malaria diagnosis and treatment and monitoring and evaluation.  A 
comprehensive malaria information system with a spatial component was developed which 
facilitated planning and monitoring of spraying by providing managers with information on 
malaria cases and vector control activities. The success of the program in reducing malaria 







CHAPTER SUMMARY  
 In terms of IVM implementation, you should consider what, where, when and by who 
interventions will be implemented and how? 
 Vector control interventions can be targeted in space and time – this is usually done 
against a background of interventions such as LLINs which are implemented on a 
continuous basis. 
 By targeting vector control interventions in space and time, we can use resources more 
strategically under routine conditions or target areas for epidemic control or foci of 
insecticide resistance.  
 The timing of implementation should also be considered in order to maximise the effects 
of the intervention on vectors and disease. 
 Interventions that require strong logistical support and technical knowledge are generally 
implemented by vector control programmes.   
 Co-delivery of interventions can have a number of benefits, including resource savings. 
 IVM should involve other sectors where possible in vector control.  Community 
participation and the skills and resources of private sector companies should be harnessed. 
 Regional partnerships such as the Lubombo Spatial Development Initiative can be 
beneficial for VBD control. 
 
  





When the locally appropriate vector control methods have been selected, an inventory should be 
made of the financial resources, human resources and infrastructure (research/training/technical 
and operational facilities) available for vector borne disease (VBD) control at national, provincial or 
district level.  As mentioned in Chapter 2, WHO materials on vector control needs assessment and 
the IVM curriculum may be helpful in assessing country capacities and resources [11, 267].  The 
organizational structures in which the resources could be used should also be assessed.  This is likely 
to vary according to the country, province and district but we provide here some suggestions to help 
you plan.   
The inventory of resources and organizational structures requires the participation of local 
stakeholders.  Possible links and collaboration with other local programmes or government services 
should be discussed, so that activities are coordinated in order to ensure consistency and avoid 
duplication.  The potential resources include those received from national programmes for VBD 
control, district health offices, local government and other public sectors, the private sector, civil 
society organizations and the community.  The amount and type of resources depend on the 
diseases and vectors targeted.  For example, vectors that breed predominantly in irrigated 
agriculture require strong engagement from the agriculture sector, whereas vectors that breed in 
the peri-domestic environment might require community participation in the removal of breeding 
sites.  Vector control programmes and other units in the Ministry of Health, along with other sectors 
may contribute to IVM financially.  However, other contributions including human resources (e.g. 
expertise or personnel time) and material resources (e.g. equipment, fuel, transport, commodities) 
are equally important and should be encouraged.   
3. Selection of 
vector control 
methods 
4. Needs & 
resources 
5. Implementation  
6. Monitoring & 
evaluation 
1. Disease situation 
• Epidemiological assessment 
• Vector assessment 
• Stratification 




The methods selected for vector control also have implications for the types of resources needed.  
For instance, IRS requires trained spraying teams under proper supervision, which often demand 
substantial financial and logistic support.  Local requirements for capacity-strengthening should also 
be identified.  Investment in training and refresher training of staff and volunteers should be 
promoted.  The role of community members, community health workers and agricultural extension 
workers could be enhanced relatively quickly by practical short courses on vector biology, ecology 
and control methods.  The experience of the agricultural sector in training farmers in integrated pest 
management could be used (see Box 5.7). 
6.1 Financial resources   
Typically costing is done at the national level based on a strategic plan with clear terms of reference.  
Sources of financing for IVM will differ by country but typically there are two sources; external donor 
funding such as that from the Global Fund or Presidents Malaria Initiative or in-country funding, for 
example from tax revenues or reprioritising country budgets.  Funding from donors is likely to 
remain disease specific to some extent.  However, it is possible to include activities or commodities 
which cut-across diseases in these proposals.  For example, Global Fund proposals could include 
developing capacity in entomological surveillance which would be of benefit to other VBD 
programmes if these programmes worked in a more integrated manner.  Innovative financing 
mechanisms such as social insurance should also be considered.  
Funding for the ISC should be provided centrally by the government since a committee funded by 
project funds will not be sustainable.   
One important aspect of IVM programmes is that cost savings can be made by using one 
intervention against more than one co-endemic diseases and by sharing entomological expertise, 
field visits, transport and equipment more efficiently across VBDs.  Savings can also be made in the 
long term by using interventions outside the health sector.  For example, well-constructed drainage 
channels may provide a long-term solution to reducing anopheline and culicine breeding sites in 
urban areas.  In this situation the cost of control could be met by the Department of Public Works 
and not the Health Department.  Encouraging other sectors to contribute resources, particularly 
financial resources, will require strong advocacy from the ISC and the Ministry of Health.   
6.2 Human resources and capacity building 
The IVM strategy requires skilled staff at central and local levels.  Training, support and career 
structures are required to be able to effectively plan, monitor, evaluate and manage IVM 
programmes.  Clear job descriptions and careers structures need to be put in place.  For example, in 
South Africa, Sudan and Zimbabwe there are clearly defined cadres of public health entomologists 
with different job descriptions, from national senior entomologist, entomologists at state level, 
assistant entomologists and mosquito collectors [268].  Clear career structures which outline 
competencies and opportunities for advancement are an important incentive for people to seek 
training and help to retain staff [269].   
Human resources should be shared both within and external to the health sector in pursuit of IVM.  
Sharing human resources starts with the effective communication of IVM objectives, indicators and 
expected targets and outcomes within the health sector and beyond.  Transparency is the key to 
  
identify the most cost effective way to deliver health services in affected communities to benefit all 
involved.  Figure 6.1 provides an example of human resource sharing within the health sector to 
support an IVM approach using IRS and LSM to control lymphatic filariasis and malaria vectors in 
affected communities.  Human resources could be shared in a similar fashion between the health 
sector and other sectors.   
 
Figure 6.1: Example of human resource sharing to support an IVM approach at district level.  
Capacity building and supportive supervision should be strengthened.  Useful training resources 
include the Core Structure for Training Curricula on IVM [267] which provides advice to regions and 
countries on preparing their own training curriculum for IVM.  The training curriculum document 
does not duplicate existing specialised courses on medical entomology and vector control since 
these materials are likely to be familiar to VBD programmes.   
Training provided should be based on a training needs assessment carried out by the Ministry of 
Health in relation to their Training Curricula on IVM to ensure that training is directly relevant to the 
expected skills of the cadre.  However, key capacity gaps may include project management skills,  
geographic information systems (GIS), mobile communication technology and information 
communication technology to enable more effective collection and response to entomological and 
epidemiological field data [268, 270].  These tools are increasingly being used to refine strategies, 
target interventions in space and time (see Box 5.1 for how surveillance data has been used to target 
interventions in South Africa) and monitor and evaluate their impact.  Capacity building in 
entomological surveillance is essential given the importance of this to deploy interventions correctly 
  
based on vector ecology and behaviour, and evaluate the impact or interventions, including on 
insecticide resistance.   
Efforts should be made to strengthen collaboration between VBD control programmes and national 
universities / training institutions, perhaps through the establishment of formal agreements [270].  
Research capacity strengthening and training on other activities could also be provided by national 
universities, training and research institutions or overseas research institutions.  A directory of 
African institutions with existing capacity for training in IVM has been produced [271].  Establishing a 
network of training and mentoring opportunities for staff including public health entomologists and 
monitoring and evaluation staff is essential.  Box 6.1 outlines examples of a number of medical 
entomology courses which are available [268]. Cross-border collaborations such as the Lubombo 
Spatial Development Initiative (Box 5.11) can also be beneficial for capacity building since training 
resources are shared across countries.   
Retention of staff and the institutional memory on IVM should also be considered.  It is important 
that IVM activities are not solely dependent on key individuals and that training documents and 
SOPs are developed.   
Box 6.1: Examples of entomological capacity building opportunities [268] 
 
6.3 Infrastructure (research/training/technical and operational facilities) 
Adequate infrastructure should exist in order to plan and implement an IVM programme.   Activities 
should be built around established structures which exist within VBD control programmes.  There 
may be opportunity to share facilities and equipment with the National Malaria Control Programme 
which in sub-Saharan Africa likely to be the most well-resourced vector control programme.  In 
particular, infrastructure such as entomological laboratories for vector collection, rearing, 
identification and bioassays may need to be upgraded and an insectary should exist at least at 
Master of Science (MSc) course in Medical Entomology and Vector Control 
The MSc was launched in 2008 by the Blue Nile National Institute for Communicable Diseases 
(BNNICD) at University of Gezira, Republic of Sudan, in collaboration with London School of 
Hygeine and Tropical Medicine, Liverpool School of Tropical Medicine and Witwatersrand 
University.  The course is supported by WHO Eastern Mediterranean Regional Office (EMRO) and 
was initiated through an EMRO Regional Committee resolution in which IVM was endorsed as the 
regional strategic approach for VBD control and capacity was identified as a key requirement.  
Over 80 people from 12 countries of the African and Eastern Mediterranean WHO regions have 
been trained over the past 3 years. 
International Masters Degree in Entomology 
This course is run jointly by the Institute for Research and Development (Benin), Montpellier 
University (France), Abomey-Calavi University (Benin) and the Entomological Research Centre of 
Cotonou (Benin).  Topics covered include systematics, biology and ecology of vectors of medical 
interest and epidemiology and control of VBDs.  In the first 6 years of the course since inception in 
2006, a total of 91 students from 24 countries have graduated from the course. 
  
national level that is able to maintain a susceptible Anopheles colony for insecticide resistance assays 
[268]. 
Strengthening information systems for IVM should be a priority.  Information, communication 
technology and mobile technology communication infrastructure should also be upgraded to 
provide fast and accurate information collection and assessment, for example tablets for remote 
collection of data.   
6.4 Tools and resources for resource planning 
To help estimate the financial resources needed for an IVM programme one could use the Tool for 
Integrated Planning and Costing (TIPAC) (http://www.ntdenvision.org/resource/tipac_multilingual). 
TIPAC is an Excel program that can be used for estimating the costs and funding gaps of public health 
programmes, including IVM programmes.  It can be used in conjunction with existing national 
strategic plans and budgets in order to effectively plan and coordinate future programme resources. 
The program is not a substitute for a plan of action or programme budget but it can help with 
resource planning and revising a national plan to meet resource constraints. 
The OneHealth Tool (OHT) can be used to determine the financial requirements associated with 
scaling up malaria interventions, as well as health impact projections, health systems planning, 
scenario analysis and fiscal space analysis [272]. It has been used by a number of countries for 
national strategic planning and costing purposes.  Other VBDs are not included in this tool as yet. 
Although to meet the target of universal LLIN access, WHO recommends that one LLIN be distributed 
for every two persons at risk of malaria, many households have odd numbers of people.  Therefore 
when procuring LLINs, WHO continues to recommend using an overall ratio of one LLIN per 1.8 
persons in the target population [35, 273].  WHO’s IRS operational manual provides guidance on 
costing, budgeting and financing [36].  An example of items that need to be costed in an IRS 
programme is shown in Table 6.1. 
Table 6.1. Example of capital and operational budgets for an IRS campaign (adapted from [36]) 







Baseline epidemiological and entomological review and 
survey 
   
Environmental impact assessment    
Compression sprayers    
Equipment, spares and replacement parts    
Tool kits    
Protective sheeting to cover household goods    
Transport: truck/boats for 3–4 spray teams    
Transport: supervisors’ motorcycles    
Transport: coordinators’ 4 X4s    
Malaria camps – storage and base    
RECURRENT 
Spray insecticides including buffer stocks    
QA / QC of IRS    
  
Salaries of spray operators for 4–8 weeks (adjust to 
minimum wage) 
   
Personal protection equipment (overalls, gloves, helmets, face 
shields with screen) 
   
Collection and disposal of empty sachets and containers    
Travel and per diems for supervisors and coordinators for 
duration of the campaign 
   
Transport hire and fuel costs    
Annual training of coordinators and supervisors    
Annual training of spray operators    
Annual IEC and campaigns (community mobilization materials)    
Annual review of environmental compliance and pesticides 
management 
   
Monthly, quarterly and annual operations management 
meetings 
   
IRS data entry and summary reports sheets    
Malaria prevalence surveys (optional)    
Entomological studies and sentinel sites    
Annual post spray review and annual report production    
 
Decision making and financial planning for tsetse control is complex due to the large number of 
variables which need to be decided on – for example location, timing, strategy and methods 
employed.  Decision support and costing tools available for human African trypanosomiasis vector 
control include ‘Tsetse Plan’ (planning of community-based operations using bait technologies), 
‘Tsetse Muse’ (planning large-scale tsetse control operations using any method and HAT-trick 
(operations intended specifically to control sleeping sickness).  All of these tools can be downloaded 
from the www.tsetse.org website.  A useful paper by Shaw et al describes the costs of tsetse control 













 An inventory should be made of the financial and human resources and infrastructure 
available and required for vector borne disease (VBD) control at national, provincial or 
district level.   
 It should also be noted that resources can be engaged from other sectors depending on the 
type of interventions put in place. 
 A number of tools are available to assist with resource planning. 
  
 Operational and implementation research to support IVM  7
Integrated vector management (IVM) programming should be evidence-based – ideally founded on 
sound operational research and surveillance data.  Countries should identify operational and 
implementation research questions around IVM planning and implementation in their setting.  A 
working group under the IVM Steering Committee (ISC) could be tasked with identifying suitable 
operational research questions.  Some of the types of questions which could be answered using 
operational research are outlined in Box 7.1.  Many of the study questions outlined in Box X are 
illustrated with practical examples in this toolkit. 
Box 7.1: Types of questions which could be addressed using operational research 
  
To answer these operational research questions, different study designs will be required.  Studies 
measuring efficacy of an intervention will use an experimental design and are often randomised.  
Studies looking at the feasibility of community delivery of interventions may assess process 
indicators looking at training, intervention coverage, cost and resource use and community 
satisfaction.  Studies looking at adherence will usually measure adherence using cross-sectional 
Efficacy   What is the added benefit of larval source management (LSM) on 
top of long-lasting insecticidal nets (LLINs) for malaria control? 
Delivery  Can community health workers delivering preventive 
chemotherapy be tasked with larviciding of breeding sites? 
  Use of community groups to conduct environmental 
management? 
  Use of community members to install, maintain and monitor traps 
for tsetse control? (Box 5.8) 
Targeting  Is targeted use of indoor residual spraying (IRS) for leishmaniasis 
more effective than blanket spraying? 
  Are people living next to irrigation canals more likely to suffer 
from malaria? 
  Can geographical information systems (GIS) be used to target 
interventions more effectively at district level? 
Community mobilisation 
/ acceptability / 
adherence 
 How effective are behaviour change communication radio spots 
for increasing adherence to use of LLINs? 
 Does an educational intervention on dengue transmission and 
prevention in schools increase knowledge of pupils and their 
families? 
Cost / cost effectiveness  Is community health worker led IRS more cost effective than 
vector control programme led IRS? (Box 7.3) 
Surveillance  Use of mobile technology to collect information on cases from 
peripheral health centres. (Box 8.2) 
  Use of school children to identify rodent habitats for zoonotic 
leishmaniasis? 
  Use of community members to operate and collect mosquitoes 
from window traps  
  Use of community members to identify and conduct larval 
surveillance of breeding sites (Box 9.2) 
 
  
   
  
  
surveys of community members using questionnaires.  A good general resource for field trials of 
different types is the book ‘Field Trials of Health Interventions in Developing Countries: A Toolbox’ 
[274]. 
7.1 Assessing the efficacy of vector control interventions which do not 
have WHO approval 
Vector control interventions which do not have WHO approval require robust clinical trials to assess 
their efficacy against epidemiological outcomes.  For an intervention to receive a recommendation 
from the World Health Organisation (WHO) it needs to show a public health impact.  In addition, 
entomological outcomes may also be assessed to help support the clinical findings.  Interventions 
tested are often thought to have a community effect on the vector population (e.g. LLINs, IRS), killing 
so many vectors that they reduce the survival of the whole vector population, helping to reduce the 
proportion of older vectors, those most likely to be infective.  These studies are generally cluster-
randomised controlled trials whereby communities or geographic areas are randomly allocated to 
control and intervention.  Studies need to be conducted in a rigorous manner with adequate sample 
sizes so that they are powered to answer the question they set out to answer. 
In order to conduct these sorts of clinical trials we would recommend that VBD control programmes 







7.2 Piloting and scaling up recommended vector control interventions 
Interventions that have WHO approval, for example World Health Organisation Pesticide Evaluation 
Scheme (WHOPES) approved insecticides for IRS or larvicides for LSM, have a robust evidence base 
and do not generally require robust randomised controlled trials to be conducted in country before 
scaling up.  Of course, it is important to make sure that local entomologic and socio-behavioural 
parameters are measured to ensure that, for example the feeding or resting behaviour of vectors 
and community acceptance are in support of the intervention.  When implementing additional 
interventions, we recommend starting small (for example in a district) and monitoring and 
evaluating their effect before going to scale.  Small pilots provide a learning opportunity to refine 
implementation of the vector control method and train staff before scaling up.  
In terms of study design for the pilot implementation, it is recommended to have a minimum of a 
controlled before-and-after design with entomological data collected before and after introduction 
of the intervention.  A diagrammatic representation of a controlled before-and-after study is given in 
Figure 7.1.   
  
KEY POINT 
Should you wish to test new interventions, perhaps developed in 
your country or elsewhere, it is a good idea to partner with academic 
or research institutes who will be able to share their knowledge on 
how to design, evaluate and analyse complex studies.  Your study 
plan should ideally be checked by someone with expertise on study 








Figure 7.1: Schematic illustrating features of a controlled before-and-after study 
Pilot studies should include between 1 and 4 clusters i.e. communities or defined geographic areas in 
each group.  Since vector density is often highly dependent on weather, in particular rainfall, it is a 
good idea to collect environmental data alongside entomological data.  Ideally, you should have a 
control site where the intervention has not been implemented but entomological measurements are 
conducted in the same fashion as the intervention site.  This can help to control for other factors 
which may be affecting your data.  A randomised trial would be better since by randomisation one is 
more likely to have similar villages (or in urban areas, sites) in either arm of the trial.  For example 
splitting a sentinel site into two areas and randomly assigning each area to receive either the 
intervention or control is a good idea.  If the interventions are allocated randomly there may not be 
any need to collect baseline entomological data, although if your number of clusters is small it is 
good practice to do this anyway. 
We would also recommend collection of entomological data for at least 4-6 months both pre-
intervention (baseline) and post-intervention, if feasible, or for a whole transmission season if 
possible.  However, this depends on the seasonality of transmission and the urgency for control.  
Ideally, the sampling sites for entomological data collection should be selected randomly.   Minimum 
expected requirements for the pilot study, alongside stricter requirements for a higher quality study 
are given in Table 7.2. 
Table 7.2: Minimum and improved pilot study requirements 
Criteria Minimum requirement Improved  
Control site Control site  
Randomisation Non-randomised allocation of 
areas to intervention and 
control 
Randomised allocation of areas to 
intervention and control 
Pre-intervention data Four to six months of baseline 
entomology data from 
intervention and control areas 
One year or transmission season of 
entomology and clinical data from 
intervention and control areas 
Post intervention data Four to six months of post-
intervention entomology data 
from intervention and control 
areas 
One year or transmission season of 
entomology and clinical data from 
intervention and control areas 
Data collection Entomological and 








Replication of study 
units  
At least one data unit (e.g.  
village or area) per arm. 
More than one data unit (e.g. village or 
area) per arm or number of data units  
justified by sample size calculations to 
show an effect on entomological 
and/or clinical indicators. 
Selection of sites for 
entomological 
monitoring 
Non-random selection of sites 
for entomological sampling. 
Random selection of sites for 
entomological sampling.    
 
The effectiveness of the intervention against entomological criteria should be evaluated.  
Epidemiological data can be collected but often this requires a study with a large sample size (with 
adequate power) to detect an effect.  We would recommend scaling up an intervention that reduces 
adult vector density by at least 50% [44, 275].  As well as measuring the effectiveness of the 
intervention, pilot studies should be used to learn and develop best practice.  Sentinel sites can then 




An example of a simple pilot study which utilised a before-and-after design to assess the effect of 




If your resources are meagre, then test the new intervention in two 
similar locations. Collect baseline entomological baseline for at least 
four to six months. Then flip a coin so that you randomly assign the new 
intervention to one of the two sites and try out the new control 
method. Collect entomological data in both villages for a further four to 
six months. 
  
Box 7.2: Controlled before-and-after study to assess contribution of microbial larvicides and LLINs 
for malaria control in Western Kenya (adapted from [276]) 
 
A small pilot study of the use of microbial larvicides was conducted in a 4.5 km2 area in and around 
a large village in rural western Kenya.  The pilot study utlised a non-controlled before-and-after 
design.  From mid-June 2002 to mid-September 2004 (the intervention period) mosquito larvae 
were controlled using B. sphaericus and B. thuringiensis var. israelensis.  Adult and larval surveys 
were conducted for 12 months before and after the intervention period (non-intervention periods).  
No control site was used.    
Application of larvicides reduced the 
proportion of aquatic habitats containing 
Anopheles larvae from 51% during non-
intervention periods to 7% during the 
intervention.  The occurrence of late instar 
Anopheles in habitats was reduced from 
39% and 33% in pre-intervention and post-
intervention periods to 0.6% during 
intervention. Overall, larviciding reduced 
Anopheles larval density by 95% and 
human exposure to bites from adults by 
92%.  The estimated cost of providing this 
protection to the human population in the 




Blood-fed Anopheles adults [Williams mean values of An. gambiae (97%) and An. funestus (3%) combined] per person 
per sampling date during non-intervention and intervention periods (black bars) in relation to rainfall pattern (blue 
area, fortnightly sum in mm). 
 
 
0.7 Anopheles bites / 
person / sampling date


































































































































2001 2002 2003 2004 2005
Pre-Intervention  Intervention Post-Intervention
0.06 Anopheles bites / 
person / sampling date
0.9 Anopheles bites / 









7.3 Other operational and implementation research questions 
Alongside efficacy of vector control interventions, there are a number of other aspects that one 
might be interested in researching: for example cost and cost effectiveness, targeting of 
interventions and feasibility of community-based delivery or surveillance.  Box 7.3 provides an 
example of a pilot study which assessed the feasibility of community-based IRS, which also looked at 
resources used, cost, coverage and satisfaction.   
Box 7.3: Implementation of vector control by health extension workers in Ethiopia [277]  
 
Ethiopia has a health extension programme with the aim of increasing access to basic curative and 
preventative healthcare in rural areas.  The government have trained about 34,000 community-
based health extension workers (HEW) and deployed them to village health posts in 15,000 rural 
kebele (smallest administrative unit consisting of about 1000 households), with two HEW in every 
kebele of about 5000 people. 
IRS is the main component of malaria vector control in Ethiopia.  Normally IRS is district led with 
spray operators hired from towns in the district that travel out to villages from one of two district 
operation sites in vehicles to conduct the IRS.  However, in many cases operators are not familiar 
with the villages and are not trusted by communities and costs of travel to the villages and 
camping equipment can be large.  In 2012 a President’s Malaria Initiative (PMI) funded pilot  study 
by the Africa Indoor Residual Spraying project (AIRS) trained existing cadres of HEW to implement 
community-based IRS in one district.   
In the programme each kebele had its own spray squad – each led by a HEW acting as squad leader 
who assumes responsibility for managing store rooms, washers, operators, and the data collection 
and reporting processes.  Operation sites were set up in the health posts.  The HEW supervises all 
members of the spray squad (consisting of four spray operators, a washer/guard and a porter, all 
paid staff) who are recruited from kebele.  Around four squad leaders are supervised by one 
district expert or team leader, who is themselves supervised by the Malaria Focal Person (MFP) for 
the District.  The MFP is in charge of the entire operations.  The Environmental Health Officer also 
closely supervised the operation.  A clerk stationed at the District Health Office was responsible for 
daily data entry and reporting.  The figure illustrates the staff organogram. 
The roles of the HEW are to: 
- select capable spray operators and train them on spraying techniques, communication and safe 
handling of pesticides, in collaboration with district health services. 
- consult with community leaders to plan the start and end dates of IRS in the kebele 
- lead and supervise the spraying 
- mobilise the community to cooperate and participate in IRS operations, including ensuring that 
all households are aware of the spraying and what they need to do to make their homes ready for 
the spray operation. 
- educate communities about benefits of IRS and what to do after their houses have been sprayed. 






A train-the-trainer approach was used.  HEW were trained over five days by district health staff on 
key IRS implementation strategies, spray pump maintenance, communication skills and messages, 
and data recording and reporting.  HEW then selected and trained spray operators from the 
communities. In 20 IRS targeted kebeles, HEWs recruited 100 SOPs (five from each kebele) and 
taught them for six days on IRS operations in their kebeles, with minimal support from the district 
health staff and the project. 
During 22 days the pilot IRS project sprayed 22,744 structures which accounts for 98% of all 
eligible structures found.  No vehicles were required to transport the spray operators and no 
camping facilities since spray operators work in the village where they live or nearby.  Only one 
vehicle was deployed for supervision and timely collection of spray operation reports from the 
kebele.  More spray operators were required than for a normal district-led IRS campaign- five from 
each kebele compared to normal practice where 20 spray operators cover the whole district.  
Training costs were higher but the team took less time to complete the IRS (22 days versus an 
average of 31 days for district-led IRS).  Although community-based IRS was only marginally 
cheaper than district-led IRS in this pilot, this was because of initial outlay on construction of soak 
pits and equipment for each kebele.  In the long run, community-based IRS is expected to produce 
savings of up to 40% compared to district-led IRS.  Spray quality was high and feedback on spray 
operator performance was good.  It is thought that a sense of ownership by the HEW and spray 
operators in serving their own communities contributed to this. 
 
  
   
CHAPTER SUMMARY 
 IVM should be evidence based.  This evidence can come from surveillance or 
operational/implementation research.  
 A working group under the ISC should be tasked with identifying operational research 
questions. 
 Operational research can look at efficacy of interventions, targeting, delivery, new 
methods of epidemiological or entomological surveillance, cost and cost effectiveness 
and community mobilisation/acceptability or adherence. 
 Interventions that are not recommended by WHO generally require testing using robust, 
well conducted randomised-controlled trials.  Research institutions should be brought on 
board as partners if these types of studies are to be conducted. 
 Interventions which have WHO approval but have not been implemented in your country 
should ideally be piloted at small scale before rolling out.  These pilot studies should 
assess the effect of these vector control interventions against entomological parameters. 
 Minimum study requirements would be a controlled before-and-after design with 
environmental and entomological data collected for four to six months pre- and post-
intervention and at least one data unit (e.g. village or geographic area) per arm. 
 Pilot studies also provide an opportunity for learning how to optimise intervention 
delivery and for training staff. 
  
 Vector surveillance 8
8.1 Functions of vector surveillance 
Routine vector surveillance should be conducted throughout the life of the integrated vector 
management (IVM) programme.  The purpose and objectives of entomological surveillance will differ 
depending on the stage of the programme.  The stages of programme can be classified as i) 
preliminary survey, ii) trend or regular observations, iii) foci investigation, iv) spot checks and v) 
vigilance [278] (Figure 8.1). 
Preliminary surveys are rapid, short term surveys and employ a limited number of techniques to 
delineate areas with vector borne diseases (VBD) and allow planning of control measures.  They are 
generally conducted where little or no information on vectors is available and are a first step in 
baseline data collection. 
Trend or regular observations can be conducted in areas either where no vector control measures 
are in place or where measures are already in place.  Where no vector control measures are in place 
regular observations can follow on from the preliminary survey and establish in more detail baseline 
information on the role of vectors in transmission, geographical & seasonal distribution, feeding & 
resting behaviour and susceptibility to insecticides.  Where vector control measures are in place 
regular entomological surveillance is used to monitor and evaluate the effect of the programme on 
the vector(s) and is mainly concerned with changes in vector density. 
Foci investigation is a short term, reactive activity conducted as part of a larger epidemiological 
investigation.  The aim of foci investigation is either to explain the reasons for non-response of 
vectors to vector control measures, for example due to reduced insecticide susceptibility or to 
investigate persistence /recurrence of VBD transmission.  The trigger to begin an epidemiological 
investigation can be either clinical (e.g. ‘hotspot’ of infection or clinical disease or persistence / 
recurrence of high levels of infection or clinical disease) or entomological (e.g. no changes in vector 
density over time despite introduction of vector control measures).   
Spot checks are conducted pro-actively to identify operational shortcomings in vector control 
measures or to detect changes in effectiveness of control measures e.g. due to insecticide 
resistance.  In this case spot checks should be conducted in areas with high transmission potential or 
areas where weaknesses in control measures are suspected.  Spot checks can also be conducted to 
check the existence and/or densities of previous vectors in receptive and vulnerable areas as a 
prelude to more comprehensive vigilance measures. 
Vigilance refers to entomological surveillance for the purposes of preparedness i.e. identifying and 
responding to introduction or re-introduction of vectors / disease risks.  Surveillance should be 
conducted in selected localities in areas receptive and vulnerable to new vectors or reintroduction of 
vectors and should be carried out during the period of high vector prevalence and at the period of 
influx of sources of infections.  Preparedness is mainly concerned with identifying geographic 
distributions and relative density of vector species, in particular identifying newly introduced vector 
species, or newly introduced pathogens.    
  













Short term survey 
employing a limited 
number of techniques 
in areas where little or 
no recent information 
on vector(s) is available. 
Long term observations in fixed locations to 
follow trends of vector density, species 
distribution and behaviour over time. 
Short term investigation in 
established foci of 
transmission. 
Rapid survey employing a 
single technique for 
detecting vector resurgence 
or transmission potential.   
Extensive short term spot 
checks and seasonal trend 
observations as part of 
epidemiological vigilance 









1. Delineate areas with 
VBDs 
2. Allow planning of 
control measures 
3. Initiate collection of 
baseline data before 
an intervention is 
implemented 
Areas with no vector 
control measures: 
1. Establish baseline 
information on role 









Areas with vector 
control measures: 
1. To monitor and 
evaluate the 
effect of control 
measures on 
entomology 
Reactive measures as part 
of epidemiological 
investigation aimed at 
explaining the reasons for: 
1. Non-response to 
vector control 
measure. 
2. Persistence of VBD 
transmission or 
recurrence. 
1. To proactively identify 
areas with operational 
short-comings or to 
detect changes in 
effectiveness of control 
measures e.g. due to 
insecticide resistance. 
2. To check existence 
and/or densities of 
previous vectors in 
receptive and vulnerable 
areas as prelude to 
vigilance measures.  
1. Check geographical 
distribution of vectors. 
2. Determine whether 
potential vectors have 
restored levels of high 
vectorial efficiency in 
receptive areas. 
3. Determine reaction of 
vectors to vector control 
measures and 
recommend measures 



















































Infection* of vectors  
Susceptibility to 
insecticides 
Changes in vector 
density 
Changes in vector 
infection* rate 
Vector density 
Vector infection* rate  
Susceptibility to 
insecticides 
Vector feeding and resting 
behaviour 
 
Susceptibility to insecticides 
Vector density 
 
Vector presence / absence 




Infection* of vectors 
Vector presence / absence 



















 Areas designated for 
VBD control. 
Conducted where little 
or no recent 
information on vectors 
is available. 
In fixed sentinel sites 
(indicator villages) on 
basis of information 
from the preliminary 
survey.  Villages should 
be sited within larger 
area where 
parasitological 
observations are carried 
out. 
In same sentinel 
sites as the 
baseline. 
For 1, in representative 
localities in areas showing 
non-response to vector 
control measures. 
For 2, in all locations 
showing persistence or 
recurrence of 
transmission. 
For 1, prioritise areas with 
high transmission potential 
or areas where weaknesses 
in control measures are 
suspected. 
For 2, in selected locations in 
receptive and vulnerable 
areas. 
Selected locations in 
receptive and vulnerable 
areas. 
In a number of locations 

















Commence in expected 
season of high vector 
prevalence. 
As soon as information 
from preliminary survey 
is available.   
After application of 
the vector control 
measures. 
As soon as epidemiological 
investigation indicates 
presence of active foci of 
transmission (for 1) or 
persistence / recurrence 
of disease transmission 
(for 2). 
For 1, during season of high 
prevalence of vectors taking 
into account the time lapse 
after the application of 
control measures. 
For 2, during period of high 
vector prevalence, as well as 
during period of influx of 
sources of infections into 
receptive and vulnerable 
areas. 
Surveillance carried out 
during the period of high 
vector prevalence and at 
the period of influx of 
sources of infections to 
receptive and vulnerable 
areas.  Seasonal trend 
observations should be 
carried out during season of 
high vector prevalence. 
* also infectivity for malaria and LF vectors 
 
  
An example of how the different stages in entomological surveillance would flow given introduction 
of a new malaria control programme utilising indoor residual spraying (IRS) and other measures for 
is as follows: 
- Preliminary survey. 
- Regular observations conducted in sentinel sites (indicator villages) to establish baseline 
data before implementation of vector control measures. 
- Regular observations once vector control measures are established to monitor and evaluate 
the effect on entomological parameters. 
- Spot checks to proactively identify areas with operational short-comings or to detect 
changes in effectiveness of control measures e.g. due to insecticide resistance. 
- Foci investigation to investigate reasons for persistence or non-response to vector control 
measures as the need arises in a prolonged attack.   
8.2 Parameters to measure in vector surveillance 
The different parameters which can be measured in vector surveillance are outlined in Table 8.1.  As 
can be seen from Figure 8.1, a number of parameters can be measured but the most common across 
all stages of entomological surveillance is vector density.  Here adults or immature forms can be 
measured.  Vector density is typically measured as the mean number of vectors (adults or immature 
forms) collected per sample per day. e.g. 30 Anopheles gambiae per light trap per night, number of 
Phlebotomus orientalis per room per night, Aedes aegypti indices including house index (percentage 
of houses infested with Aedes aegypti larvae and/or pupae).  When collecting adult vectors it is 
typically only females that are counted since only this sex feeds on people and can transmit the 
disease (except for tsetse where both males and females are capable of transmission).  Identifying 
the species of vector is critical.  This can be done using established taxonomical keys, although in 
some cases morphologically identical species can only be separated using molecular techniques 
requiring a laboratory.  Countries without the capability to assess species using molecular 
techniques should develop their capacity in this area.  In some situations it may also be important to 
measure infection in the vectors.  This can be done morphologically e.g. microscopic examination of 
mosquito salivary glands for the presence of sporozoites or may involve laboratory tests e.g. reverse-
transcriptase polymerase chain reaction (RT-PCR) for arboviruses.     
If the event of a new VBD spreading, then it may be important to assess the competence of your 
local vectors to this new pathogen e.g. West Nile virus, Rift Valley fever, Japanese encephalitis.  If 
possible, this should be done by specialists within the IVM group or expert advice should be sought 
to do these important studies. 
Along with vector density, there are a number of other factors which need to be measured. It is 
essential to measure the susceptibility of your local vectors to locally-used vector control insecticides 
at regular intervals.  More information on insecticide susceptibility and how this can be measured is 
given in 8.6.   
Density of some vectors is heavily dependent on weather patterns including rainfall and 




Table 9.1: Parameters which should be measured in a vector assessment in sub-Saharan Africa 
 
8.3 Methods used to sample vectors 
Methods used to sample vectors, along with useful references are described in Table 8.2.  The 
method used may differ depending on the vector species, the life stage you are trying to collect 
(adults versus immatures) and its habitat. 
Table 8.2: Commonly used vector sampling tools by disease 
Parameter Questions answered How measured? 
Vector density Vector presence / absence 
During which times of the year 
are vectors most prevalent? 
What is the geographic  
distribution of the vector? 
What habitats do vectors 
occupy (adults / immatures)? 
Adult or immature vector catches. 
Longitudinal density surveys.  
Species identification (species 
complex / molecular forms) using 
identification keys or laboratory 
tests.  
 
Vector feeding and 
resting behaviour 
What is the feeding behaviour 
of the vectors (humans, 
intermediates / indoor, 
outdoor)?  
Are there reservoir hosts? 
Laboratory test e.g. ELISA to 
determine the origin of blood meal. 
Animal baited traps. 
Indoor / outdoor man biting rate 
comparisons. 
Where and when do vectors 
rest? 
Adult resting catches.  
When is the vector active? Repeat vector density catches over a 
24 hour period. 
Infection of vectors Are vectors infected and with 
which pathogen? 
Microscopic examination  e.g. 
sporozoite rate for malaria vectors or 
laboratory studies e.g. polymerase 
chain reaction (ELISA) 
Insecticide susceptibility Are there physiological or 
behavioural adaptations in the 
vector which are impacting on 
insecticide susceptibility? 
Bioassays (e.g. WHO tube bioassay, 
CDC bottle bioassay, WHO cone 
bioassay, larval bioassays) 
Resistance intensity assay 
Biochemical enzyme assays 
Molecular (biological) tests  
Synergist assays 
Indoor / outdoor human landing 
catches 
KEY POINT 
When conducting vector surveillance it is very important to 
take measurements of latitude and longitude using a global 
positioning system (GPS).  This is so that you can map the 
vector distribution.   
  
Disease Tools Useful references 
Malaria Human landing catch (HLC), Center for Disease 
Control (CDC) Light Trap, exit trap, Pyrethrum spray 
catch (PSC), Larval sampling, odour baited trap, tent 




Human landing catch (HLC), Center for Disease 
Control (CDC) Light Trap (Anopheles), Latrine 
emergence trap, Larval sampling, odour baited trap, 
tent trap,  ovi trap (culicines) 
[27] 
Dengue Larval sampling (Figure 8.3), pupal sampling, Ovi trap, 
Tyre larvitraps, resting collections, odour baited trap, 
gravid trap, aspirator (e.g. battery powered aspirator, 
Prokopack) 
[84, 281-283] 
Yellow Fever Larval sampling, ovi trap,  [284] 
Chikungunya Larval sampling, pupal sampling, ovi trap, resting 
collections (aspirator or handheld net) 
[285] 
Leishmaniasis Center for Disease Control (CDC) Light Trap, 
Quantitative sticky paper trap, Outdoor/indoor 
resting catch, Animal baited trap (animal depends on 
species you are trying to catch), Knockdown catch of 
sandflies resting indoors, Funnel trap over animal 
burrow 
[29, 286, 287] 
Human African 
Trypanosomiasis 
Gambiense HAT (riverine) – biconical / pyramidal trap 
Rhodesian HAT (riverine - Uganda) – biconical / 
pyramidal trap 
Rhodesian HAT (savannah) – odour baited / episilon / 
Nzi trap or fly round 
[148] 
http://www.tsetse.org/ 
Onchocerciasis Human landing catch, Larval sampling, odour baited 
trap, crab catching and examination (S. neavei) 
[288-295] 
Schistosomiasis Snail surveys [296] 
Trachoma Fly trap  
 
8.4 Standard indicators for vector surveillance   
 Anopheles vector surveillance [279, 280] 8.4.1
A common sampling tool for estimating the number of mosquitoes entering houses, a proxy 
measure of transmission intensity, is the CDC light trap.  The two main advantages of this method is 
that when placed next to someone sleeping under a long-lasting insecticidal net these individuals are 
protected from biting and this represents a non-biased method of sampling since it is not dependent 
on the ability of the collector to catch vectors.  However, these traps are expensive and the batteries 
need re-charging regularly.  A cheaper alternative for estimating relative numbers of vectors would 
be to use window traps to collect mosquitoes leaving houses. These can be emptied by the 
householders themselves.  Indicators for Anopheles surveillance are indicated in Table 8.3. 
Table 8.3: Indicators for Anopheles vector surveillance 





 PSC = (Number of females ÷ Number of 
houses)   ÷ Number of nights 
Man biting rate 
(ma) 
Number of bites 
a person 






the whole night i.e. 
12 hours) 
= Number of mosquitoes collected ÷ 
Number of collectors 
HLC (collections 
performed for a few 
hours of the night) 
= Number of mosquitoes  ÷ Number of 
collectors  ÷ Number of collection 
hours 
PSC = Blood fed females ÷ total number of 
occupants  in rooms used for collection 
CDC light trap 
(approximates to 
ma) 







fed on humans 
 = Number of mosquitoes feeding on 
human blood ÷ Total number of blood-
fed mosquitoes 
 
Sporozoite rate Proportion of 
mosquitoes of a 
given species 
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person per night 
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Figure 8.2: a) Human landing catch b) CDC light trap and c) window exit trap, clockwise from top 
left (photo courtesy of S. Lindsay) 
 Aedes vector surveillance 8.4.2
  
The key indices for immature Aedes vectors are: house index (HI= percentage of houses infested 
with larvae and/or pupae), container index (CI=percentage of water-holding containers infested with 
larvae or pupae) and Breteau index (BI=number of positive containers per 100 houses inspected) 
[84].  Pupal demographic indices can also be used, whereby the number of Ae. aegypti is expressed 
per person [84]. 
 
Adult density can be expressed as per malaria indicators.  Human landing catches are however not 
recommended since collectors are exposed to dengue and no prophylaxis is possible. 
 
 
Figure 8.3: Surveillance for Aedes larvae in tyres (photo courtesy of S. Lindsay) 
 
 Black fly surveillance 8.4.3
Indicators for black fly surveillance include vector density (number of black fly vectors per trap / unit 
time), infection rate (proportion of vectors infected with microfilariae) and parous rate (proportion 
of vectors that have oviposited at least once). 
 Tsetse fly surveillance 8.4.4
Indicators include the average number of tsetse caught per trap per day, proportion of blood-fed 
flies per total number captured (fed rate) and proportion of tsetse flies that are infected with 
trypanosomes. 
 Snail surveillance 8.4.5
Surveys for snails may measure positivity of water bodies, density of snails per unit area and/or 




8.5 Selecting and using sentinel sites 
For vector assessment it is recommended to set up sentinel sites for vector surveillance, or use 
existing sentinel sites (if appropriate).  During preliminary surveys the vector control programme 
managers and entomologists should become familiar with the regions where the programme will 
work including population distribution, eco-epidemiological areas and accessibility.  This early 
reconnaissance will prove useful for later more systematic and extended surveys when there is a 
need to establish a network of sentinel sites.  
There are a number of considerations when deciding where to set up sentinel sites (adapted from  
[278]): 
1. Disease endemicity 
Vector control programme managers should ensure that all VBD are covered by sentinel sites.  
There may be the potential for overlap in sentinel sites and used of shared surveillance tools 
depending on the diseases in question, for example malaria and lymphatic filariasis transmitted 
by Anopheles gambiae in rural areas. 
Observations will generally be carried out in areas of high endemicity.  Therefore to select sites 
the vector control programme manager should work jointly with the overall control programme 
manager to combine knowhow on both entomology and clinical data.  Regular collection of data 
on infection / disease prevalence or incidence should be conducted in the sentinel sites.  
Therefore, it may be a good idea to establish sites in existing Health and Demographic 
Surveillance Sites (DHSS) or close to health centres with established, well-functioning health 
monitoring information systems.  Clinical data collected in parallel with entomological data is 
useful for monitoring the impact of interventions.   
2. Ecological zones 
Sentinel sites should be selected from different ecosystems within the country or region - village, 
urban, riceland, river and estuary, small scale farming or plantation.  For example, livestock 
areas may be reservoirs of zoonotic disease, such as Rhodesian human African trypanosomiasis.   
Identification of the different eco-epidemiological zones present in the country should be have 
been conducted as part of the broad level disease situation analysis outlined in Chapter 3.  
Sufficient sites should be selected so that all ecosystems are represented.  An example of 
ecological stratification of Nigeria for the purpose of siting sentinel sites is shown in Figure 8.4.  
Here a slightly different ecological classification is used [Mangrove, forest, forest Mosaic, 
Skills and resources of entomologists in VBD control 
programmes could be shared across programmes to 
expand vector surveillance activities.  This is particularly 
the case if vector sampling tools, methods or areas 
where samples are being taken are duplicated across 
programmes. 
  
tropical African savannah (Guinea / Sudan / Sahel)] but the same principles apply and sentinel 
sites are located in each zone.  
  
 
Figure 8.4: Ecological stratification of Nigeria for purpose of locating sentinel sites 
(adapted from [297]) 
 
Ecological zones should correspond to some extent to areas of vector dominance, if VBD in the 
country or region are transmitted by more than one main vector.  In certain types of terrain 
there may be a sharp transition from one dominant vector to another.  For example, this is the 
case with malaria vectors in the Senegambia region.  An. melas predominates in salt water 
mangroves of The Gambia, An. gambiae s.s. in Upper river regions and An. arabiensis in inland 
savannah areas of Senegal [298]. 
  
3. Areas of different seasonal incidence of the vector 
Seasonal changes in breeding foci will affect the distribution and abundance of vectors within an 
area.  For example, in malaria endemic areas, breeding sites may be widespread and abundant in 
the rainy season and restricted to perennial streams or swamps in the dry season.  Selecting 
sentinel sites during the rainy season may indicate that An. gambiae is the dominant vector and 
show a drop in density during the dry season, whereas there may be some dry season foci which 
may have been missed where An. funestus is the dominant vector.  This needs to be taken into 
account when selecting sentinel sites and collecting stations within sentinel sites so that we 
obtain a full picture of vector seasonal incidence related to type and variability of breeding 
potentialities.   
 
4. Accessibility of sentinel sites 
Sentinel sites need to be accessible throughout the year so that regular observations can be 
made.  Difficulty in accessing a site to conduct observations due to for example flooding should 
be anticipated but missing observations for several months at a time due to inaccessibility at a 
peak time of vector breeding should be avoided. 
  
 
5. Areas with high use of insecticides  
Sentinel sites for insecticide resistance monitoring should be placed in areas with high incidence 
of disease and / or high use of insecticides for either public health or agriculture.  Here the 
threat and potential impact of insecticide resistance is likely to be greatest.  The majority of 
guidance on insecticide resistance monitoring is available for malaria vectors, in particular the 
Global Plan for Insecticide Resistance Monitoring in malaria vectors (GPIRM) [42]. The WHO 
Regional Office for Africa [299] and the Presidents Malaria Initiative (PMI) [300] have proposed, 
as an approximate guide, that there should be at least one sentinel site for insecticide resistance 
monitoring in malaria vectors per every 500,000 nets distributed or 200,000 houses sprayed.  
This is equivalent to about one site per 1 million people protected, although the exact number 
would depend on the country.  Small countries should generally have one sentinel site per 
region.   
 
6. Number of sentinel sites  
Vector control programme managers are faced with many challenges including scarce financial 
and human resources, transport and time.  Therefore, they may need to make a compromise 
between selecting a greater number of sentinel sites which are visited less frequently and fewer 
sites visited on a more regular basis and assessed more fully.   
Point 5 discusses how many sentinel sites are required for insecticide resistance monitoring in 
malaria vectors.  Similar recommendations for other diseases vectors are not currently available 
and although it is difficult to make strong recommendations since each country situation is 
different, in general we would recommend a minimum of two sentinel sites for a representative 
epidemiological area although four sites would be preferable.  Ideally collections should be 
made at least monthly during the main transmission season. If a site is not well characterised 
and seasonality of the vector of interest is not known, then monthly surveys for the entire year 
are required.    
7. Number and arrangement of collecting stations in sentinel sites 
Appropriate selection of collecting stations, for example houses or animal shelters is critical.  The 
location of collecting stations can be selected purposively or randomly.  Purposive selection, for 
example to encompass different housing types, distances from breeding sites or attractive sites 
where high vector density would be expected (productive collecting sites) can be useful.  This 
type of selection also allows you to take into account daily or seasonal shifts or movement of 
vector populations within the sentinel site.  However, if you would like to get a representative 
picture of the level of transmission in your sentinel site that is directly comparable over time and 
between sites, it is best to select collecting stations randomly.  For example, if houses are to be 
sampled, random selection can be done by mapping your study site, numbering the houses and 
then randomly selecting several numbers using a random number generator in Microsoft Excel.   
Vector control programme managers also need to decide how many collecting stations they will 
locate per sentinel site – generally this should be between two and three collecting stations per 
sentinel site. 
  
8.    Frequency of sampling 
The frequency of sentinel surveillance sampling depends on the capacity and needs of the 
control programmes – for example, the vector in question, what data you are collecting and 
why.  Sampling should be done at a minimum of once a year.  Generally, insecticide resistance 
should be measured every 6-12 months and species composition/density every month.  
However, this may not always be possible. 
An example of the structure and scope of an entomological surveillance system in The Republic of 
Sudan is given in Box 8.1.  





















Sentinel sites were selected to meet the following criteria (Adapted from WHO (1975). Manual on 
Practical Entomology in Malaria - Part I - Vector Bionomics and Organisation of Anti-Malaria 
Activities.):  
1. Sufficient vector density to allow study of the vector habits, resting, feeding and vector 
distribution (indoor and outdoor). 
2. Representing different geographical and ecological zones 
3. History of vector borne diseases transmission in the area. 
4. Accessibility of site in the different seasons. 
5. Type of dwellings and breeding sites present. 
6. Considering livestock areas as a potential burden of zoonotic disease.  
7. Considering urban and rural areas. 
Sites were selected at first administrative level (State), since this geographic area was considered 
to fulfil the criteria listed above.  Countrywide there are 106 vector surveillance sites with on 
average 4 to 6 sites per state, except for large states such as Khartoum, the capital of the country 
(9 sites) and Gezira State, that hosts the largest irrigated agricultural scheme in Africa (7 sites).   
Of the 106 vector surveillance sites, 64 monitor also insecticide resistance.  Of these 64 sites, 40 
sites monitor insecticide resistance annually (irrigated schemes and areas with high use of 
insecticides for example big cities and Internally Displaced Persons (IDP)/refugee camps) and the 
remainder monitor resistance only every two years since in these sites insecticides are used 
seasonally.  
Responsibility for conducting surveys is devolved to State / District entomology teams consisting of 
a Senior Entomologist and three Entomology Technicians who report back to personnel at the 
Integrated Vector Management (IVM) unit in the Federal Ministry of Health.  For the 
entomological surveillance, target vectors are three genera of mosquitoes, as well as sand flies, 
ticks and snails where sampling sites neighbour water bodies.  Sentinel sites are visited monthly 
and recommended collection methods are used to sample the insects and snails. State level 
surveys collect information on vector species, vector density (adult and larvae, including Aedes 






























Data collected at State level is sent to the National IVM Unit electronically using a standard form.  A 
sub-set of the insects/snails collected are sent to national level for additional analysis, including vector 
identification and infection rate analysis, for example RT-PCR for arbovirus identification.  Once 
analysed, findings are fed back to the State level in a timely manner.  The IVM unit in the Federal 
Ministry of Health conducts regular supervision to all states a minimum of twice a year to make sure 
they conduct vector surveillance as planned.  In addition, in service training is conducted for State 
level staff on an annual basis and  there are minimum of three meetings a year to discuss the progress 
of VBD control including vector surveillance. 
 
  
8.6 Responsibility for vector surveillance 
Entomological surveillance is usually carried out by vector control personnel.  However, in some 
programmes community members have supported this effort and this is a valid approach given the 
right training and support is provided.  For example, community members participated in 
entomological surveillance for monitoring and evaluation of IRS using DDT for malaria control in 
Mozambique [302].  Window exit traps were installed on 6 houses with the home-owners 
permission at each of 19 sentinel sites in Zambézia province.  Home-owners were trained to empty 
the traps on a daily basis into pre-labelled specimen jars containing isopropanol and complete 
checklists indicating the nights for which the traps were checked.  Specimen jars were then collected 
by programme staff who assessed species abundance and sporozoite rates.  Community members 
have also been involved in tsetse trapping, monitoring traps and collecting flies in South Sudan (Box 
5.8).  Another example of using community members in entomological activities is the use of 
community-based resource persons to map and monitor breeding sites for larval source 
management (LSM) in Dar es Salaam, Tanzania.  How this participatory mapping activity was set up 
is outlined in Box 8.2 and more information can be found in references [303, 304].   
 
 
Figure 8.5: Larval surveillance using dipper (photo courtesy of S. Lindsay) 
  
Box 8.2: Mapping of malaria vector breeding sites to facilitate operational larval source 
management (LSM) in Dar es Salaam, Tanzania (adapted from [304]) 
The Dar es Salaam Urban Malaria Control Programme (UMCP) aims to control aquatic-stage 
mosquitoes using community-based resource persons (CORPs), and to evaluate the effectiveness of 
this intervention.  The UMCP in its current form was launched in March 2004 and operates on all five 
administrative levels of the city: the city council, three municipalities, 15 wards, 67 neighbourhoods 
and more than 3000 ten-cell-units.  The four upper levels in this hierarchy are responsible for project 
management and supervision, while the actual monitoring, mosquito larval surveillance and control 
is organised and implemented at the level of the smallest administrative units, the so-called ten-cell-
units (TCUs).  A TCU typically comprises about ten houses, in some cases even more than one 
hundred.  On a weekly basis, larval surveillance CORPs monitor and document the larval habitats of 
mosquitoes in every TCU, receiving minimal remuneration.  Since 2006, additional CORPs have been 
recruited and trained who are responsible for applying biological larvicide (Bacillus thuringiensis var. 
israelensis) to all potential larval habitats of malaria vectors.  
The mapping procedure involves several steps: 
1) CORPs produce sketch maps of the TCUs 
marking plots (and detailing separately 
their characteristics and ownership), as 
well as roads, pathways, drains or other 
landmarks. 
2) Verification of sketch maps through 
technical teams using laminated aerial 
photographs in the field which were 
later digitized and analysed using 
Geographical Information Systems. 
 
 
Example of a sketch map, aerial picture and 
technical map. A. Sketch map of a TCU drawn by 
the responsible CORP. Features comprise plots 
with continuous numbering, streets, drains, 
agricultural areas and ponds. B. The same area 
on the aerial picture. The yellow lines are 
connecting identical features on the sketch maps 
and the aerial picture. C. The same area on the 
laminated aerial photograph used for the 
technical mapping in the field. Features to be 
mapped were marked with non-permanent 




8.7 Insecticide resistance 
 What is insecticide resistance? 8.7.1
Insecticide resistance can be defined as “a heritable change in the sensitivity of a pest population 
that is reflected in the repeated failure of a product to achieve the expected level of control when 
used according to the label recommendation for that pest species” [305].  Selection pressure for 
development of resistance results from use of insecticides for public health and agriculture, and may 
also be driven by household use of insecticides and hydrocarbon pollution [42].  
There are 2 key mechanisms by which resistance can occur: behavioural resistance and physiological 
resistance.  In behavioural resistance a vector adapts its feeding or resting behaviour to actively 
avoid contact with the insecticide.  For example, there is some suggestion that malaria vectors may 
have adapted to bite outside the home and earlier in the evening when individuals are not protected 
by LLINs [306].  Physiological resistance can be conferred by 3 different mechanisms: metabolic 
resistance, target site resistance and cuticular resistance.  Metabolic resistance involves a change or 
amplification in the enzymes that metabolize the insecticide meaning that a lower amount of 
insecticide eventually reaches the target site.  Target site resistance involves a genetic mutation 
which directly impacts on the target site of the insecticide thereby reducing or eliminating the effect 
of the insecticide.  Cuticular resistance occurs as a result of modifications in the insect cuticle which 
prevent or slow the adsorption or penetration of insecticides. 
Cross resistance occurs when resistance to one insecticide confers resistance to another insecticide, 
even where the insect has not been exposed to the latter product.  Cross resistance often occurs 
where insecticides share a common mode of action, for example kdr mutations in malaria vectors 
can confer cross resistance to both DDT and pyrethroids [42].   
 Testing for insecticide resistance in malaria vectors  8.7.2
The level and intensity of insecticide resistance should be monitored.  Two main methods exist for 
malaria vectors: the WHO tube test and CDC bottle assay [307, 308].  Either or both types of tests 
may be used but the results are not directly comparable.  The WHO tube test exposes mosquitoes to 
discriminating concentrations of insecticides on impregnated papers [308].  Test kits and insecticide-
impregnated papers are prepared on behalf of WHO by a third party.  Procedures and conditions for 
procuring test kits and impregnated papers are available [309].  The test used and procedures, 
including any deviation from the standard protocol should be documented. 
A mortality of less than 98% (as long as mortality in the control tubes remains below 5%) 24 hours 
after the one hour exposure period is suggestive of the existence of resistance and further 




To measure insecticide resistance intensity, mosquitoes are exposed to discriminating 
concentrations of insecticide for differing time periods so percentage mortality can be plotted over 
time (50% lethality time, LT50; see [310] for example).  Guidelines are being prepared on how to 
measure intensity and this measure may be useful for measuring changes in resistance over time. 
Where insecticide resistance is confirmed, then it is recommended to conduct additional testing to 
identify the mechanism of resistance (e.g. kdr, metabolic resistance, behavioural resistance etc.).  
Countries should draw on WHO and research institutes for assistance, as required. 
If insecticide resistance is identified at a site, then the programme should drill down and conduct 
more intensive sampling at that site and in the neighbouring area.  Insecticide resistance is often 
very focal and presence or absence, intensity and mechanisms may vary over short distances.  
Insecticide resistance data should be coupled with other data sources, in particular epidemiological 
data from Health Management Information Systems (HMIS) and data on intervention use/coverage 
to gain a full picture of the situation.  Data on use of insecticides in other sectors, such as the 
agricultural sector should also be examined.    
More information on the WHO strategy against insecticide resistance is provided in the 2012 WHO 
Global Plan for Insecticide Resistance Management in Malaria Vectors (GPIRM)  [42].  A Framework 
document which helps countries to develop their own national insecticide resistance monitoring and 
management plans is being prepared by WHO.   
 
 
 Testing for insecticide resistance in non-malaria vectors  8.7.3
The procedures for measuring insecticide susceptibility are well documented for malaria vectors, 
and generally involve WHO tube assays or CDC bottle assays [307, 308].  The same techniques can be 
applied for other mosquito vectors, including lymphatic filariasis and dengue vectors, although care 
KEY POINT 
A mortality of less than 98% in tests that have been conducted under 
optimum conditions of temperature and humidity with a sample size of 
at least 100 mosquitoes, replicated two or three times using fresh 
impregnated papers (i.e. before the expiry date on the box) that have 
not been used more than six times and whose efficacy is confirmed with 
susceptible mosquitoes, is a strong suspicion of resistance and requires 




Insecticide resistance data should be viewed in tandem with other data 
sources including epidemiological data, data on intervention use and 
coverage and use of insecticides in other sectors e.g. agricultural sector 
to gain a better picture of the impact of insecticide resistance on 




should be taken to make sure you are using the correct discriminating dose.  Key documents and 
specific guidance for non-malaria vectors is given in Table 8.4. 
Table 8.4: Measuring insecticide susceptibility of non-malaria vectors - useful resources 
 
 Current status of insecticide susceptibility 8.7.4
8.7.4.1 Malaria Vectors  
Vector control, particularly LLINs and IRS is a critical component of malaria control strategies.  Only 4 
classes of insecticide are used as adulticides: pyrethroids, organochlorines 
(dichlorodiphenyltrichloroethane, DDT), organophosphates and carbamates.  Currently, pyrethroids 
are the only class of insecticide available for use on LLINs.  It is therefore of great concern that there 
has been a rapid increase in the distribution and intensity of resistance in malaria vectors in sub-
Saharan Africa, with resistance being reported in nearly two thirds of countries with ongoing malaria 
transmission [42].  Insecticide resistance has been reported in all major malaria vectors and involves 
all classes of insecticide (but particularly pyrethroids).  At the moment there is no strong evidence 
that this resistance is actually compromising malaria control.  For example, a recent review did not 
find evidence that insecticide resistance was attenuating the effect of ITNs on entomological 
outcomes [313].  However, the distribution and intensity of resistance is increasing very rapidly in 
many parts of Africa and therefore, it is considered that it is only a matter of time until the 
effectiveness of malaria control is reduced or at the extreme control failure becomes apparent. 
Information on the status of insecticide resistance in malaria vectors can be found in the GPIRM 
document [42] and on the website Insecticide Resistance Mapper (www.irmapper.com) [314, 315].  
An example of the maps produced by this website is shown in Figure 8.6.  This website consolidates 
published reports of insecticide resistance in malaria vectors onto filterable maps to inform vector 
control strategies.  Where lymphatic filarasis is transmitted by An. gambiae information on 
insecticide susceptibility can also be obtained from this website.  Another source of insecticide 
resistance information is IRBase (https://www.vectorbase.org/irbase) which includes published as 
well as unpublished data.  However, this database has fewer datapoints and is not updated 
regularly.  Insecticide resistance datapoints from border regions of neighbouring countries should 
also be assessed. 






[27] - Annex 5 gives methods for monitoring and 
managing resistance to insecticides 
Leishmaniasis Phlebotomus spp. (Old 
World)) 
[311], [27] - gives advice on testing susceptibility to 
insecticides and strategies for preventing 
development of resistance 
Onchocerciasis Simulium spp. (Black fly) [311, 312] 
 
Dengue Aedes aegypti and Aedes 
albopictus 




Figure 8.6: Screenshot from Insecticide Resistance Mapper (www.irmapper.com) showing 
locations of confirmed (red dots) and possible resistance (orange dots) of all malaria vectors to all 
classes of insecticide from 2000 to 2015 (accessed 30th March 2015) [314] 
8.7.4.2 Other disease vectors 
Insecticide susceptibility is less well characterised and documented in other vector species [222].  
There have been several reports of insecticide resistance in Culex quinquefasciatus including from 
Zambia, Sudan and Zanzibar [82, 316, 317].  However, there is currently no resource available which 
synthesises this information.   
Complete information on the susceptibility of sandflies to the range of insecticides used in vector 
control programmes is not known.  Sandfly resistance to malathion and pyrethroids has been 
reported in Sudan, presumably due to use of these insecticides for malaria control [318].  With 
increasing use of insecticides for leishmaniasis control, resistance in these vectors should be 
monitored and resistance management strategies developed. 
Use of temephos as part of the Onchocerciasis Control Programme in west Africa led to resistance 
(followed by development of resistance to chlorphoxim when the insecticide was switched) [222, 
319].  Resistance in this species is currently being managed by a rotation of temephos, Bti, and 
permethrin, the insecticide usage being determined by the rate at which water is flowing in rivers 
forming the major breeding sites of these vectors.   
DDT, pyrethroid and organophosphate resistance are very widespread in dengue vectors [320, 321].  
There is a low likelihood of development of insecticide resistance in tsetse flies due to the long life 
span of the flies and production of small numbers of offspring. 
8.8 Entomological data management  
  
Entomological data should be collected on standardised forms.  Data should be collated and 
reported from sentinel sites to district/provincial VBD control programmes in a timely manner.   
To allow proper interpretation of data for decision-making, entomological data should integrated 
with epidemiological data (e.g. HMIS and surveys) and intervention coverage information.  Data can 
be visualised in the form of maps.  More information on integrated data management is given in 9.7.  
Data should be reviewed across VBD programmes because insecticide use in one VBD control 




















 Vector surveillance should be conducted throughout the life of the IVM programme, 
although objectives and parameters measured will change depending on the stage of the 
programme. 
 The most commonly measured parameter is vector density (mature or immature forms), 
although other parameters are important, particularly insecticide susceptibility. 
 Sampling tools vary by vector, although there may be some overlap. 
 When setting up sentinel sites there are a number of factors which should be considered 
including disease endemicity, ecological zones, accessibility of the site and use of 
insecticides in the area. 
 Vector surveillance is usually conducted by vector control programme personnel, however, 
there are some good examples of community involvement in these activities. 
 The presence and intensity of insecticide resistance in malaria vectors is increasing and so 
it is imperative to measure susceptibility on an ongoing basis in SSA.  Insecticide resistance 
is also present in some other disease vectors, including culicines.  
 Data management systems need to be established to manage and integrate the vast 
quantities of data generated on entomology, case surveillance, surveys and intervention 
coverage to allow for effective decision making. 
  




9.1 What is monitoring and evaluation? 
Monitoring refers to the continuous tracking of programme performance and involves checking the 
progress against pre-determined objectives and targets.  Monitoring allows you to verify whether 
activities have been implemented as planned, ensures accountability and detects any problems or 
constraints early in order to allow corrective action to be put in place.  Monitoring focuses mainly on 
inputs and outputs.   
Evaluation of outcomes and impact is needed to document periodically whether programme 
activities lead to expected results in terms of: 
 Outcomes: for example, intervention coverage / usage or reduction in vector populations 
 Impact: the assessment of impact, e.g. reduction in mortality or morbidity due to vector 
borne diseases (VBD).  
Monitoring and evaluation (M&E) are interlinked.  For example, monitoring will help you to identify 
possible weaknesses in implementation should the evaluation not show any impact of your 
programme.  While monitoring is a continuous process, evaluation will need to be conducted 
intermittently.  The periodicity of evaluation varies considerably according to the changes expected 
in the different areas evaluated. 
A proposed M&E Framework including examples of illustrative data and example indicators for each 
of the domains (input → process → output → outcome → impact) is shown in Figure 9.1. 
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Figure 9.1: M&E Framework for IVM programmes (adapted from [322])  
where LLIN = long-lasting insecticidal net 
 
M&E of integrated vector management (IVM) is covered broadly in the WHO document on  M&E 
Indicators for IVM [269].  More information on M&E of individual diseases can be found using 
sources listed in Table 9.1.   
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Table 9.1: Sources of more information on M&E of VBD 
Disease Sources of more information 
Malaria  RBM (2000) Framework for monitoring progress & evaluating outcomes and 
impact [323] 
GFATM (2011) MONITORING AND EVALUATION TOOLKIT HIV, Tuberculosis, 
Malaria and Health and Community Systems Strengthening - Part 4: Malaria. 
[322] 
MEASURE Evaluation – M&E Learning Center [324] 
Lymphatic filariasis WHO (2011) Lymphatic  filariasis: monitoring and epidemiological assessment of 
mass drug administration programme. A manual for national elimination 
programmes.  [325]  
Cutaneous 
leishmaniasis 
WHO - EMRO (2014). Manual for case management of cutaneous leishmaniasis 
in the WHO Eastern Mediterranean Region. [326] 
Visceral leishmaniasis WHO Regional Office for South East Asia / TDR (2010). Indicators for monitoring 
and evaluation of the kala-azar elimination programme - Kala-azar elimination in 
Bangladesh, India and Nepal. [327]  
HAT Bouchet B, et al. (1998). "Key indicators for the monitoring and evaluation of 
control programmes of human African trypanosomiasis due to Trypanosoma 
brucei gambiense." Trop Med Int Health. 3(6): 474-481. [328] 
Dengue  WHO (2009). Dengue – Guidelines for diagnosis, treatment, prevention and 
control. [84] 
Trachoma WHO (2006). Trachoma control - A guide for programme managers. [329] 
Emerson P, Frost L, et al. (2006). Implementing the SAFE Strategy for Trachoma 
Control - A Toolbox of Interventions for Promoting Facial Cleanliness and 
Environmental Improvement, The Carter Center / International Trachoma 
Initiative. [195] 
Ngondi J, Reacher M, et al. (2009). "Trachoma survey methods: a literature 
review." Bulletin of the World Health Organization 87: 143-151. [330] 
Onchocerciasis No guidelines available for vector control M&E 
Yellow fever WHO (2008). WHO–recommended standards for surveillance of selected 
vaccine-preventable diseases. [331] 
WHO (2008). Investigation of yellow fever epidemics in Africa - Field Guide. [284] 
Chikungunya WHO- PAHO (2011). Preparedness and Response for Chikungunya Virus 
Introduction in the Americas. [332] (No Africa specific guidance available) 
Schistosomiasis WHO (2006) Preventive chemotherapy in human helminthiasis.  Coordinated use 
of anthelminthic drugs in control interventions: a manual for health 
professionals and programme managers [53] 
 
9.2 Responsibility for M&E and data flows   
IVM works across diseases and therefore vector control programmes for different diseases should 
ideally be working from a single IVM M&E plan.  Efforts should be made to convince donors of the 
need for cross disease control by submitting funding requests including more than one disease, 
where diseases are co-endemic.  However, initially funding is likely to remain disease specific and so 
it is likely that M&E of the IVM programme will not replace M&E of the disease specific programmes.   
Ownership of the IVM M&E plan remains with the country since this is for their use to assess their 
own IVM programme.   
In monitoring and evaluating the IVM programme, the individual disease specific programmes are 
accountable to the IVM Focal Person at national level.  At each level (district, province and national 
  
level), the IVM focal person is responsible for collating data from individual VBD control programmes 
which fits into IVM M&E plan. 
M&E data from district level is used to inform vector control activities on the ground.  IVM should be 
based on local M&E data and therefore proper assessment and use of these data are essential.  Data 
should be collated and fed to provincial level, who in turn report back to national level to give 
information on the impact of IVM.  Often data are collated and analysed by the Central Statistics 
Office.  The need for detailed data is generally lower at higher levels where a strategic overview 
becomes more imperative.  Feedback loops should operate from national and provincial level VBD 
control programmes so that information once collated at national level is communicated back 
downstream.  
Monitoring and evaluation conducted by an external agency, for example an academic institution is 
likely to increase accountability for vector control and help ensure unbiased results. 
There are a number of users of information generated by M&E.  These range from operational staff 
on the ground, to Programme Managers, the IVM Steering committee (ISC), country policy makers, 
international policy makers and donors.  Data should be disseminated to the ISC and other 
stakeholders on a regular basis. 
9.3 Choice of indicators 
Indicators for M&E of IVM programmes are of 2 types - intervention/disease-specific and IVM 
programme-specific.  Intervention/disease specific indicators are for example intervention 
distribution, coverage, changes in vector populations and impact on infection or disease.  IVM 
programme specific indicators include process indicators on training of personnel on IVM and impact 
indicators on reductions in toxic units of insecticide used.  Outcome and output indicators can be 
borrowed from disease specific log frames which programmes should already have in place.   
How you are going to monitor and evaluate the programme should be detailed in an M&E plan 
which includes a logical framework or log frame.  This should include expected reductions in 
indicators and expected impact of the programme.  An example of a hypothetical log frame for 
monitoring an IVM programme tackling both malaria and lymphatic filariasis in a rural area using 
LLINs, IRS and LSM is shown in Appendix 3.   
9.4 Evaluation design and attributing change  
A number of different evaluation designs are available for evaluating your IVM programme.  These 
vary in the strength with which you can attribute changes in impact indicators to the interventions in 
your programme.  For example, randomised controlled trials or randomised step wedge designs are 
very robust and due to the randomisation process exclude the influence of other factors which may 
influence the outcome.  Therefore we can say with reasonable certainty that changes which 
occurred are attributable to the programme.  However, it is most likely that you will be using a 
longitudinal design (pre- post- comparison) without any control group.  Here, other factors which 
influence the outcome may change over time and so attribution of effect is more difficult.  When 
using longitudinal data on disease or infection to measure impact of your IVM programme, it is 
important to note (and where possible measure) external factors which may be influencing the 
  
outcome.  For example these external factors may include, parallel programmes initiated by a non-
governmental organisation (NGO), changes in diagnosis and treatment practices or changes in 
weather conditions which may affect vector abundance.  
9.5 Measuring Impact of IVM Programmes 
There are 4 main impacts of an IVM programme that we are interested in: effect on disease burden, 
cost effectiveness, ecological soundness and sustainability of the programme.  These impacts are 
outlined in Table 9.2.   
Table 9.2: IVM Impact indicators split by domain (adapted from [333]) 
Impact domain Indicators 
Health Disease burden (number of cases/infections), mortality 
from disease, equity 
Economic Cost effectiveness  
Environmental  Insecticide use 
Sustainability  Social Collective action, organisation, networking, community 
acceptability 
Institutional Intersectoral collaboration, local involvement 
Political Access to government, resource allocation, policy change, 
continued resource allocation 
 
 Effect on disease burden 9.5.1
It is important to measure the effect of your programme on disease burden, including morbidity or 
mortality.  A standardised definition of clinical disease (including diagnostic confirmation where 
possible) should be used to allow comparison across sites and between countries. Information on 
recommended case definitions can be found in the disease specific documents mentioned in Table 
9.1.   
Sources of data on infection and/or disease will vary depending on the country setting and the 
disease involved (Box 9.1).   







Where the outcome of interest is death from the disease, it may be possible in some countries to 
gather this information from civil registration and vital statistics data. 
Population based: censuses, civil registration and vital statistics (deaths and causes of death), 
health management information system (HMIS), population-based surveys (DHS, MICS), active 
case detection strategies, Integrated Disease Surveillance and Response (IDSR) system  
Institution based: Individual records (public and private health facilities), service records (public 
and private health facilities), resource records, school or employer absentee records, school or 
other institution-based surveys 
Others: NGO data, agricultural records 
 
  
Data on disease incidence can be obtained from health management information systems (HMIS),  
collated from public and private health facility records or from the Integrated Disease Surveillance 
and Response (IDSR) system, if the particular VBD is captured in this system [334].  Data are 
generally compiled either weekly or monthly at each health facility and then reported up a vertical 
chain, with further aggregation at each level in the health system (district then province) until 
reaching the most central level.  Data collected in this way is known as passive case detection i.e. 
patients seek care at health facilities and cases are recorded by the health worker and reported to 
the appropriate epidemiological surveillance system.  This system captures only a proportion of 
cases since access to health care is often limited, patients may not seek care and patients attending 
private health facilities are often missed.  The passive case detection system is only as effective as 
the health system in which it is embedded.  A number of aspects are important.  For example, case 
reporting should be based on confirmed diagnosis as standard.  High quality, complete data are 
necessary and data should be reported in a timely manner to higher levels of the health system to 
allow rapid action against focal VBD, in particular malaria and dengue.  Support and supervision to 
quality control the surveillance system are also necessary.  Despite these potential failings of a 
passive case detection system, epidemiological data collected in this way can still be used to 
measure trends.  There are some excellent resources on disease surveillance for malaria control and 
elimination which could be drawn upon for other VBDs [335-337].  An example of malaria sentinel 
surveillance system in Ethiopia which relies on case reporting from a selected number of health 
facilities rather than the HMIS is given in Box 9.2.  
Box 9.2: Sentinel surveillance system to monitor malaria trends in Oromia Regional State, Ethiopia 














Ethiopia’s National Malaria Control Strategic Plan includes goals to eliminate malaria transmission 
in low transmission areas and achieve zero malaria deaths by 2015.  In order to plan interventions 
and monitor progress towards these goals, a robust surveillance system is necessary.  This system 
in particular needs to be able to quickly identify changes in malaria transmission, morbidity and 
mortality and given the focal nature of malaria transmission in some areas of Ethiopia, identify 
transmission hot spots.     
A system of 10 malaria sentinel sites was set up in Oromia Regional State, Ethiopia in 2010 to 
collect data on key malaria morbidity and mortality indicators.  Ten primary health care units 
(PHCUs) were selected, each serving a catchment area of approximately 25,000 people and 
consisting of district (woreda) level health centres and associated satellite community (kebele) 
health posts. 
Health centres are primarily located in urban areas and are usually staffed by health officers, lab 
technicians, pharmacists and midwives.  Most have inpatient facilities and are the first referral 
point for severe malaria cases from the health posts.  Health posts are located in rural areas and 
are staffed by health extension workers (HEW) who are salaried staff generally drawn from the 
communities which they serve.  HEWs are able to diagnose malaria cases using a rapid diagnostic 
test (RDT) and provide artemisinin combination therapies (ACTs) to confirmed cases.    
The following criteria for selecting sentinel PHCUs were decided during a national stakeholder 
meeting: 
1) presence of an outpatient clinic that sees an average of at least 50 patients per day 









3) ability to provide ACT as first-line treatment for uncomplicated malaria during selection visit 
4) pre-existing designated personnel responsible for data collection and reporting at the 
facility during selection visit 
5) situated below 2,000 metres above sea level in a malaria transmission area 
6) electricity available and year-round access via road.  
Initially the health centres were the central focus of each sentinel site but over time the system was 
expanded and in 2012 (after ~ 2 years), data were being collected and reported from 10 health 
centres and their 73 satellite health posts.   
At health centres, data were collected from an outpatient department (OPD) register and a 
laboratory register.  The OPD register collected information on: patient age, location of residence, 
fever history, laboratory tests requested, laboratory results for malaria and relapsing fever  (e.g. 
microscopy or RDT), species-specific final diagnosis (i.e., uncomplicated malaria, severe malaria, 
other), drugs prescribed, inpatient admittance, death and referral to higher level facilities.  At health 
posts, data were collected from the routine fever and malaria patient register.  
The sentinel facilities send aggregate weekly data through short message service (SMS) to a central 
database server.   
 
Screen shot of mobile phone displaying data reporting format used at the health post level. 
To reduce the potential for error, a number of logic checks are in place so that if numbers sent in by 
SMS from health facilities are implausible a message is sent indicating that resubmission is 
necessary.  Once the SMS data is compiled on the central server web-based reports can be 
generated which allow users to view the data in near real-time for assessment of expected and 
actual malaria cases occurring within the defined area.  Alerts can be set up so that managers as 
well as staff from the particular PHCU receive an SMS or email if the number of cases exceeds a 
predefined threshold value for that health facility. 
For the purposes of quality control, surveillance field support staff visited health centres (initially 
every 2 weeks) and worked with staff to extract relevant malaria data from the registries.  These 
data were considered gold standard and were compared to SMS data.  Overall concordance 
between paper and SMS reporting was generally high and improved over time (~15 weeks). 
The use of SMS for reporting surveillance data shows promise allowing accurate tracking of malaria 
trends in Oromia Regional State, Ethiopia.  Small-scale sentinel surveillance with enhanced 
supervision and rapid reporting mechanisms are a viable alternative to relying solely on data 




Alternatively, active case detection strategies can be employed.  This means that health workers visit 
communities and actively screen the population to find cases.  Active case detection is useful when a 
disease is rare, occurs in isolated clusters, where patients do not present at health facilities (e.g. 
asymptomatic or stigmatised disease) or where you want to understand disease incidence in a 
specific sub-population.  For example, lymphatic filariasis is normally identified through population-
based surveys for microfilaraemia or antigenaemia [53].  Resources can be shared across VBD 
control programmes for conducting surveys.  For example, lymphatic filariasis and onchocerciasis 
surveys could be conducted in tandem.  More accurate estimates of malaria incidence or 
parasitaemia in children under 5 years old can be obtained by conducting population-based surveys.  
Examples of some active case detection techniques that have been used effectively for leishmaniasis 
are given in Box 9.3.   
Box 9.3: Active case detection strategies for measuring disease burden (adapted from [29]) 
 
 Cost and cost effectiveness of IVM programmes versus standard practice 9.5.2
IVM is expected to be more cost effective than conventional vector control programmes because it 
reduces duplication across disease specific vector control programmes and evidence based use of a 
diverse range of vector control tools is likely to lead to more effective control.  However, this needs 
to be systematically assessed by programmes and an increased evidence base on cost effectiveness 
of IVM versus conventional programmes will help to build the advocacy case for IVM.   
The idea of cost effectiveness analysis is to assess whether we can prevent more mortality or 
morbidity at a lower cost by using IVM compared to conventional vector control.  The first step 
should be to assess the cost of implementing your IVM programme and the cost of implementing 
routine vector control.  In order to make sure you haven’t missed out any costs you should adopt an 
‘ingredients approach’ i.e. listing costs for different types of activity by category rather than just 
listing the total costs or total expenditures.  For example, programme costs include capital costs 
(vehicles, equipment, buildings) and recurrent costs (personnel, operating expenditures, training, 
media campaigns and IEC).  It is important to make sure you have included all costs, for example 
supporting interventions such as community engagement campaigns as well as the cost of the 
interventions themselves.  Costing using the ingredients approach can be done using the open-
source software Cost-It available on the WHO-CHOICE website [339].   
House to house search:  Health workers visit houses and screen every household member 
for disease. 
Camp approach:  Health workers set up a camp in a village e.g. central point or 
school and, after a community awareness campaign, community 
members are invited to attend the camp for screening. 
Index case approach: A positive (index) case is identified and then households nearby to 
the index case are screened for cases.   
Incentive-based approach: An incentive (monetary or otherwise) is given to health volunteers 
who facilitate case detection. 
  
The cost effectiveness of the IVM strategy is measured by looking at the cost of preventing a death 
or case of disease or infection (incidence or prevalence) compared to the conventional VBD control 
strategy (see Box 9.4).   



















Although the simplified example in Box 9.4 only describes malaria, it is important to look at the 
impact of programmes on the number of disease cases or deaths occurring from all vector borne 
diseases in the area.  For example, if an area is endemic for both malaria and lymphatic filariasis, the 
costs and benefits (cases or deaths averted) of the individual programmes should be compared to 
the costs and benefits of the combined IVM programme.  When costing the IVM programme it is 
good practice to subtract any cost savings made through prevention of cases, for example inpatient 
treatment costs, although this information might be harder to obtain.   
The comparison of costs and effectiveness between conventional vector control and the IVM 
programme can be of 2 kinds: i) before and after comparison (conventional vector control 
programme versus IVM programme) or ii) comparison between IVM programme area and another 
area concurrently implementing conventional vector control.   
A conventional malaria vector control programme in a district involving use of LLINs is being 
replaced by an IVM programme which involves LLINs, larviciding and drainage of surface water.  
We want to compare the cost effectiveness of the two programmes. 
First we need to look at how the effective the programmes were in preventing malaria cases.  
Historically, before implementation of any vector control programmes there were on average 
1500 malaria cases.  Under the conventional vector control programme there were 1000 malaria 
cases in the district.  However, once the IVM programme was introduced the number of malaria 
cases in the district fell to 500.   
The next step is to look at the costs of the programmes.  The conventional malaria vector control 
programme cost on average $25,000 per year, while the IVM programme cost $40,000 per year.   
We can now calculate the cost per malaria case prevented:  
Programme Cost ($) Malaria cases 
prevented  
Cost per malaria case 
prevented ($) 
Conventional vector control 
programme 
25,000 1500 - 1000 = 500 25,000 / 500 = 50 
IVM programme 40,000 1500 – 500 = 1000 40,000 / 1000 = 40 
 
The IVM programme costs $40 per malaria case prevented compared to $50 for the conventional 
vector control programme.  So, in conclusion we can say that the IVM programme is more cost 
effective than conventional vector control.  Note that the IVM programme was actually more 
expensive than conventional vector control but being cheaper is not the same as being cost 
effective! 
  
More information on how to perform a cost effectiveness analysis is available [341]  
When looking at the cost effectiveness of an IVM programme in its early stages (for example in year 
1 or 2 of implementation) we need to bear in mind that start-up costs are likely to be higher than 
long run costs of the programme and so the cost effectiveness of IVM may initially look poor 
compared to a long-standing conventional vector control programme.  This phenomenon of high 
initial start-up costs but increasing cost effectiveness over time was observed in an analysis of 
environmental management and house modification for malaria control in copper mining 
communities in Zambia in the 1920s and 1930s [233].   
 Reducing insecticide use versus standard practice 9.5.3
Insecticide-based interventions such as LLINs and IRS are the mainstay of vector control for many 
VBDs.  However, diversification of vector control tools used through IVM may help to reduce 
insecticide use thus reducing the risk of developing insecticide-resistant vectors, the impact of vector 
control on the environment and adverse effects on health.  This can be systematically assessed by 
comparing the number of toxic units of insecticide used per disease case averted between standard 
vector control and the IVM programme.  The toxic units of insecticide measure is used rather than 
simply the volume of insecticide because some insecticides may be more toxic than others.  In order 
to measure this indicator it is important for programmes to keep good records of insecticides used.  
Further information on calculating the number of toxic units of insecticide used per disease case 
averted can be found in the WHO Monitoring & Evaluation Indicators for IVM booklet [269].  
 Sustainability of the IVM programme 9.5.4
Sustainability of the IVM programme can be measured in a number of ways.  The WHO Indicators for 
M&E document recommends assessing whether there is a strategy in place to ensure continued 
mobilisation of resources for vector control [269].  To measure this indicator an interview or survey 
should be conducted with the relevant government bodies and a copy of the relevant strategy 
document obtained.  The ‘institutional memory’ of VBD control programmes can also be assessed – 
for example are there standard operating procedures (SOPs) and training documents available to 
ensure the continuation of activities should key staff retire or leave the programme. 
Programmes with greater resources may also be interested in the social, institutional or political 
impact of the programme since these are important aspects which will influence whether the IVM 
programme is sustained (Box 10.6).  For example, community acceptability is a social impact of the 
programme – if interventions or the programme are not acceptable to the community then this will 
have a dramatic impact on programme success and sustainability.  Measuring social, institutional or 
political impacts of the programme will require specialised quantitative and qualitative techniques.  
More information on social research methods is given in Box 9.5 and in further reading [342, 343].  
Practical examples of where these types of techniques have been used to assess community 




Box 9.5: Social research methods for measuring social, institutional and political impacts of IVM 



























Social research methods allow us to look at and understand aspects of programmes in greater 
depth.  They help us to answer the ‘How?’ and ‘Why?’ questions.  The methods most commonly 
used in monitoring and evaluation are: 
Focus groups:   
A group of approximately 8-10 individuals is brought together to discuss a particular topic for 
approximately 60-90 mins.  The discussion is guided by a facilitator who normally has a topic guide 
(which lists down the topics they want to cover in the discussion) and guides the discussion by 
asking open-ended questions, for example “What is your opinion on the new vector control 
programme?”.   The discussion is either tape recorded or recorded by a dedicated note taker.  It is 
important to consider the participants in a focus group since people will be more likely to interact 
well if they see other participants as being like themselves.  Group interaction often means that 
data and insights are produced that might be less easily accessed in a one-to-one discussion.  
In-depth interviews:   
Interviews vary depending on how structured they are.  In un-structured interviews the pace, 
subject and questions vary according to the interviewee.  Structured and semi-structured 
interviews follow an interview guide consisting of a series of questions.  In structured interviews, 
the interviewer asks questions strictly according to an interview guide so that every respondent is 
asked the exact same questions in the same order.  More commonly used are semi-structured 
interviews where the interview guide is followed more loosely and the interviewer has freer rein to 
probe the respondent.  Interviews can be conducted by telephone or in person. 
Observations:  
There are 2 main types of observation: participant observation and direct observation.  In 
participant observation the observer becomes a member of the community or population they are 
trying to observe.  The observer participates in activities and observes how people interact with 
each other and other organisations.  Participant observation may be difficult in the context of a 
programme unless the observer is external.  A more useful technique may be direct observation 
where the observer watches activities but does not participate in them.  Their role can be covert 
(individuals being observed do not know the purpose and role of the observer) or overt (individuals 
being observed know the purpose and role of the observer).  If the population being observed are 
aware of the role of the observer, bias can be introduced if they change their behaviour in 



















Document review:  
Programme documents such as policies, meeting minutes, correspondence and routine records on 
clients or services are a useful source of information on programme activities and processes and 
can help generate questions which can be answered using other qualitative methods.  Document 
review has the advantage that you can review activities that have happened in the past and recall 
is not a problem since the documents were produced at the time of the event.    
Analysing Qualitative Data: 
Once you have qualitative data in hand whether this is from a focus group discussion or interview 
you should go through it to identify the main themes, see how often these  themes appear in your 
data and think about how themes are related i.e. are there patterns developing?.  There are 
specialised software packages which are available to help you organise and analyse your data, such 
as NVIVO, ATLAS.ti or EZ-text (downloadable for free from the CDC website: http://www.cdc-
eztext.com/).  It is often interesting to compare themes and patterns between groups or 
individuals.  For example, a focus group held with farmers who according to new IVM policy have 
to dry their fields once a week may have different views on the programme compared to members 
of a community group. 
Survey research: 
The first step in survey research is to produce the survey.  You should consider carefully the 
questions you want to ask, how you want to ask them and the order in which these questions 
should appear.  Questions can be closed (requiring simple yes/no answers) or open-ended 
(requiring longer free-text answers).  Surveys can be administered either in person using an 
interview or the respondent can fill out the questionnaire themselves.  It is also important to 
consider how you will sample your respondents – this can be probability sampling (e.g. simple 
random sampling, systematic random sampling) or non-probability sampling (e.g. convenience 
sampling or purposive sampling). 
 
  




























Community involvement plays a large role in the National Malaria Control Strategy in Kenya.  The 
Municipal Council of Malindi has created an environmental and mosquito control activity 
mandate under the national Primary Health Care programme.  Community groups, partly 
supported by government funds are responsible for environmental management tasks and 
implementation of malaria control activities. Community groups are involved with treating 
ditches, making and selling LLINs, draining stagnant water, organising clean ups, making and 
selling repellent neem soap and organising community campaigns such as the “Malaria Mosquito 
Day”.   
The study used key informant interviews, focus group discussions and a stakeholder meeting.  The 
idea was to determine which malaria control activities community groups were involved with and 
identify successes and obstacles to successful implementation of vector control.  Key informants 
from the Ministry of Health, Municipal Council of Malindi and the Ministry of Culture and Social 
Service, Gender and Sports were identified.  These key informants were interviewed by facilitators 
trained in participatory techniques.  A stakeholder meeting was held with representatives of 
community groups, NGOs, businesses and public offices responsible for organising vector control 
within Malindi.  Focus groups were held with 8 community groups randomly selected from a total 
of 19 groups identified as having a role in mosquito control.  The focus group discussions covered 
roles and responsibilities of community groups in vector control, operational constraints to 
effective control and challenges faced.  Focus group discussions were led by a facilitator and there 
was a separate note taker.  All discussions were recorded using a dictaphone as well.  Information 
was transcribed and explored to generate categories and explanations using a thematic 
framework.  Data collected using the three different methods were compared to see if similar 
themes were emerging. 
A number of challenges were identified which are potential barriers to sustainability of the 
community based vector control.  For example, support from the municipal council was identified 
as an important enabler.  Prior to 1999 a high degree of municipal support was provided in terms 
of training and guidance, equipment, monitoring and supervision and regularity of control 
activities declined following withdrawal of this support.  Community groups reported that this 
support and supervision was a motivating factor and made them feel recognised and appreciated.  
Another barrier identified was that projects did not generate sustainable income (e.g. ITN 
manufacturing and sales community group) and that volunteerism could not be sustained in the 
absence of income generation when the community group members themselves were poor. 
  











Intersectoral action is one of the key aspects of an IVM programme whereby actors and 
organisations from different sectors come together to take action against VBD.  It is therefore 
important to assess how intersectoral action is working and to learn from experience. 
The materials used by the WHO when generating case studies on intersectoral action to tackle 
social determinants of health provide some excellent guidance on describing and assessing 
intersectoral action. 
Some important questions are outlined below. 
APPROACHES: 
What mechanisms and tools were used to support intersectoral action?  For example: 
- information e.g. research, knowledge transfer, communication, evaluation results 
- institutional arrangements or mechanisms e.g. National Commission 
- financial mechanisms e.g. source of funding, budgeting structure 
- legislation and regulation 
- accountability frameworks or monitoring mechanisms 
- planning and priority setting 
What are the architectural arrangements of the intersectoral action / programme / policies?  For 
example: 
- Who were the principal actors responsible for influencing the policy decision, its 
implementation and evaluation?  What role did they play? NB: this role can be beneficial 
or non-beneficial! 
- What was the role of the health system/sector in terms of leadership, coordination etc? 
- What is the best descriptor of the level of integration?  See Box 10.9 for categories of 
integration.  
- Were there participatory mechanisms involved?  What were these mechanisms?  Who 
participates and what are their motivations?  Participation can be categorised as follows:  
Score  Classification Explanation 
0 Informing To provide the public with balanced and objective information to assist 
them in understanding the problem, alternatives, 
opportunities and/or solutions 
1 Consulting To obtain public feedback on analysis, alternatives and/or decisions 
2 Involving To work directly with the public throughout the process to ensure that 
public concerns and aspirations are consistently understood and 
considered 
3 Collaborating To partner with the public in each aspect of the decision including the 
development of alternatives and the identification of the 
preferred solution 







- What was the model of the relationship?  Examples of models illustrating the relationships 
are shown below.  Informal relationships could be depicted using dotted lines. 
 
- Were there budgeting and financing mechanisms that promote intersectoral action? What 
were these mechanisms e.g. funding pools? Which sector or entity proposed the 
mechanism and how was it set up? 
IMPACT AND LESSONS LEARNT 
- What were the actor’s responses to the process and outcomes, given their expectations? 
- How did the perspective of the health sector or other sectors change? 
- Did concerns about VBD become a stronger issue within the public, other sectors or the 
government due to this initiative? 
- What is the impact/role of data/evidence on VBD in stimulating action? 
- Which structures, mechanisms, platforms and incentives work well or poorly, and why? 
- How could implementation have been improved? 
- How can specific barriers be overcome, including those related to funding/budgets, 
personnel and skills mix etc. 
  






















9.6 A quality assurance framework for IVM  
Quality assurance (QA) is the implementation of systematic and well planned activities to prevent 
sub-standard services or products. Although this approach is commonly used in the manufacturing 
and other commercial industries, until now QA has not been well defined in the context of vector 
control. However, increasing pressure for greater accountability from donors and other stakeholders 
is prompting disease control and elimination programmes to move toward more formal and 
transparent methods of communicating: service quality standards;  the methods by which the 
probability of a successful programme outcome are increased; methods for performing monitoring 
An example of a simple method for assessing intersectoral action is provided by Owusu et al. 
(2013) who examined the degree and determinants of intersectoral action among organisations 
working in malaria control in two districts of Ghana (one urban and one rural).  The researchers 
interviewed representatives from 32 core institutions (16 from each district) engaged in malaria 
control in Kumasi metropolis and Ahafo Ano South district, including institutions from the health 
sector, agriculture, education, environment, economic/finance sectors and community groups.  
Institutions were selected based on a document review and consultation with representatives 
from the Ghana Health Service who oversee the implementation of health policies and 
programmes in Ghana.  The types of personnel interviewed included service providers, 
administrators, service users/community members (including local politicians). 
The researchers used a simple classification for the different levels of intersectoral collaboration: 
Score Classification Explanation 
0 Non-awareness Institution has no knowledge of another institution's malaria 
programmes 
1 Awareness Institution has knowledge of another institution's malaria control 
programmes, but does not participate in their activities 
2 Communication Institution has knowledge of another institution's malaria 
programmes and they only share information on their activities 
3 Cooperation Institution has knowledge of another institution's malaria 
programmes and not only shares information, but also shares ideas 
to guide and modify their own planning and activities 
4 Collaboration Institution has knowledge of another institution's malaria control 
programmes, they share both information and ideas and also jointly 
plan and modify delivery of service based on mutual consent 
 
The representatives from each institution were asked to rate their level of integration with the 
other institutions according to this scale and the results were inputted into a matrix.  This allowed 
the authors to compare how well each institution thought they integrated with other institutions 
(self-reported depth of integration) and the how well other members of the network thought the 
institution integrated (group-reported depth of integration).   
  
checks and assigning quality scores to assess programme performance, and standardised protocols 
that delineate how problems are identified and the feedback loops in place to effectively correct 
them.  
Good QA is a proactive approach which aims to maximize resources to increase the likelihood of 
programme success. Resources are valuable and sub-optimal quality outcomes and lack of impact 
can be traced back to an absence of quality assurance during the input, process and output phases 
of the programme.  If planned outcomes and impact are or are not achieved the QA approach 
ensures that the strategic and operational levels of a programme have sufficient information to 
either support the current strategy or make necessary changes. This type of structured approach of  
identifying strengths and weaknesses in the different programme stages can lead to innovative ways 
of dealing with challenges upfront and avoid the potentially devastating consequences of poor 
vector control management.  
 
Figure 9.2: Quality assurance of indoor residual spraying: filter paper on the wall used for 
measuring insecticide application (photo courtesy of S. Lindsay)  
The success of an IVM approach is largely dependent on quality assurance of individual interventions 
alone and in combination. Implementing multiple interventions without knowledge of the 
effectiveness of single interventions when properly performed is not necessarily a cost effective 
choice leading to better impact, and managers and stakeholders at strategic and operational levels 
should drive the QA agenda in order to gather this knowledge to support effective IVM. Risk 
communities who are the primary beneficiaries should be consulted to understand their 
expectations.   
Planning quality insurance for an IVM approach starts at a strategic level with the development of a 
quality assurance framework (QAF) document followed by operational guiding documents (QAG) 
(Figure 9.3).  
  
 
Figure 9.3: Quality assurance planning at strategic and operational levels. 
The QAF aims to strategically define the quality of IVM, describes the methods to ensure this quality 
throughout the process/system as well as action plans. From the QAF more detailed guidelines 
(QAG) will follow to assist with the breakdown of detail and facilitate operational implementation.  
Figure 9.4 is an extract of an example of a QA guide showing one IRS quality standard (>80 % room 
coverage), advocacy as an example focus area related to this standard, input, process and output 
factors associated with success or failure, tactics to minimize risk of failure, checks and scoring and 
the corrective action proposed if required.  
Many vector control programme objectives, activities, indicators and targets will feed into a QA 
framework and guide. Duplication of efforts should be prevented and it is advised that a dedicated 




Figure 9.4: Example of a section within QA guidelines for IRS, expanding on IRS advocacy as a focus area to achieve good room coverage. 
  
9.7 Data management for M&E 
Disease and vector surveillance will produce a vast quantity of data for the monitoring and 
evaluation of a programme.  Data needs to be integrated on entomology, epidemiology, 
interventions and other factors such as meteorological information.  In order for these data to be 
used to their full advantage for donor reporting, measuring progress and impact and evidence-based 
decision making it is important to establish a data management system (Figure 9.5).  Outputs of the 
system such as results of queries e.g. what was the coverage of LLINs in district X during the last 
universal coverage campaign and reports and also potentially maps if the programme has GIS 
capability.  These outputs can be used be operational staff and programme managers to trouble-
shoot, adapt and problem solve.  They can also be used to advocate to policy makers and for 















Figure 9.5: Schematic showing integration of data using a data management system 
An excellent summary of the setup of a health management information system (HMIS) is provided 
in the document: WHO Western Pacific Region (2004) Developing health management information 
systems: a practical guide for developing countries [349].  While this handbook is geared towards 
case data and the EPI system, many of the concepts are valid for vector control programmes and are 
summarised below. 
The first step is to consider the role of users in the hierarchy (Table 9.3) and the indicators they need 
to perform their function. 






















Table 9.3: Function of programme entity by administrative level 
 
The data collected and reported in the data management system should tie in with the indicators 
you are interested in for monitoring and evaluation of the IVM programme.  Looking at these 
indicators you should consider the source of information for the numerator and denominator and 
the frequency of data collection.  For example, for an LLIN universal coverage campaign coverage 
indicator you need to know is the number of vouchers distributed during the enumeration process 
(denominator) and how many LLIN were distributed (vouchers redeemed - numerator).  In another 
example, to measure disease incidence in a district you need to know the number of cases 
presenting at district health centres (numerator) and the corresponding district population (census - 
denominator).   
Not all data needs will be met by the routine system of data collection, as mentioned above.  There 
may be a need to do specific surveys for data required less frequently or required for only certain 
subsets of the population. 
It is important to consider the lowest level where computers will be used for data management.  
This depends on budget, technical ability of the staff entering the data, technical assistance available 
for system maintenance, data security and compatibility of software with existing hardware.   
Data collection and processing at lower levels is usually paper based although this may vary 
depending on the setting.  For example, field data collection can be paper based or in some cases 
control programmes may issue personal digital assistants (PDAs) or smart phones for electronic data 
collection.  Data collection tools need to be designed carefully and piloted before roll out.  It is 
important to keep tools simple!  Data consolidation and management at district, province and 
national should ideally be computerised. The data management system should ideally be overseen 
by staff with technical expertise with access to equipment such as computers and appropriate 
software.   
Data will need to be recorded and managed so that it flows from the periphery to the central level 
and then aggregated data needs to be fed back to provinces/district/local levels.  For example, data 
collection from individual sampling sites by field entomologists may be summarised in weekly 
reports by the district manager who reports to the provincial level authorities.  The provincial level 
authorities will report to national level managers on a perhaps monthly basis.  In addition, there may 
be non-health sector users and suppliers of data in this hierarchy.  For example, data on insecticide 
use in the agricultural sector should be provided by the Ministry of Agriculture and assessed 
alongside insecticide resistance data in disease vectors.   
Administrative level Function 
Village Case finding, service delivery, entomological surveillance, IEC and 
BCC, outbreak identification and response 
District Monitoring (case management, entomology, interventions) and 
supervision, operational planning, outbreak identification 
Province Evaluation, strategic planning (where appropriate), programme 
planning 
National Policy formulation, strategic planning 
  
The frequency at which data is reported to the next hierarchical level depends on the needs of the 
user and how often the phenomenon is observed e.g. weekly reports on larval abundance or a 
report on a LLIN coverage survey conducted yearly needs to be reported on a yearly basis.  As the 
data moves up the hierarchy it becomes more and more summarised so that a good overview can be 
obtained.  The most detailed data should be kept at the source level and reporting requirements 
should be kept to a minimum [349].   
It is important to conduct training so that data collection and management is of a high standard.  
Training should cover completion of forms, computer input, data analysis, interpretation and 
utilisation [349].   
When thinking about dissemination of the data it is important to consider the users of the data, 
what information should be disseminated, how often it should be disseminated and in what format,  
for example a written report, formal meeting or other mode of communication (Table 9.4).   
Table 9.4: Example of data dissemination activities (Adapted from [349]) 
 
At each level (district, province, national) data should be assessed, interpreted and there should be a 
feedback loop to inform operational activities.  Motivation of data producers is key to ensuring 
sustainability of the data management system and ensuring that high quality data is produced.  
Motivation can be increased by providing regular feedback (positive and negative) on data outputs.   
An example of a computerised disease data management system which is able to integrate data on 
entomology, case reports, surveys and intervention coverage is outlined in Box 9.9.   
  
Example of report/ 
activity 
To whom it needs to be 
disseminated 




Government Statistics Office 
Secretary of Health 
Malaria control programme 
managers and staff (including 
province and district) 






Malaria incidence by 
province  
National malaria control 
programme staff 
Health facilities 














Meeting Weekly (for 































The Innovative Vector Control Consortium (IVCC) has produced a Disease Data Management 
System (DDMS) which facilitates monitoring and evaluation (M&E) of VBD control programmes.  
Currently the DDMS supports M&E of malaria, dengue and visceral leishmaniasis, but allows the 
addition of other vector-borne diseases as well.  The system has been fully road-tested and is 
being used by a number of programmes including malaria control programmes in Bioko Island, 
Zambia and Ethiopia and the visceral leishmaniasis control programme in India.   
The DDMS uses open-source software which can be installed on a central server and accessed via 
an internet browser from remote computers.  It is a modular system comprising individual 
modules capturing information on case surveillance, entomological surveillance, survey data (for 
example from malaria indicator surveys) and intervention monitoring.  It also has modules which 
can be used for intervention planning and stock control. Data can be inputted into the system 
either directly or imported - a facility which is useful should a programme have historical data or if 
control programme staff are generating data in a different format or if they don’t have online 
access to the DDMS. 
 
Screenshot of DDMS interface and query builder (NB: Data is fictitious) 
The DDMS is also able to support decision making.  The data can be queried and reports generated 
easily, with clear visuals including graphs and maps.  Reports generated online are interactive and 
so it is possible to drill-down to the underlying data.  Maps can be used to show differences in 
intervention coverage, entomological indictors or clinical cases by geographic area and can display 
either polygons or individual point data, for example larval abundance at sampling sites where 
these have been geo-located using a GPS.  In addition, thresholds can be entered into the system 
to automatically flag and generate email alerts if, for example, there is an increase in cases in an 

























9.8 Making change, continue or stop decisions 
As noted previously, VBD dynamics and programme goals (e.g. control versus elimination) will 
change over time and so the IVM programme will also need to change in time.  Decisions on 
changing, continuing or stopping with a selected IVM tool should be based on thorough evaluation 
by the ISC who can advise the relevant departments.  These decisions need to be made after 
assessing the effect of the intervention on epidemiological and entomological outcomes, along with 
The system has been developed by Liverpool School of Tropical Medicine (LSTM) and IVCC and the 
team is able to provide training and technical support.  However, full country ownership of the 
system is preferred and it is possible to train up a technically savvy country programme staff 
member in several weeks that would then be able to administer and run the system in country 
with little additional support.  
 
 
Screenshot of reports showing multi-disease capability (NB: Data used to generate these reports is 
fictitious) 
  
information on a number of parameters including cost, cost effectiveness, human resources and 
feasibility.   It is also important to consider the receptivity and vulnerability of area to disease 




 Monitoring refers to the continuous tracking of programme performance and involves 
checking the progress against pre-determined objectives and targets.   
 Evaluation of outcomes and impact is used to determine whether programme activities 
were successful. 
 Disease specific programmes are likely to have their own monitoring and evaluation plans 
but these data should be collated into an IVM specific plan which covers 
intervention/disease-specific indicators and IVM programme-specific indicators (e.g. cost 
effectiveness, sustainability, intersectoral collaboration etc.). 
 Vector control activities under IVM should have a quality assurance framework.  
 Data management for monitoring and evaluation is hugely important and it should 
integrate data on disease surveillance, entomological surveillance, meterological 
information, and intervention coverage/use. 
 Change, continue or stop decisions on vector control should be made based on through 
evaluation. 
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Appendix 1: Tool for stakeholder analysis (adapted from [350])  
Step 1: Identify key stakeholders 
The first step is to brainstorm who your key stakeholders are in the IVM programme.  A stakeholder is a person or organisation that has something to lose 
or gain from a project.  They can be people who are affected by the programme, those who have influence or power over it or have an interest in its 
successful or unsuccessful conclusion.  
Step 2: List key characteristics of stakeholders 
The characteristics of each stakeholder should be detailed – in particular the name of the specific person in the organisation/group you are dealing with and 
the role of the stakeholder.   
Step 3: Prioritise your stakeholders  
 
Prioritise your stakeholders by considering their power/influence over the programme and 
their level of interest.  The matrix shown below will help you to think this through.  The power 
and level of interest of the stakeholders should influence the action taken with regards to this 
stakeholder.  For example, powerful and important stakeholders should be engaged closely, 
while stakeholders with less power and importance may only need to be monitored.   
 
Step 4: Understand your stakeholders 
 
The next step is to brainstorm what you know about your stakeholders.  How do they feel 
about the IVM programme?  What motivates them e.g. emotion, finance?  Who or what 
influences their opinion of the IVM programme?  Is their opinion based on good information?  
What is the best method of communicating and engaging with them?  What resources do they 
have?  How will you gain their support of the IVM programme or manage their opposition? 
 
 
Step 5: Develop a plan of action 
Finally you should develop a plan of action with regards to your stakeholders.  You should document the actions taken, who will be responsible for the 




An example of a fictitious stakeholder analysis for an IVM programme which is expanding to include drain rebuilding and maintenance is given below: 
Stakeholder Person Role Power/ 
influence 
Interest Action taken Responsible Timeline 
Ministry of 
Health 
 Delivering health 
services 
     
Ministry of 
Finance 
Mr. Ali Determining level of 
financial support to 
other govt. ministries 
High  Low  Lobby for increased funding for 
Ministry of Public Works 










maintenance of  drains 
High High  Lobby and educate on health benefits 
of filling and drainage.  Ensure filling, 
drain rebuilding and maintenance is 
prioritised and conducted in areas 








High Low Engage community leaders to promote 










Involved in regular 
‘clean up’ days 
Low High Encourage more regular clean up days, 
provide support to clean up days, 
including promoting health benefits 





 Refuse collection for a 
fee 
Low High Encourage refuse collectors to look for 
opportunities to make money from 
garbage disposal and recycling. 
District level IVM 
focal person 
 
Landlords NA Responsible for upkeep 
of housing / collect rent 
from tenants  
Low Low No action. - - 
Tenants NA Tenants Low Low  Ensure tenants are being reached 






Responsible for tax 
collection 
High Low Lobby for more efficient tax collection   
 
  
Appendix 2: Local determinants of disease 
Introduction 
The presence of Vector Borne Diseases (VBDs) depends on a complex interaction between 
pathogens, vectors, humans (animals in some cases) and the environment (Figure A2.1).  It is 
important to consider these determinants and their interaction to understand why diseases occur 
and point to ways in which to control them.  As a consequence of the interaction between these 
determinants, diseases can vary markedly in time and space.  Some diseases such as malaria may be 
more stable in their geographic distribution over time, while others such as dengue may be patchier 
in their distribution and vary from year to year.  Diseases may also be unequally distributed within 
the population because some individuals or communities may be more at risk of disease than others.  
Typically, 80% of the disease burden is experienced by 20% of the population [351].  For example, in 






Figure A2.1: The pathogen, vector, human, animals and environment depicted as five categories of 
determinants of vector-borne disease 
It is important to recognise that many determinants of disease are outside the scope and jurisdiction 
of conventional programmes for VBD control, such as irrigation systems, urban development, 
sanitation, and housing.  These determinants are still extremely important and call for coordinated 
action with other sectors and local communities. 
Vector 








The first step is to consider which parasites or pathogens cause disease and identify where VBDs are 
endemic in your area.  It is also important to consider medical options available for prevention (e.g., 
vaccines or preventive chemotherapy) or treatment of the disease.   Some questions for 
consideration are outlined in Table A2.1. 
Table A2.1 Identifying pathogen-related determinants of disease 
Question Rationale 
Which VBD are endemic in your area 
and are VBD co-endemic? 
A central tenet of IVM is to use evidence to plan and 
implement vector control.  Maps provided in this Toolkit 
provide an indication of what diseases are present and 
how they are distributed.  This should be supplemented 
with collection and analysis of epidemiological data to 
prioritise VBD control at lower levels. 
What medical options are available for 
disease prevention? 
Vaccines and preventive chemotherapy are available for 
some VBDs.  A vaccine is available for yellow fever 
(although this is mainly for travellers and may be out of 
reach for most residents of endemic countries) and 
vaccines are in development for some other diseases.  
 Preventive chemotherapy is the mainstay of control for a 
number of VBDs including onchocerciasis and lymphatic 
filariasis. For malaria, intermittent preventive treatment 
of malaria in pregnancy using sulphadoxine-
pyrimethamine (IPTp-SP) is recommended by the WHO in 
areas of moderate-to-high transmission [352].   The WHO 
also recommends the use of seasonal malaria 
chemoprevention in children aged 3-59 months in areas 
of highly seasonal malaria transmission across the Sahel 
sub-region [353]. 
Which parasites or pathogens cause 
disease? 
Diagnostic capability to distinguish between parasites 
Falciparum versus vivax 
Co-infection within an individual e.g. leishmaniasis and 
HIV 
What medical options are available for 
treatment? 
For some diseases, effective treatment is available and 
WHO guidelines on choice of drug and dosing should be 
followed.  Where drug treatment is available, vector 
control programmes should also have an awareness of 
whether drug resistance is developing or where 
counterfeit or sub-standard drugs are a problem.     
For some diseases, effective drug treatment is not 
available and only supportive care is provided e.g. dengue 





It is important to identify the dominant vectors of VBD in your area.  Vector distribution maps 
presented in this Toolkit will be of use here, but should also be supplemented by data collected in-
country, for example vector surveillance data from sentinel sites.  Identifying the relative abundance 
of vectors present in an area should be considered an ongoing activity since vector populations are 
rarely constant and new vector species may be introduced into your area e.g. Aedes albopictus - an 
efficient vector of chikungunya.  Here are a few questions than can be asked to gain key information 
on vectors in your country (Table A2.2). 
Table A2.2 Identifying vector-related determinants of disease 
Question Rationale 
What are the main local vectors? It is important to identify the main vectors since control 
programmes need to be tailored to the characteristics of 
individual vectors.  The species composition of vectors 
may change over time, for example due to climatic and 
environmental change and so regular re-assessment is 
necessary. 
Where and when do they occur? Vector control needs to be targeted in areas where and 
when the vector is present.  Habitat suitability and 
seasonal changes in weather e.g. temperature or rainfall 
are big drivers of vector abundance.   
What are the behavioural 
characteristics of vectors?  
 
e.g. diurnal activity pattern, endophily, 
anthropophily etc. 
Some control methods rely on key vector characteristics 
for their efficacy.  For example, insecticide treated nets 
are effective against indoor, night time biting mosquitoes.  
Indoor residual spraying is effective against mosquitoes 
resting indoors.   
Some vectors feed on both humans and other animals and 
here there may be potential to control the vector by 
targeting the secondary host.  For example Glossina 
(tsetse flies) of the morsitans group which are responsible 
for transmitting Rhodesian human African 
trypanosomiasis may be targeted by treating cattle with 
insecticides.   
The behavioural characteristics of vectors should be 
assessed regularly over time, since vectors may adapt 
their behaviour in response to control measures. 
Where and when do the vectors breed? Larval stages of vectors cannot run or fly away and so may 
be suitable targets for vector control provided that 
breeding sites are few, fixed and findable.  It is therefore 
important to identify where and when vectors breed and 
consider vector control tools against this stage.  For 
example, LSM could be considered against mosquito 
larvae for control of malaria or dengue or sandfly vectors 
breeding in rodent burrows could be targeted by residual 
insecticide. 
Are they susceptible to insecticides? It is important to monitor the susceptibility of vector 
populations to insecticides since if susceptibility is 
reduced vector control interventions may be less 
efficacious.   As well as presence or absence of insecticide 
resistance, the intensity of resistance and specific 
mechanisms involved should be investigated. 
  
 
Figure A2.1: Water storage jars provide excellent breeding sites for Aedes mosquitoes (photo 
courtesy of S. Lindsay) 
Human-related determinants 
Human related determinants can influence i) vector-human coexistence, e.g. poor housing 
conditions or population movement into new areas, ii) disease transmission e.g. non-use of 
preventive measures and iii) the infectious reservoir, e.g. population groups less resilient due to 
poor nutrition or co-morbidities, poor access to healthcare and effective drug treatment.   
It is important for the control programme manager to identify what human related determinants are 
present and how these conspire to make some population groups more at risk of VBD and more 
likely to fuel disease transmission.  These population groups should be targeted as a priority.  
Tackling many of these determinants will need involvement of other actors within the health sector 
and outside the health sector.      
Table A2.3 outlines some questions that can help define what the most important human-related 
determinants are. 
Table A2.3 Identifying human-related determinants of disease 
Question Rationale 
Where do the high risk groups live? Programmes should focus disease control activities where 
the high risk groups live.  On a large scale this information 
can be gleaned from the disease distribution maps 
included in the toolkit (Chapter 3).  On a smaller scale, 
programmes will need to identify where there are likely 
hotspots of disease.  This could be a dynamic situation, for 
example disease outbreaks in areas of economic or socio-
  
political instability.  On a routine basis, hotspots could be 
identified from health centre records, which alongside 
participatory mapping and community consultation is an 
effective method of determining risk factors.   
Where is infection most likely to occur? It is important to understand where transmission occurs 
in order to target control efforts here.  Is it in their home, 
when they travel or where they work?  This will require a 
deeper understanding of population movement and 
vector behaviour in the high risk areas. 
Are some population groups more 
susceptible? 
e.g. socioeconomic status, co-
morbidities, age, sex 
Low socioeconomic status is often associated with low 
economic resilience (e.g. availability of savings), poor 
nutrition and resilience against disease, poor housing 
conditions, high population density and overcrowding and 
poor sanitation and hygiene.  These are all risk factors for 
VBD transmission.  Disease control measures and support 
need to be targeted at these communities.  
Co-morbidities such as malnutrition or HIV infection may 
make individuals more susceptible to infection with vector 
borne pathogens and they may suffer greater 
morbidity/mortality as a result.  These morbidities need to 
be identified in the population and addressed. 
What are local practices and attitudes 
towards vector-borne disease? 
It is important to gain an idea of how local communities 
perceive and understand vector borne diseases since this 
may impact on their practices and behaviours.  For 
example, this may relate to risky behaviours and practices 
such as storage of water which may increase dengue risk 
(Figure A2.1), open defecation which can increase 
schistosomiasis or trachoma risk or washing/bathing in 
contaminated waters (Figure A2.2).  Alternatively, it may 
relate to non-use or poor adherence to preventive 
measures such as LLINs.    
What is their access to diagnosis and 
treatment? 
There are a number of factors to consider under access to 
treatment and diagnosis.  Firstly, health service capacity 
varies depending on the location.  In some countries, 
capacity in rural and remote areas will be lower than in 
more populated areas.  Barriers to access include also 
awareness of disease signs and symptoms, physical 
distance of the health facilities (public and private) from 
communities or pastoralist societies, costs (e.g. travel, 
user fees), gender dynamics and acceptability.  People 
may seek care in the public or private formal health 
sector, pharmacies and drug sellers or the traditional 
sector.  Availability of accurate diagnosis and effective 
treatment is likely to differ by sector.  Different groups, 
for example children and adults may seek care in different 
sectors or may use multiple sectors.  The importance of 




Figure A2.2: Increased schistosomiasis risk due to collection of water from potentially 
contaminated source, Lake Victoria, Kenya (photo courtesy of S. Lindsay) 
Environment-related determinants 
Understanding the environment around VBD hotspots is important because it may allow the control 
programme officer to target interventions in space and time.  For example, in areas of seasonal 
transmission LLIN distribution or IRS is best practiced at the beginning of the rainy season.  Here are 
some questions related to the environment that will help inform you (Table A2.4).  
Table A2.4 Identifying environmentally-related determinants of disease 
Question Rationale 
What are the local ecosystems? Different vector species are adapted to specific ecological 
settings.  More information on ecosystems and 
prevalence vector-disease complexes is given in Box 3.1.  
Recognising the different ecosytems allows one to get a 
rough idea of what vectors are present and their level of 
abundance e.g. Relatively low numbers of An. gambiae 
will be found in forest and urban areas as compared to 
rural areas.  The dengue vector Aedes aegypti is often 
associated with water storage tanks and discarded 
containers in urban areas. 
How is land used? Land use for agricultural purposes can alter vector 
habitats and increase the risk of VBD (Figure A2.3).  For 
example, commercial forest plantations create habitats 
suitable for tsetse flies.  High intensity agriculture (e.g. 
cotton-growing areas) often associated with pesticide use 
can lead to insecticide-resistance in the local vectors.  
  
Irrigation will often increase mosquito production.  This 
can lead to increased malaria in areas of unstable 
transmission, where people have little or no immunity to 
malaria parasites, such as the African highlands and 
desert fringes.  In areas of stable malaria transmission, 
irrigation will not generally increase malaria due to 
changes in the dominant vector species and increased 
wealth generated in these areas leading to better housing 
and increased use of personal protective measures [354].   
Urbanisation can also alter breeding sites leading to 
increases in VBD, including for example dengue.    
What are the weather patterns in your 
area? 
The life cycle of many vector species is dependent on 
rainfall and temperature.  Identifying the seasonality of 
disease transmission will provide you with information 
about when it is best to initiate control activities. e.g. in 
areas of intense seasonal transmission, LLIN distribution 
or mass drug administration (MDA) should be done at the 
beginning of the rains.  In the case of seasonal malaria 
chemoprevention (SMC), up to four doses are 
recommended during the malaria transmission season 
[353].  LSM using larvicides may have a role in suppression 
of larval habitats during the dry season in areas with cool 
seasons as in parts of Southern Africa [37] 
In areas where epidemics may occur such as dengue or 
malaria, it may be possible to prepare for outbreaks by 
closely monitoring the rainfall patterns and vector control 
interventions should be in place throughout the epidemic 
period. 
What is the extent and distribution of 
the breeding habitat? 
Where do vectors breed?  Is the habitat aquatic or not?  
Are there many breeding sites?  Are breeding sites large 
e.g. flood plains or large scale rice irrigation?  Are 
breeding sites relatively fixed and permament?  With this 
information in hand you will have a better idea of 
whether LSM is a potential control option. 
 
It is the combination of interactions between pathogens, vectors, humans and the environment that 
determine the range and abundance of VBDs.  Understanding these complex interactions allows the 




Figure A2.3: Anopheles breeding sites in irrigated ditches (photo courtesy of S. Lindsay) 
Animal-related determinants 
A number of VBDs are zoonoses, diseases that also occur in animals and therefore it is important to 
identify whether wildlife or domestic animals are carriers of vector borne pathogens.  For example in 
parts of Ethiopia visceral leishmaniasis is transmitted by sandflies from rock hyrax to people living in 
villages situated on river banks or rocky hills, the natural habitats of rock hyrax. Identifying 
settlements at high risk of zoonotic diseases would allow targeting of disease control. Some 
questions that would help identify high risk communities are shown below (Table A2.5).  In many 
cases it would be helpful to discuss these questions with local veterinarians and wildlife experts who 
may be able to provide up-to-date information that is locally appropriate. 
Table A2.5 Identifying animal-related determinants of disease 
Question Rationale 
What are the common species of 
wildlife present in your area? 
Wildlife are infected with many different pathogens, some 
of which may also infect humans. Birds, rodents, small 
mammals and ruminants can all act as reservoirs of 
infections for diseases of humans. For example 
rhodesiensis sleeping sickness can spill-over from wild 
ruminants (Figure A2.4), whilst gambiensis sleeping 
sickness is primarily a disease of people. 
What are the common species of 
domestic animals? 
In certain situations domesticated animals can harbour 
VBD pathogens. e.g. cattle can be reservoirs of infection 





Figure A2.4: Savannah tsetse flies commonly feed on buffalo (photo courtesy of S. Lindsay)
  
Appendix 3: Example M&E logframe for IVM programme tackling malaria and lymphatic filariasis in a rural 
area 
Goal: To have reduced morbidity and mortality from malaria and lymphatic filariasis in a cost effective and ecologically sound manner 
Goal Area Impact Indicators Data type Data source 
To have reduced 
morbidity and 
mortality from 
malaria and lymphatic 
filariasis using IVM in 






Total confirmed outpatient uncomplicated malaria cases (per 
1000 population per year) 
Numerical Health facility records 
Under 5 mortality rate (per 1000 live births per year) Numerical Vital statistics 
Slide / RDT positivity rate at health facility level Numerical Health facility records 
Malaria parasite prevalence Numerical Representative household surveys 
(DHS, MICS, MIS) 
Lymphatic filariasis 
infection 
Antigenaemia prevalence among endemic populations Numerical Household surveys 
Antigenaemia prevalence among under 5s Numerical School or household surveys 
Cost effectiveness Reduction in cost per case of disease averted per year Numerical Programme reports 
Ecological soundness Reduction in toxic units of insecticide used per case of disease 
averted per year 
Numerical Programme reports 
Sustaining resources 
for vector control 
Strategy in place to ensure continued mobilisation of resources 
for vector control 
Logical IVM Steering Committee meeting 
minutes 
 
Outcome  Outcome indicator Data type Data source 
Risk for transmission / effect on vector Reduction in density of An.gambiae measured over specified 
time period at sentinel sites 
Numerical Entomological surveys at sentinel sites 
Maintain high coverage and use of LLINs  Proportion of households with at least one LLIN Numerical Household survey 
Proportion of pregnant women sleeping under LLIN Numerical Household survey 
Proportion of U5 sleeping under LLIN Numerical Household survey 
Maintain high coverage with indoor residual 
spraying in the targeted areas 
Proportion of targeted households sprayed in past 12 months Numerical Household survey 
Proportion of targeted sleeping rooms sprayed in past 12 months Numerical Household survey 
Target a high proportion of productive vector 
breeding sites of vectors of both diseases with 
environmental management or larvicide 
Proportion of productive breeding sites drained or treated with 
larvicide 
Numerical Entomological surveys at sentinel sites 
 
  
Output Output indicator Data type Data source 
Universal distribution of LLINs through 
appropriate channels 
Number of LLINs distributed through mass campaigns Numerical Programme reports 
Number of LLINs distributed through health facilities Numerical Programme reports 
Number of nets retreated with insecticide Numerical Programme reports 
Number of BCC campaigns conducted to encourage correct use 
of LLINs 
  
Indoor residual spraying in the targeted areas Number of HHs (or rooms) sprayed in specified time frame (e.g. 
last 12 months) 
Numerical Programme reports 
Percentage of targeted HH covered by IRS Numerical Programme reports 
Volume of insecticides used in specified time frame (e.g. last 12 
mth) 
Numerical Programme reports 
Larval source management of vector breeding 
sites using draining or larviciding 
Number / volume of breeding sites that have been drained or 
treated with larvicide in specified time frame 
Numerical Programme reports 
 
Process Process indicator Data type Data source 
INTERVENTION SPECIFIC 
LLIN Number of people trained in distribution / retreatment  Numerical Programme reports 
Number of distribution points (community and health facilities) 
established 
Numerical Programme reports 
Number of LLINs guidelines distributed Numerical Programme reports 
Number of meetings held with stakeholders Numerical Programme reports 
Number of mass distribution campaigns implemented Numerical Programme reports 
IRS Number of target HHs mapped  Numerical Programme reports 
Number of spray operators trained Numerical Programme reports 
Number of IRS guidelines distributed Numerical Programme reports 
Larval source management Number of productive breeding sites identified Numerical Programme reports 
Number of larviciding operators trained  Numerical Programme reports 
Number of LSM guidelines distributed Numerical Programme reports 
IVM / SYSTEM SPECIFIC 
Training on IVM Number (and percentage) of staff trained in IVM Numerical Programme reports 
Human resources Number (and percentage) of staff with job descriptions that 
make reference to vector control 
Numerical Programme reports 
Advocacy, communication and social Number (and percentage) of sites at which campaigns on Numerical Programme reports 
  
mobilisation behavioural change on vector control were conducted 
Number (and percentage ) of villages in which communities have 
been mobilised for vector control 
Numerical Programme reports 
Planning and implementation Number (and percentage) of sentinel sites with functioning 
vector surveillance and insecticide resistance monitoring 
Numerical Programme reports 
Operational research Number (and percentage) of operational research priorities on 
vector control that have been addressed 
Numerical Programme reports 
Number of operational research outcomes on vector control that 
have been used in implementing programmes 
Numerical Programme reports 
 




LLIN guidelines developed Logical Programme reports 
Number of LLINs purchased Numerical Programme reports 
Number of retreatment kits purchased Numerical Programme reports 
IRS 
 
Number of spray equipment purchased Numerical Programme reports 
Volume of insecticide purchased Numerical Programme reports 
IRS guidelines developed Logical Programme reports 
Larval source management LSM guidelines developed  Logical Programme reports 
Volume of larvicide purchased Numerical Programme reports 
Number of spray equipment purchased Numerical Programme reports 
IVM / SYSTEM SPECIFIC 
Policy National IVM policy in place Logical Programme reports 
National policy on pesticide management in place Logical Programme reports 
National strategic and implementation plan on IVM in place Logical Programme reports 
Institutional arrangements National steering committee on IVM in place Logical Programme reports 
National coordinating unit on vector control in place Logical Programme reports 
Capacity building Certified training courses on IVM and judicious use of pesticides 
in place at national or regional level 
Logical Programme reports 
Organisation and management Standards for professions and careers in vector control and 
public health entomology in place 
Logical Programme reports 
  
 
